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ABSTRACT 
A mixture of different mtDNA molecules in a single sample is a significant obstacle to 
the successful use of standard methods of mtDNA analysis (i.e., dideoxy dye-terminator 
sequencing). Forensic analysts often encounter either naturally occurring mixtures (e.g., 
heteroplasmy) or situational mixtures typically arising from a combination of body fluids 
from separate individuals. The ability to accurately resolve and interpret these types of 
samples in a timely and cost efficient manner would substantially increase the power of 
mtDNA analysis and potentially provide valuable investigative information by allowing 
its use in cases where the current approach is limited or fails. Therefore, this research 
was aimed at developing a strategy for the use of Denaturing High-Performance Liquid 
Chromatography (DHPLC) as a developmentally-validated forensic application for 
resolving mixtures of mtDNA. To facilitate the adoption of this technology by the 
forensic community, a significant effort has been made to ensure that this technology 
meets the Scientific Working Group on DNA Analysis Methods (SWGDAM) 
developmental validation criteria and interfaces smoothly with previously validated 
methods of forensic mtDNA analysis. To do this, the method developed using DHPLC 
employs mtDNA amplicons, PCR conditions and DNA sequencing protocols validated for 
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use in forensic laboratories. These factors are essential in implementing DHPLC analysis 
in a forensic casework environment and for the admissibility of DHPLC and Linkage 
Phase Analysis in court. 
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Chapter 1: The Introduction 
§ 1 - 1 General Background 
When traditional genomic DNA analysis based on short tandem repeat 
(STR) loci fail to yield results, forensic analysts have sought alternative means in 
order to determine a genetic profile. Mitochondrial DNA (mtDNA) analysis has 
often proved to be a powerful analytical approach to such forensic 
investigations. Conventional DNA typing relies on high molecular weight nuclear 
DNA, which can degrade quickly and thus fail to yield sufficient probative 
information to investigators. In these cases, the abundance, small size and 
circular nature of mtDNA make it an attractive target for forensic analysis. The 
scientific basis for mtDNA analysis have been thoroughly tested and validated by 
the forensic community and standard operating procedures are in place for 
sample handling, amplification and data analysis. The high copy number per cell 
(hundreds to thousands of copies/cell), subcellular sequestration and 
exonuclease-resistant circular nature aid in the successful analysis of severely 
degraded or otherwise challenging samples (Budowle et al., 1999; Holland and 
Parsons, 1999). The small size of the amplification product obtained from 
mitochondrial hypervariable regions 1 and 2 (HV1 and HV2) also facilitates the 
analysis of challenging evidentiary material. This has been helpful in solving cases 
such as the identification of skeletal remains from the Vietnam War (Holland et 
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al., 1993); identification of bone material from a grave in Yekaterinburg, Russia, 
thought to belong to Tsar Nicholas II (Ivanov et al., 1996); and the identification 
of shed hairs from robbery caps (Allen et al., 1998). 
Developments based on these and other studies have resulted in an 
accepted approach to mtDNA analysis that has withstood several court 
challenges (e.g., State v. Council, 335 S.C. 1, 515 S.E.2d 508 (S.C., Apr 05 (The 
State v. Donney S. Council, 1999)) (NO. 24932), People v. Klinger, 713 N.Y.S.2d 
823, 2000 N.Y. Slip Op. 20450 (N.Y.Co.Ct., Sep 05 (People v. Micheal Klinger and 
Raymond Klinger, 2000)) (NO. 0849/00), State v. Ware, 1999 WL 233592 
(Tenn.Crim.App., Apr 20 (State of Tennessee v. Paul William Ware, 1999)) (NO. 
03C01-9705CR00164)). 
§ 1 - 1.1 Mitochondrial DNA Genetics 
The two strands of the ≈16Kb human mtDNA genome differ considerably 
in their base composition. The heavy strand is rich in guanine and the light 
strand, rich in cytosine. A duplicated stretch of the heavy strand exists as an 
independent fragment (7S DNA). This fragment binds to the D-loop where it 
participates in the formation of a triple helical DNA structure. The sequence of 
the mitochondrial genome encodes a total of 28 genes on the heavy strand and 9 
genes on the light strand. Of these, 22 encode mitochondrial tRNAs, two encode 
rRNA components (16S and 23S) of mitochondrial ribosomes, and the remaining 
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thirteen are templates for mRNAs that direct the synthesis of polypeptide 
subunits that contribute to the structure of mitochondrial respiratory complexes.  
The mitochondrial genome contains very little non-coding sequence (7%), 
in contrast to the nuclear genome where approximately 97% of the sequence is 
thought not to be expressed. The 37 genes of the mitochondrial genome lack 
introns, are nearly contiguous with each other, and even overlap in some cases. 
With the exception of one or two non-coding bases that often exist between 
neighboring genes; the only significant non-coding region of the mitochondrial is 
the displacement loop also known as the D-Loop. This region of triplex DNA, also 
known as the “control region”, contains the origin of replication for the heavy 
strand and the predominant transcriptional promoters for the generation of 
large multigenic transcripts. Portions of this region, designated hypervariable 
region 1 (HV1) and 2 (HV2), are of particular forensic utility because of the high 
degree of sequence polymorphism they exhibit within human populations. A 
third region, hypervariable region 3 (HV3), has also been described and is used 
only by a handful of laboratories and then only to try and differentiate 
indistinguishable HV1/HV2 samples (Lutz et al., 2000; Bini et al., 2003). 
The mitochondrial sequence database MITOMAP (www.mitomap.org) 
which maintains a list of published mtDNA polymorphisms currently lists 845 
polymorphisms (as of January 28th, 2011) that occur throughout the 674 bases of 
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the forensically informative HV1 and HV2 regions. Single base substitutions (56% 
transitions and 33% transversions) account for the overwhelming majority of 
these polymorphisms, although insertions and deletions are also seen. Even 
though many of these polymorphisms are seen only infrequently or are limited to 
specific ethnic populations, pair-wise comparisons of mtDNA sequences for both 
hypervariable regions between maternally unrelated individuals usually reveal 
multiple sequence differences. Based on studies of 4839 unrelated individuals 
the highest amounts of sequence diversity recorded are observed in populations 
of African extraction with an average of 14.5 sequence differences between 
individuals (Monson et al., 2002). The lowest diversity was seen in Caucasians 
where an average of only 7.9 differences has been reported between individuals. 
Even so, the most common HV1/HV2 haplotype found in Caucasians account for 
approximately 7% of the population. Only 12 additional haplotypes are found at 
frequencies greater than approximately 0.5% (ignoring C-stretch polymorphism 
in HV2). 
By some estimates, mutations arise and are fixed in the mitochondrial 
genome at a rate approaching twenty times that of equivalent sequences in 
nuclear genomes (Parsons et al., 1997). A number of factors have been proposed 
to account for this degree of sequence instability including an inefficient system 
for DNA repair, oxidative damage, and the greater number of replicate cycles 
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that mtDNA undergoes relative to nuclear DNA during cell growth and 
development (Pinz et al., 1995; Shadel and Clayton, 1997; Dianov et al., 2001). 
§ 1 - 1.2 Inheritance Issues 
The mitochondrial genome is maternally inherited thus an individual’s 
haplotype is a direct reflection of the up to 100,000 copies of the mitochondrial 
genome present in the oocyte at fertilization. The preponderance of evidence 
examined to date suggest that in most individuals, in spite of an accelerated 
mutation rate, the majority of mtDNA molecules within any single individual at 
maturity will still be represented by a single sequence (homoplasmy). 
Occasionally, a de novo mutation may arise and proliferate within the mtDNA 
population resulting in the existence of two distinct haplotypes within a single 
individual (heteroplasmy). This should theoretically, increase the discriminatory 
power of forensic mtDNA analysis by providing an additional character state for 
inclusion in the haplotype. This was the case for forensic analyses of mtDNA that 
were used to help identify the putative remains of Czar Nicholas II exhumed in 
1991 from Yekaterinburg, Russia (Ivanov et al., 1996). Haplotyping of bone 
fragments suspected of being those of Czar Nicholas revealed a rare 
heteroplasmic mixture of mtDNA at position 16169 in HV1 where C and T 
appeared to account for about 70% and 30% of the mixture, respectively. 
Haplotyping of mtDNA from the exhumed remains of the Czar’s brother Grand 
Duke Georgij's revealed a similarly rare heteroplasmic mixture of C and T at 
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position 16169. When combined with sequence identity throughout the 
remainder of the D-loop, the inclusion of a shared heteroplasmy significantly 
strengthens the weight of the mtDNA match. In practice, however, the 
overlapping peaks seen in direct sequencing data from the PCR-amplified mtDNA 
of heteroplasmic individuals often complicates interpretation of the 
electropherogram. In cases of near equal mixtures of mtDNA, such positions are 
often discarded by the analysis software or the analyst as ambiguous bases. In 
other cases, the position may be subjectively called by an experienced DNA 
analyst. The exclusion of a base from consideration results in a decrease in 
discriminatory power. 
§ 1 - 1.3 Mutation Rates 
Due to the lack of recombination and the lack of highly effective DNA 
repair mechanisms, mtDNA provides an excellent opportunity to investigate 
human evolution and migration. Mitochondrial genetics, due to strict maternal 
inheritance, enables researchers to gain a higher resolution perspective on 
modern human population structures and divergence times (Cann et al., 1987; 
Ingman et al., 2000) than would be possible based on nuclear markers. More 
significantly, this makes it possible to divide humans into a collection of mtDNA 
haplogroups which can be used as biogeographic indicators of genetic 
populations. 
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The high rate of nucleotide substitutions in mtDNA has been of interest in 
the scientific community for some time. Various contributing factors have been 
proposed to explain this. These include the oxidative environment of the 
mitochondria, and insufficient repair mechanisms (Shadel and Clayton, 1997). 
Poor DNA replication activity could also be raised as a contributing factor, since 
only one DNA polymerase is dedicated to mtDNA replication. While polymerase 
gamma (γ), a high fidelity polymerase, with 3’-5’ exonuclease activity (Copeland 
and Longley, 2003), would not be predicted to result in high mutation rates, 
oxidative damage can cause misincorporation during DNA replication (Pinz et al., 
1995). Additional DNA repair mechanisms include nucleotide excision and base 
excision repair. Nucleotide excision repairs (NER) restores the majority of UV-
induced DNA damage (e.g. thymine dimers) by removing a short section of single 
stranded DNA surrounding the lesion. This is subsequently filled in by DNA 
polymerase using the opposite strand as a template. Base excision repair (BER) 
restores the integrity of DNA bases that have been modified by deamination or 
alkylation, causing incorrect base pairing. This is achieved by removing the 
modified base to yield an abasic site. This is subsequently filled in by DNA 
polymerase much as is the case for NER (Friedberg et al., 1995). While BER 
appears to be efficient in the mitochondria, NER is not as well developed 
(Clayton et al., 1974; Dianov et al., 2001).  
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Human mtDNA recombination and the possibility of paternal inheritance 
have been topics of discussion in recent years. There is a lack of evidence 
supporting recombination of human mtDNA and periodic reports in the literature 
claiming recombination of human mtDNA have been strongly criticized as being 
due to sequencing errors, incorrect phylogenetic construction due to 
assumptions of hypothetical ancestral haplotype extinction and rejection of 
mutational hot spots (i.e., sites within the mitochondrial D-loop which mutate 
even more rapidly than others in the same region) (Budowle et al., 2003). The 
inability to even detect recombination of mtDNA has been largely unsuccessful, 
even in experiments where hybrid cells are formed from two donors (Shadel and 
Clayton, 1997). If, in fact, recombination does occur, it would appear to be 
extremely rare. The same can be said for paternal inheritance of mtDNA. Initial 
claims were reported by Hagelberg et al., where a rare mutation was detected in 
three unrelated populations within one geographic origin. This could only be 
explained by paternal leakage and recombination. The paper was later retracted 
due to sequencing alignment errors, but the argument continues as reports of 
paternal mitochondria entering the egg have periodically appeared in the 
professional literature (Cummins, 2000). Even in cases where this might occur, 
however, the paternal mtDNA sequence would be rapidly and enormously 
diluted since unfertilized eggs have been reported to have as many as 100,000 
mtDNA genomes (Chen et al., 1995). Furthermore, selective destruction of sperm 
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mitochondria by the developing zygote due to ubiquitin tagging which takes 
place during spermatogenesis would appear to effectively eliminate the potential 
for paternal leakage (Sutovsky et al., 1999).  
A single case of paternal leakage has, however, been reported in the 
literature (Schwartz and Vissing, 2002). In this case, the subject suffered from 
mitochondrial myopathy as a result of a novel 2bp deletion in the gene encoding 
for a subunit of the enzyme complex I of the mitochondrial respiratory chain. It 
could be that the pathogenic mutation conferred a selective advantage allowing 
it to escape destruction. Additional studies of individuals suffering from the same 
muscle disease have, however, failed to identify any evidence of paternal 
transmission of mtDNA (Filosto et al., 2003; Johns, 2003; Taylor et al., 2003).  
§ 1 - 2 Forensic Assessment and Validation Standards 
Ever since scientific evidence became an integral part of the criminal 
justice system a question of whether the evidence is trustworthy and based on 
accurate and consistent scientific methods has been asked. In order to be 
admissible to a court of law, any item of evidence must be obtained, presented 
and analyzed in a manner that is generally accepted in the scientific community. 
Ever since 1923, following a decision by the District of Columbia Court of 
Appeals, and subsequently referred to as the Frye standard (Frye v. United 
States, 293 F. 1013, 1014 (D.C. Cir. (Frye vs. United States, 1923)), a technology 
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or methodology cannot be considered admissible until it has been widely 
accepted by the relevant scientific community. The Frye standard, however, was 
and still is criticized for being overly restrictive, as it can dismiss testimony based 
on novel but credible scientific approaches which have yet to gain wide 
acceptance as measured by the professional literature. As the speed of scientific 
development increases, this imposes a significant obstacle for newer 
technologies. 
As a result of Daubert vs. Merrell Dow Pharmaceuticals, Inc. (509 U.S. 579 
(Daubert vs. Merrell Dow Pharmaceuticals, Inc., 1993)) the rules of general 
acceptance have been broadened such as to allow for admission of scientific 
technologies and resulting evidence that are lacking in broad acceptance in the 
scientific literature. Known as the Daubert standard, admissibility requires that 
the technology rest on sound scientific footing; that it has been thoroughly 
tested and validated; that it has representation in the peer review literature and 
that it has an established error rate. The change to the Federal Rules of Evidence 
in 2000 cemented the evolving Daubert standard, bringing into practice rules 
that not only outlined the standards associated with the evidence, but also the 
testimony of expert witnesses based around that evidence. 
Testability of the scientific methods must be obtained through extensive 
validation studies performed within the laboratory as well as between 
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laboratories. In terms of DNA validation studies, several agencies have published 
explicit guidelines on factors to be taken into consideration when performing 
them and the specific experiments to be conducted. Results of the validation 
studies are used to determine the error rates necessary for the method to be 
considered scientifically sound. Data from validation studies are then published 
in peer review journals. 
The Scientific Working Group on DNA Analysis Methods (SWGDAM) has 
published revised developmental validation guidelines for the implementation of 
new forensic DNA analysis technologies (SWGDAM, 2004). For the purpose of 
mtDNA mixture analysis, previously validated procedures for mtDNA analysis on 
genetic markers, species specificity and amplification conditions were not 
repeated as they were not germane to the application being developed. 
However, reproducibility, sensitivity and accuracy of the mixture separation 
method in question were determined in accordance with the established 
guidelines and the previously validated amplification procedures and conditions. 
§ 1 - 2.1 Current Approaches to Forensic Analysis of mtDNA 
In contrast to the majority of forensic DNA profiling methods that rely on 
the identification of length polymorphisms in nuclear DNA, mtDNA profiling 
relies on direct examination of DNA sequence from an extra-nuclear molecule of 
DNA. With rare exception (Iwabe and Miyata, 2001), mtDNA is present in the 
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cytoplasm of virtually all eukaryotes. In humans, the mitochondrial genome is a 
single circular molecule of DNA typically consisting of 16,569 base pairs 
(Anderson et al., 1981). The majority of human cells contain several hundred to 
thousands of copies of the mitochondrial genome such that the total compliment 
of mtDNA accounts for as much as 0.5% of the DNA in a nucleated cell. The 
abundance of mitochondrial molecules makes mtDNA an especially robust target 
for forensic analysis since it can often be amplified from tissues where sufficient 
amounts of chromosomal DNA may be absent (e.g., hair shafts and 
environmentally degraded tissues). 
The profiling of human mtDNA is achieved by comparison of DNA 
sequence data to the revised Cambridge Reference Sequence (rCRS) (Anderson 
et al., 1981; Andrews et al., 1999) (Figure 1.1). Differences are noted and 
reported by indicating the nucleotide position and the identity of the altered 
base. Automated DNA sequencing of PCR-amplified hypervariable regions of 
mtDNA is the current method of choice for forensic analysis. Amplification of the 
HV1/HV2 regions of the D-loop is achieved by use of up to four pairs of PCR 
primers (Wilson et al., 1995). For hairs without follicle tissue or for degraded 
tissues where severely fragmented or low levels of mtDNA are likely to be 
present, all four primer pairs are employed. Two primer pairs amplify HV1 to 
yield overlapping products of 278 and 271 base pairs, respectively. These primers 
pairs are designated L15997/H16236 (defining HV1A) and L16159/H16391   
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Figure 1.1: Schematic representation of the circular human mitochondrial DNA 
genome showing the locations of the D-loop and genes encoded by the circular 
genome. The D-loop region is divided into two large fragments, HV1 and HV2 
(433 and 401bp, respectively) which for forensic purposes are further divided 
into two amplicons each (HV1A, HV1B, HV2A and HV2B). These smaller 
fragments are amplified using the primers listed in table 2.1. 
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 (defining HV1B) where “H” and “L” refer to the heavy and light strand and the 
number indicates the base position of the primer relative to the Anderson 
sequence (Anderson et al., 1981; Budowle et al., 2000). Two other primer pairs 
(L048/H285 defining HV2A and L172/H408 defining HV2B) amplify the HV2 
region to yield overlapping products of 278 and 277 base pairs, respectively 
(Figure 1.1). 
Additional primer pairs have been developed and are currently in use in 
the forensic community. The Armed Forces DNA Identification Laboratory 
(Rockville, MD) has developed primer sets which include “mini-primers”. These 
are sets of amplification primers optimized for amplification of severely degraded 
remains. These further divide the mtDNA hypervariable regions into eight 
overlapping regions maximizing the potential to amplify target sites from highly 
fragmented mtDNA molecules (Gabriel et al., 2001). 
The PCR amplified fragments serve as templates for DNA sequencing by 
the dideoxy chain termination method (Sanger et al., 1977). The DNA templates 
are cyclically denatured and nascent strands of DNA are synthesized in the 
presence of fluorescently labeled dideoxyribonucleotide terminators. The use of 
PCR and laser-induced fluorescence for sequencing makes it possible to analyze 
extremely minute quantities of evidentiary material.  
15 
 
Alternative sequence detection/screening technologies for the analysis of 
mtDNA have been investigated. In recent years, these include the use of 
immobilized sequence-specific oligonucleotide (SSO) probes (Reynolds et al., 
2000; Gabriel et al., 2001), microarrays (Fukushima, 1999) and time-of-flight 
mass spectrometry (Butler and Becker, 2001). These approaches are limited to 
the detection of polymorphisms for which the researcher has a priori knowledge. 
Thus, it is often necessary to design additional probes in order to detect novel or 
population-specific polymorphisms. 
§ 1 - 2.2 Mitochondrial DNA Validation for Forensic Casework 
Validation studies have been performed for consistency in mtDNA 
profiling. These span a variety of tissue types, varying degrees of degradation and 
environmental contaminants as well as cross amplification testing between 
species (Wilson et al., 1995). Sequencing results were obtained for known 
samples of hair and blood as well as blood and semen stains on various 
substrates. These substrates included fabrics, such as nylon and denim, carpet, 
leather, wallboard and wood, all of which represent frequently encountered 
types of evidentiary material. To test the detection capabilities of the 
amplification process with degraded material, tissue samples were incubated at 
room temperature for a number of weeks prior to DNA extraction. Sequences 
were also obtained from blood subjected to environmental contaminants 
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commonly encountered in a forensic context such as used motor oil, gasoline, 
soil, detergent, NaOH and acetic acid.   
Additional validation studies tested the cross-reactivity of the human 
specific primers on non-human samples, such as rabbit, chicken, goat, horse 
among others, as well as several species of primates (macaque, orangutan, 
Celebes ape and gorilla). Macaque, orangutan and gorilla yielded amplifiable 
products; however, sequencing results on 215 bases from gorilla yielded 37 
polymorphisms and 5 insertions when compared to the human reference 
sequence. For the same region, a database search of 1907 human sequences 
revealed that the greatest number of polymorphisms observed was 13. 
Haplotyping of hairs subjected to a variety of treatments was performed 
as part of the validation study. DNA extracts were prepared from hair treated 
with conditioners, dyes and microscopic mounting media, as well as hair 
contaminated with dirt and body fluids. Hair samples were recovered from 
deceased individuals as well as from various areas of the head and body. Due to 
the rudimentary extraction procedures as well as insufficient knowledge of the 
ease of mtDNA cross-contamination at the time of the validation study, reagent 
blanks and negative controls frequently resulted in amplification at a level 
greater than 10% of the amplified product from the known sample. This was 
most likely due to reuse of grinding vessels employed during the extraction 
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process. For samples that were not contaminated, the haplotypes obtained 
matched the donor’s blood sample haplotype in all cases. Current interpretation 
guidelines, however, still follow the 10% “contamination standard”, where the 
presence of underlying peaks in the sequencing electropherogram are 
considered dye-terminator artifacts as long as they account for <10% of the 
major peak. Due to improvements in sample extraction protocols, cross 
contamination between samples has been significantly decreased from that 
reported in the original DNA extraction validation studies. For example, the 
contamination rate was determined to be 2.4% based on an analysis of 1218 
casework extractions. Furthermore, in no case was contamination seen for all 4 
amplification reactions needed for complete mtDNA haplotyping (Melton and 
Nelson, 2001).  
Thus, the original mtDNA validation studies showed that PCR 
amplification and subsequent sequencing of PCR products is a reliable method 
for mtDNA typing from hair, blood and semen. Although significant 
precautionary methods must be employed to minimize the potential for sample 
contamination during processing, the approach yields reproducible and 
dependable results. 
Sequence analysis of mtDNA has since then been used to identify 
weathered skeletal remains for which nuclear DNA analysis had failed (Holland et 
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al., 1993). In these cases, bone samples were pulverized and the DNA was 
subsequently isolated (Hochmeister et al., 1991) and sequenced for direct 
comparison to known maternal reference samples. Identification of skeletal 
remains, through mtDNA typing has since become a mainstay of the Armed 
Forces DNA Identification Laboratory, giving closure to families of soldiers that 
have gone missing in action. 
§ 1 - 3 The Problem of Mitochondrial DNA Mixtures in Forensics 
While mtDNA analysis is usually advantageous in a forensic context 
(Wilson et al., 1993), mtDNA sequence data can also be compromised by 
contaminating DNA (i.e., DNA from a minor source contributor) (Wilson et al., 
1995; Budowle et al., 2000). As pointed out previously, studies to date suggest 
that as long as the contaminating DNA accounts for less than 10% of the 
amplified product it will not compromise the accuracy of sequencing results 
obtained for the major source amplicon. While this makes sequencing somewhat 
“tolerant” of low-level DNA contamination, it also prevents the accurate 
detection and characterization of many cases of sequence heteroplasmy (i.e., 
those where the heteroplasmic sequence is <10% of the major haplotypes). 
Conversely, the presence of one or more DNA sequence variants (especially 
length variants) at levels greater than 10% of the amplified major source product 
makes interpretation of sequence data difficult if not impossible. The challenge 
of analyzing mtDNA mixtures is one of the most significant obstacles to the 
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broader use of mtDNA in forensics. Mixtures can be either “natural” (i.e., 
heteroplasmy within an individual) or “situational” (i.e., resulting from a mixture 
of DNA from multiple unrelated individuals). In forensics, natural or situational 
mixtures of mtDNA molecules that differ by sequence or length can prevent an 
analyst from being able to determine the true level of discrimination between 
sequences that are thought to “match” (Fourney, 1998). Variations in DNA 
sequence result in ambiguous base calls while variations in DNA length result in 
large stretches of unreadable sequence data (Figure 1.2). In these cases, an 
analyst can try to employ additional sequencing primers in an effort to obtain 
readable sequence from amplicons that flank rather than traverse the site of the 
length variant. Even when this approach works, however, the total amount of 
sequence data that can be used to characterize a given haplotype is reduced 
(Holland and Parsons, 1999). 
Extensive casework records indicate that a significant proportion of hairs (20.1%) 
are either heteroplasmic or display a mixed profile (Melton et al., 2005). 
Moreover, the occurrence of non-heteroplasmic mixed mtDNA profiles appears 
to increase with the age of a sample and is usually not ameliorated even when 
following extensive validated cleaning methods (Melton et al., 2005). This, 
however, is likely to represent only the “tip of the iceberg” since samples which 
are suspected to contain mixtures are usually not accepted for analysis. 
Therefore, a reliable means of identifying the individual sequences within a  
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Figure 1.2: DNA Sequencing electropherogram showing ambiguous base calls as 
indicated by overlapping electrophoretic peaks (arrows in Figure 1.2A) and 
unreadable sequence data resulting from a mixture of mtDNA length variants 
(Figure 1.2B). Length variants cause the sequence to fall out of register beginning 
at the site of the insertion/deletion that produces the variation in length.  
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mixture could greatly aid investigators by increasing the range of casework 
samples suitable for mtDNA testing. 
§ 1 - 3.1 Current Strategies for mtDNA Mixture Separation 
In forensics, medical diagnostics and basic research, the accurate 
detection of DNA sequence variation is critical. Its excellent resolving power has 
long made polyacrylamide gel electrophoresis through slab gels or capillaries the 
technology of choice for DNA sequencing. The mobility and separation efficiency 
of nucleic acid fragments in these systems, however, can be adversely influenced 
by the conductivity difference between the analyte and the surrounding buffer 
unless measures are taken to ensure efficient removal of salts from the sample. 
Additionally, the denaturing gel systems that are the mainstay of mtDNA typing 
are often incapable of producing useful data from mixed populations of 
molecules that either differ in sequence but are identical in length or that are 
nearly identical in sequence but which contain at least one length polymorphism, 
(e.g., cases of mtDNA sequence and length heteroplasmy). 
Several alternative strategies have, therefore, been proposed to separate 
DNA mixtures. These include denaturing gradient gel electrophoresis (DGGE) 
(Hanekamp et al., 1996), single-strand conformational polymorphism (SSCP) 
(Barros et al., 1997) analysis and sub-cloning into bacterial vectors (Hatsch et al., 
2007). These approaches are generally time consuming, necessitate multiple 
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handling steps, require laborious product purification and are not readily 
adaptable to automation. These factors have all been obstacles to the 
implementation of these technologies by forensic laboratories. Both DGGE and 
SSCP require manual recovery of fractionated DNA from polyacrylamide gels and 
a second round of PCR amplification to generate enough template for DNA 
sequencing. This poses a significant problem in a forensic context as 
reamplification of PCR products increases the risk of contamination and effects 
of polymerase-mediated nucleotide misincorporation events. Also, in 
comparative studies, SSCP is only able to detect mixtures in 50-97.5% of samples 
depending upon the length and base sequence of the analyzed fragment (Gross 
et al., 1999; Dobson-Stone et al., 2000). Similar results were found for other 
methods including DGGE (Liu et al., 1998; O'Donovan et al., 1998; Jones et al., 
1999).   
Subcloning is an even more time and labor-intensive approach. It would 
require forensic scientists to screen and sequence DNA from multiple 
transformed bacterial colonies to ensure that observed sequence differences 
reflect genuine contributors to the starting template rather than artificial 
variants that were introduced as a result of DNA nucleotide misincorporation by 
the Taq polymerase used for PCR. While alternate methods (e.g., sub-cloning) 
could readily separate the contributors to a mixture, such approaches are time 
consuming; contamination prone due to increased sample manipulation and 
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interpretation of the resulting data can be compromised by artificial sequence 
variants that frequently arise. 
§ 1 - 3.2 The Current State of DHPLC Technology 
Denaturing HPLC, widely used in medical research, is an accurate method 
for rapid, low-cost detection of DNA mixtures and fractionation into their 
individual components in preparation for subsequent characterization by direct 
DNA sequencing. While doing so, DHPLC addresses the limitations of the 
alternative strategies described above. Forensic laboratory implementation of a 
commercial DHPLC analysis system can be achieved with minimal training at a 
very reasonable startup cost that is comparable to that of existing DNA 
sequencing technologies. Seamless incorporation, integrated software and 
minimal sample consumption also allow for a high degree of automation and 
streamlining of sample processing and analysis. Finally, the reagent cost for 
DHPLC analysis is significantly less than that for alternative approaches. 
Denaturing HPLC is a method of comparative nucleic acid sequence 
detection that employs crude PCR products and which is not compromised by the 
presence of salts or sequence/length heteroplasmy. As originally developed, the 
technique allows comparative sequence analysis based on the chromatographic 
separation of denatured and renatured nucleic acids. DHPLC enables the 
fractionation and subsequent recovery of a DNA mixture on the basis of either 
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nucleotide sequence or length. Thus, it is possible to isolate and identify the 
individual contributors to a mixture even in cases where two DNA molecules are 
identical in length but differ in sequence. The fundamental principle that makes 
this possible is Temperature Modulated Heteroduplex Analysis (TMHA). This 
process separates DNA molecules into a series of discernable chromatographic 
peaks (Huber et al., 1993) (Figure 1.3). The injected DNA binds to a hydrophobic 
HPLC column in a buffer of triethylammonium acetate (TEAA), which acts as an 
ion pairing reagent between the negatively-charged backbone of the DNA and 
the alkylated poly(styrene-divinylbenzene) resin of the HPLC column (Huber et 
al., 1993). The chemistry and nonporous structure of the column matrix ensure 
high-resolution nucleic acid separation with rapid regeneration and equilibration 
between runs.  
The DNA is eluted from the column with an increasing gradient of 
acetonitrile at an elevated temperature. Under these conditions, partial 
denaturation of double-stranded DNA occurs such that even subtle sequence 
differences (i.e., single nucleotide substitutions, insertions, deletions) between 
DNA molecules are readily indicated by the appearance of one or more early 
eluting peaks/shoulders in the resulting chromatographic profile. These early 
eluting (i.e., shorter retention time) peaks are produced by heteroduplex 
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Figure 1.3: DHPLC chromatographic trace of a mtDNA mixture illustrating hetero- 
and homoduplices produced by cross-hybridization of two HV2A amplification 
products. One amplicon has an A/T basepair while the other has a G/C basepair 
at the same site. The earliest eluting peak contains the most destabilizing 
basepair mismatch (i.e., A/C) while the latest eluting peak has the most 
stabilizing basepair (i.e., G/C) at the same position.  
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molecules that denature and elute at lower concentrations of acetonitrile than 
corresponding homoduplices (O'Donovan et al., 1998; Hou and Zhang, 2000). As 
illustrated in figure 1.3, the retention times at which individual heteroduplex and 
homoduplex peaks resolve is a function of the specific base composition, 
nucleotide mismatch(es) and nearest neighbor interactions of the molecules 
being separated. Accordingly, the presence of a single chromatographic peak is 
consistent with sequence identity between the questioned and reference 
samples. Conversely, the presence of more than one peak is consistent with 
sequence non-identity between a questioned and reference sample. 
A major challenge for DHPLC-based mtDNA mixture fractionation has 
been the difficulty of completely eliminating the secondary component of a 
mixture from all recovered fractions. While it is often possible to significantly 
enrich for one component over another, some fractions still show secondary 
peaks (i.e., mixed bases) on sequencing electropherograms. Though the 
electrophoretic peaks for these minor-components are reduced relative to non-
fractionated samples, their presence can complicate the interpretation of the 
mixture. Initial efforts to minimize the presence of these secondary peaks 
focused on improving the precision with which individual chromatographic peaks 
are captured. Although this has improved the quality of separations that can be 
achieved, discussions with Terry Melton (Mitotyping Inc., State College, PA) have 
resulted in an innovative strategy that allows DHPLC to resolve most if not all 
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mixtures. Several key experiments (detailed in chapters 5 and 6) have 
demonstrated the accuracy and reliability of this approach, now coined “linkage 
phase analysis.”  
§ 1 - 3.3 Linkage Phase analysis 
Although the term linkage analysis originates from the study aimed at 
establishing linkage between genes on a chromosome, due to their close 
proximity and tendency of being inherited together (Ott, 1999), linkage phase 
analysis in a forensic mtDNA context applies the concept of coordinated 
nucleotide linkage to the analysis of DNA sequence data from mixed samples.  
The underlying principle of linkage phase analysis is that peak heights on 
sequencing electropherograms reflect the relative efficiency with which DNA 
molecules are terminated at a given position together with the efficiency of 
laser-induced florescence of individual dideoxy dye-terminators. While sequence 
context results in significant peak height differences among individual bases, 
these relative differences in the height of any one peak relative to any other peak 
are highly reproducible. When a DNA mixture is sequenced, overlapping 
electrophoretic peaks occur wherever the amplicons differ in primary sequence. 
Because peak height is sequence context dependent, measurements of peak 
height alone cannot be used to determine the relative abundance of the 
amplicons within the mixture. However, studies have shown that a change in the 
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ratio of one component to another in a mixture produces a corresponding 
change in the ratio of the fluorescence signals for the overlapping 
electropherogram peaks (Danielson et al., 2007). In other words, the peak 
heights for all bases associated with one amplicon will increase while the peak 
heights for all bases associated with the other amplicon will decrease. By 
analyzing this “linkage phase” of the bases at all mixed base positions, the 
correct haplotype for each contributor to a mixture can be reliably determined. 
§ 1 - 3.4 Impact on the Criminal Justice System 
The practical significance of DHPLC-based mtDNA mixture fractionation is 
that this technology may aide criminal investigations by making it possible to 
obtain crucial probative information in cases where existing methods yield 
ambiguous or uninterpretable results. The successful forensic validation of 
DHPLC for mtDNA mixture analysis will provide the forensic community with 
tools to efficiently fractionate and interpret mixtures of mtDNA in casework 
samples. As an added benefit, DHPLC has the potential to streamline the overall 
process of mtDNA analysis. This has the potential to provide the analyst with a 
rapid and cost-effective means of assessing mtDNA sample integrity and 
determining whether a sample is a mixture requiring fractionation. Once such a 
determination has been made, DHPLC yields a product which is ready for 
conventional sequencing analysis without reamplification or further purification. 
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The equipment start up cost for DHPLC is comparable to other analytical 
instruments used in forensic DNA laboratories such that implementation of 
DHPLC-based analysis can be achieved with minimal training and at a reasonable 
equipment startup cost ($135K). The cost of separating and recovering individual 
components of a DNA mixture by DHPLC is significantly less than it would be for 
the far more labor-intensive electrophoretic techniques or subcloning. 
Separation and recovery of a two-contributor mixture of DNA by DHPLC can be 
performed for less than $10 in reagent cost. The technology also offers analysts a 
significant opportunity to streamline the standard workflow at nearly every step 
in the process. On the front side, DHPLC makes it possible to determine with near 
100% accuracy whether an amplified mtDNA sample consists of a single amplicon 
or represents a mixed product (i.e., either a heteroplasmic or situational 
mixture). If the product is mixed, it is often possible to determine by DHPLC the 
approximate level of complexity (e.g., 2 contributors vs. >2 contributors). Also on 
the front end of the mtDNA amplification process, DHPLC makes it possible to 
very accurately determine the amount of template amplified in the PCR process 
and to simultaneously purify the target template for optimal dye terminator 
labeling. This not only eliminates the need for laborious yield gels and expensive 
PCR product clean up columns but also ensures that the analyst is using an 
optimal quantity and quality of mtDNA for the dye terminator labeling reaction. 
In the case of mixed samples, fractionation allows the mtDNA sequence of 
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individual contributors to be unambiguously determined without secondary 
amplification or excessive manipulation. Finally, this technology is amenable to a 
high degree of automation with minimal sample consumption. In toto, the ability 
to accurately analyze evidentiary material that is not amenable to existing 
methods of analysis while also enabling the forensic analyst to streamline the 
overall analytical process would represent a significant contribution to enhanced 
justice and public safety. 
§ 1 - 4 Objectives and Soundness of the Dissertation Research 
A mixture of different mtDNA molecules in a single sample is a significant 
obstacle to the successful use of standard methods of mtDNA analysis (i.e., 
dideoxy dye-terminator sequencing). Forensic analysts often encounter either 
naturally occurring mixtures (e.g., heteroplasmy) or situational mixtures typically 
arising from a combination of body fluids from separate individuals. The ability to 
accurately resolve and interpret these types of samples in a timely and cost 
efficient manner would substantially increase the power of mtDNA analysis and 
potentially provide valuable investigative information by allowing its use in cases 
where the current approach is limited or fails. Therefore, the ultimate goal of this 
research is to develop a strategy for the use of DHPLC as a developmentally-
validated forensic application for resolving mixtures of mtDNA. To facilitate the 
adoption of this technology by the forensic community, a significant effort has 
been made to ensure that this technology meets SWGDAM developmental 
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validation criteria and interfaces smoothly with previously validated methods of 
forensic mtDNA analysis. To do this, the method developed using DHPLC employs 
mtDNA amplicons, PCR conditions and DNA sequencing protocols validated for 
use in forensic laboratories. 
§ 1 - 4.1 Hypothesis 
The central concept being tested is that DHPLC will provide a rapid, 
accurate, and cost effective method of separating DNA mixtures. This will 
increase the number of forensic samples for which definitive sequence analyses 
will be possible. The specific experimental core hypotheses of this project are 
that: 
(1) DHPLC will be able to sufficiently detect and fractionate mtDNA 
mixtures regardless of the location (i.e., base position) and number of 
mixed sites being assayed. 
(2) There will be a significant correlation between a change in DNA 
mixture ratios (i.e., based on quantity) and DNA electrophoretic peak 
height ratios at all mixed base positions and that this will allow for 
high-confidence linkage phase analysis of mtDNA mixtures for the 
subsequent determination of individual contributor haplotypes. 
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(3)  DHPLC fractionation and linkage phase analysis will have the 
quantitative sensitivity, reproducibility and accuracy to meet forensic 
/ SWGDAM validation standards. 
§ 1 - 4.2 Summary of Research Goals 
§ 1 - 4.2.1 Chapter 2 
The focus of Chapter 2 are experiments to support the development of a 
single specific DHPLC assay for each of the four forensically relevant fragments of 
the D-loop of mtDNA for the purpose of detecting sequence identity/non-
identity. This will serve as a presumptive test for detection of mixed mtDNA 
amplicons arising from a two (or more) contributor mixture. 
§ 1 - 4.2.2 Chapter 3 
The focus of Chapter 3 is a set of experiments to determine the 
applicability of HPLC for the purification and accurate quantification of PCR 
amplicons prior to dye-terminator labeling. The combination of the purification 
and quantification process into a single step will minimize sample consumption, 
decrease analysis time and provide an opportunity for automation. 
§ 1 - 4.2.3 Chapter 4 
The focus of Chapter 4 is a set of experiments to investigate the degree of 
consistency in context-specific differences in relative peak heights across mtDNA 
sequencing electropherograms. Additional tests evaluate the use of a DNA 
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sequence electropherogram pattern matching algorithm for the detection of 
peak height anomalies, changes in peak height context specificity and mutation 
analysis by comparison to a reference sequence pattern. This computational 
approach will facilitate the automated analysis of sequence electropherograms 
allowing the analyst to more readily focus on genuinely anomalous areas of 
sequence and to, therefore, interpret results with greater confidence. 
§ 1 - 4.2.4 Chapter 5 
The focus of Chapter 5 is a set of experiments designed to determine the 
extent to which mtDNA mixtures can be analyzed as a function of changes in 
overlapping electrophoretic peak height fluorescence ratios at individual mixed 
base positions. A strong correlation between a change in DNA quantity ratio and 
a corresponding change in DNA peak height ratio will allow for the accurate 
determination of relative DNA quantities and thus linkage phase for virtually all 
two-contributor mixtures and the subsequent ability to correctly identify the 
individual mtDNA haplotypes present in a mixture. 
§ 1 - 4.2.5 Chapter 6 
The focus of Chapter 6 is a set of experiments designed to determine the 
efficacy of DHPLC for the fractionation of two-component mtDNA mixtures. The 
efficacy with which sequence-ready DNA can be recovered without 
reamplification represents a critical bench mark. The development of a statistical 
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approach for the accurate determination of linkage phase of the individual 
contributors to a mtDNA mixture, will also be presented. 
§ 1 - 4.2.6 Chapter 7 
The focus of Chapter 7 is a series of studies designed to validate the 
linkage phase approach, detailed in Chapter 6. Using simulated forensic samples, 
DHPLC in combination with linkage phase analysis will be used to predict the 
haplotypes of contributors to a series of two-component mixtures. The results of 
these studies will establish the applicability and reliability of statistical 
approaches to the analysis of sequence data from DHPLC-fractionated mixtures. 
§ 1 - 4.2.7 Chapter 8 
The focus of Chapter 8 is a series of studies designed to validate the use 
of the DHPLC instrumentation for mtDNA analysis of forensic casework samples. 
These include tests for column and injection reproducibility, column and fraction-
to-fraction cross-contamination, detection sensitivity, concentration accuracy 
and determination and negative control screening. The results of these studies 
will serve to validate DHPLC in accordance with SWGDAM and DNA Advisory 
Board (DAB) standards. 
§ 1 - 4.2.8 Chapter 9 
The focus of Chapter 9 is a summarization of an optimized overall sample 
process flow for mtDNA analysis by DHPLC, prior to dye-terminator sequencing. 
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Additionally, data are presented to demonstrate and validate the mixture 
detection and linkage phase analysis capabilities of a prototype expert 
bioinformatic system, i.e., the Fractional Linkage Phase Analysis Resource 
Software (FLiPARS). 
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Chapter 2: Comparative Sequence Analysis of the HV1 and 
HV2 Regions of Human Mitochondrial DNA by 
Denaturing High-Performance Liquid 
Chromatography 
§ 2 - 1 Introduction 
Analysis of mtDNA for forensic casework is relatively expensive, time 
consuming and requires the expertise of skilled analysts currently employed by a 
limited number of public and private laboratories. Many efforts to streamline the 
processing of forensic mtDNA casework have sought to develop rapid, cost 
effective and reliable methods of comparative mtDNA sequence analysis to 
“assay” for sequence identity/non-identity between samples or for the presence 
of mtDNA mixtures within a single sample prior to direct sequence 
characterization. 
A variety of approaches for mtDNA comparative sequence analysis have 
been investigated in recent years. These include, hybridization to linear arrays of 
sequence-specific oligonucleotides (SSO) (Reynolds et al., 2000; Gabriel et al., 
2001); denaturing gradient gel electrophoresis (DGGE) (Hanekamp et al., 1996; 
Steighner et al., 1999); single-strand conformational polymorphism (SSCP) 
analysis (Alonso et al., 1996; Barros et al., 1997); time-of-flight mass 
spectrometry (Butler and Becker 2001); and microarray-based analysis 
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(Fukushima 1999). These approaches, suffer from a number of limitations which 
include: the interrogation of only a subset of variant sites; cross-hybridization to 
non-target sequences; laborious manipulations of gels (Meyers et al., 1988; 
Reynolds et al., 2000); and interference by primer impurities (Butler and Becker 
2001). Most critically, however, all of these approaches suffer from the fact that 
they consume often precious forensic evidence while not necessarily providing a 
reliably comprehensive assessment of all possible sequence differences across 
the entire amplicon.  
Denaturing high-performance liquid chromatography (DHPLC) 
circumvents these limitations while offering the potential to characterize 
sequence differences between mtDNA amplicons in an accurate, rapid and cost-
effective manner that can be automated. Moreover, DHPLC makes it possible to 
recover the assayed DNA from the column eluent at the end of an assay. As 
currently employed in a variety of biomedical applications, the technique 
facilitates discrimination between amplicons that differ in sequence (i.e., single 
nucleotide substitutions, insertions, deletions) but which may be identical in 
length. When all DNA molecules in a sample are identical, denaturation and 
renaturation produce only homoduplices which elute simultaneously to yield a 
single chromatographic peak in a DHPLC assay. Conversely, a mixture of non-
identical DNA amplicons yields a combination of homo- and cross-hybridized 
heteroduplices. Heteroduplices elute more readily than homoduplices 
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(O'Donovan et al., 1998; Hou and Zhang 2000) from the DHPLC DNASep® column. 
Thus, sequence non-identity between DNA molecules is readily indicated by the 
appearance of one or more early-eluting heteroduplex peak(s) on the resulting 
chromatogram (Huber et al., 1993; O'Donovan et al., 1998; Hou and Zhang 2000).  
In comparative studies of DHPLC-based detection of sequence 
polymorphisms versus alternate approaches such as SSCP and DGGE, DHPLC has 
often been found to provide superior sensitivity and accuracy (Abrams et al., 
1990; O'Donovan et al., 1998; Gross et al., 1999). Using carefully designed assay 
conditions, the concordance between direct DNA sequencing and comparative 
sequence analysis by DHPLC typically ranges from 95-100%. In some cases, 
DHPLC has proven to have greater sensitivity than direct DNA sequencing for the 
detection of minor component sequence variants. The accuracy and sensitivity 
with which sequence variants can be detected by DHPLC can be significantly 
influenced by the length, GC content and other thermodynamic characteristics of 
the amplicon being assayed. The current study, therefore, investigated the 
potential utility of DHPLC to specifically detect sequence variants throughout the 
forensically relevant portions of the HV1 and HV2 regions of human mtDNA. A 
high degree of concordance between DHPLC and direct sequencing for the 
comparative analysis of those amplicons commonly used by forensic 
practitioners could facilitate the development of less consumptive approaches to 
comparative mtDNA sequence analysis for screening purposes. 
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§ 2 - 2 Methods 
This research was conducted in compliance with U.S. Federal Policy for 
the Protection of Human Subjects (56 FR 28003). Blood samples were collected 
from 103 unrelated subjects who had provided informed consent, of these, 8 
samples were used to generate of mtDNA subclones. All samples were stored at -
20°C until DNA extraction. 
§ 2 - 2.1 Mitochondrial DNA Extraction from Dried Blood 
Total DNA was extracted from dried reference blood stains using a 
QIAmp® 96 Well Blood Kit (Qiagen Inc., Valencia, CA) per the manufacturer’s 
recommended protocol. For consistency, the extraction was performed using a 
Biomek® 2000 automated liquid handler (Beckman Coulter Inc, Fullerton, CA). 
Purified DNA was eluted into 200µL of nuclease free ddH2O and stored at -20°C 
until PCR amplification.  
§ 2 - 2.2 Mitochondrial DNA Amplification and Sequencing 
Mitochondrial DNA control region amplification reactions (50μL) were 
prepared using 50pmol each of forensically-validated PCR primers (Wilson et al., 
1995; LaBerge et al., 2003) (Table 2.1); 2.25U AmpliTaq GOLD® DNA polymerase 
(Applied Biosystems, Foster City, CA) supplemented with 0.25U Pfu DNA 
polymerase (Stratagene, La Jolla, CA); AmpliTaq GOLD® Buffer (Applied 
Biosystems); 10nmol of each dNTP (Stratagene) and 10μL of an approximately  
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Table 2.1: Forensically validated and additional primers developed in-house for 
control region amplification. Location indicates strand corresponding to the 
primer (L for light strand and H for heavy strand) followed by the nucleotide 
position of the 3’ end of the primer. 
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10pg/μL DNA extract. Amplifications were performed on a GeneAmp® 9700 
thermocycler (Applied Biosystems) with an initial denaturation at 95°C for 10 
minutes, followed by 32 cycles of 95°C for 20 seconds, 60°C for 30 seconds and 
72°C for 45 seconds. The final extension at 72°C was for 15 minutes. The resulting 
PCR yield for each fragment was then quantified by HPLC under a non-denaturing 
column temperature of 50°C. The near perfect regression (R2 = 0.9982) between 
chromatographic peak area and DNA quantity made it possible to reliably 
determine the DNA quantity from each amplification reaction. This approach, 
which requires ≤7 min/assay, has been internally validated for fragments ranging 
in size from 200-1000bp and for quantities ranging from 1.25-140ng (data not 
shown). 
Approximately 0.8ng of amplified DNA was labeled for sequencing using 
the BigDye® Terminator v1.1 Cycle Sequencing kit (Applied Biosystems). Labeling 
reactions were primed using the PCR primers employed above or additional 
internal sequencing primers (HV1R and HV2F) developed in-house (Table 2.1). 
Labeled products were purified by ethanol precipitation or on Performa® DTR V3 
96-Well Short Plates (Edge BioSystems, Gaithersburg, MD) and then resolved on 
a PRISM® 310 Genetic Analyzer (Applied Biosystems) according to the 
manufacturer’s protocols using the POP-6™ polymer and 47cm x 50µm capillaries 
(Applied Biosystems). The raw electrophoretic traces were analyzed using the KB 
Basecaller (Applied Biosystems) together with the appropriate dye set mobility 
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file for the v1.1 kit. Appropriate positive and negative controls were included at 
all stages of the process to monitor for contamination and reagent integrity. The 
resulting sequence data were analyzed using the Sequencher™ v4.2 DNA analysis 
software (Gene Codes Corp, Ann Arbor, MI). 
§ 2 - 2.3 Mitochondrial DNA Subcloning 
Primers A1 and D1 (Table 2.1) were used to amplify an mtDNA fragment 
of approximately 1021bp which encompassed both HV1 and HV2. The resulting 
amplification products representing eight mtDNA haplotypes were purified using 
Wizard® PCR Preps (Promega, Madison, WI), ligated into the pGEM®-T vector 
(Promega) and electroporated into DH5α electrocompetent cells. Cells were 
selected on LB agar plates containing 50μg/ml ampicillin and screened by PCR to 
identify plasmids containing target inserts. Plasmids were isolated from 
overnight cultures of these colonies by alkaline lysis and capture on glass-filter 
binding plates (Millipore, Bedford, MA). DNA was sequenced as described above. 
§ 2 - 2.4 DHPLC-Based Temperature-Modulated Heteroduplex 
Analysis (TMHA) 
DNA sequence data for each of four forensically-relevant amplicons 
(HV1A, 278bp: A1/B2; HV1B, 271bp: B1/A2; HV2A, 278bp: C1/D2; and HV2B, 
277bp: D1/C2) (Table 2.1) were compared to identify individuals with different 
mtDNA haplotypes (Wilson et al., 1995). Fragments were then combined at a 1:1 
molar ratio to generate a series of pair-wise mixtures which were cross-
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hybridized by denaturation at 95°C for 4 minutes and gradual cooling (1.5°C/min) 
to a final temperature of 25°C (LaBerge et al., 2003).  
The cross-hybridized mixtures were analyzed by TMHA (Kuklin et al., 
1997) on a WAVE® 3500HT DNA Fragment Analysis System (Transgenomic Inc., 
Omaha, NE) using a DNASep® analytical column (Huber et al., 1993). 
Triethylammonium acetate (TEAA) pH 7.0 at a final concentration of 0.1M served 
as an ion-pairing reagent. Cross-hybridized mixtures were analyzed under 
partially denaturing conditions at the empirically determined optimal 
temperatures for each of the four mtDNA amplicons (i.e., HV1A, 58°C; HV1B, 
59.2°C; HV2A, 56.5°C and HV2B, 57°C). The optimal acetonitrile linear gradient 
generated from differential mixing of buffer A (0.1M TEAA) and buffer B (0.1M 
TEAA, 25% ACN) were a 56% to 65% buffer B increase in 3.5 minutes for HV1A, 
HV2A and HV2B and a 55% to 64% buffer B increase in 3.5 minutes for HV1B. All 
samples were eluted at a 0.9ml/min flow rate and detected by UV absorbance at 
260nm. Standard DHPLC controls included: zero-volume injections to screen for 
DNA carryover between assays; no-template PCR controls to check for reagent 
contamination; and manufacturer mutation control standards for buffer and 
column quality control. Where necessary for enhanced sensitivity, temperate 
titrations were conducted in ±0.5°C increments using an integrated oven 
accurate to ±0.1°C.  
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The resulting chromatograms were visually examined. The presence of a 
single homoduplex peak was scored as consistent with sequence identity. The 
presence of more than one chromatographic peak or a shoulder on a 
homoduplex peak was scored as consistent with the presence of one or more 
sequence differences between the two amplicons in the sample being assayed, 
i.e., sequence non-identity (O'Donovan et al., 1998; Hou and Zhang 2000).   
§ 2 - 3 Results and Discussion 
§ 2 - 3.1 Essential Modification of Forensically-Validated Protocols 
In evaluating the utility of DHPLC for comparative mtDNA sequence 
analysis, the current study employed forensically validated oligonucleotide 
primer pairs and standard operating procedures (Wilson et al., 1993). Two minor 
modifications to these procedures were made, the exclusion of bovine serum 
albumin (BSA) from the amplification reaction and the supplementation of 
AmpliTaq GOLD® with higher fidelity Pfu DNA polymerase.  
The presence of >10% w/v BSA in a sample reduces the functional 
lifespan of the DNASep® column. BSA, however, is often used to ameliorate the 
effects of endogenous PCR inhibitors in some DNA extracts. These include IgG 
and heme in blood (Al-Soud and Rådström 2001), melanin in hair (Eckhart et al., 
2000), collagen in bone (Scholz et al., 1998) and such environmental inhibitors as 
humic acid in soil (Watson and Blackwell 2000) which are not efficiently removed 
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by inorganic extraction methodologies (e.g., Chelex™). In our laboratory, both 
endogenous and environmental inhibitors have been effectively removed from 
hair, bone and environmentally contaminated samples by the use of organic 
extraction, silica-gel membranes or by systems that employ paramagnetic 
particles such as the Qiagen® EZ1 DNA tissue kit.  
In the current study, the silica-gel membrane based QIAamp® DNA Blood 
purification kit was used to prepare all DNA extracts from whole blood. The 
purity of the resulting extracts was evaluated by PCR amplification of mtDNA in 
the presence and absence of BSA at a final concentration of 0.16μg/μl. Yields for 
individual amplification reactions were generally in the range of 20-25ng/μl as 
determined by optical absorbance at 260nm. The amplification of mtDNA from 
QIAamp® prepared extracts was equally efficient regardless of whether or not 
BSA was added (data not shown). If the use of BSA is unavoidable, purification of 
the PCR amplification products by organic extraction or other protein removal 
method may be needed prior to DHPLC analysis.  
The fidelity of the DNA polymerase used for amplification may also 
impact the accurate interpretation of DHPLC chromatograms. The relatively high 
nucleotide misincorporation rate of Taq DNA polymerase (8.0×10-6 
mutations/bp/duplication) (Cline et al., 1996) typically produce DHPLC 
chromatograms from single sequence samples which erroneously appear to 
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indicate a DNA mixture. A mixture of Taq and Pfu DNA polymerases at a 9:1 ratio 
effectively eliminates these anomalies. The 3´→5´ exonuclease activity and lower 
nucleotide misincorporation rate (1.3×10-6 mutations/bp/duplication) of Pfu 
yields greater uniformity in amplification products (Cline et al., 1996).  
§ 2 - 3.2 DHPLC Assay Development  
Recognizing that mtDNA heteroplasmy is detected by DHPLC as a mixture 
of non-identical sequences, the initial optimization of DHPLC assay parameters 
was conducted using a group of eight mtDNA subclones as templates for PCR 
amplification of the HV1 and HV2 amplicons (Table 2.2). Collectively, these 
subcloned sequences differed from each other at an average of 9.4 positions (0-7 
positions in HV1A; 0-10 positions in HV1B; 0-5 positions in HV2A; 0-4 positions in 
HV2B). The use of subcloned sequences ensured that each sample represented a 
single distinct haplotype. This eliminated heteroplasmy as a potentially 
confounding variable for the purpose of assay optimization. 
§ 2 - 3.3 Optimization of DNASep® Column Temperatures  
Comparative DHPLC-based DNA sequence analysis relies on temperature-
dependent chromatographic separation of the nucleic acids under partially 
denaturing conditions. In accordance with manufacturer recommendations and 
empirical observations by the authors and other researchers, optimal resolution 
is generally obtained using amplicons of less than 400bp in length and a column  
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Table 2.2A: Sequence polymorphisms in HV1 subclones based on the revised 
Cambridge Reference Sequence (rCRS). 
 
 
Table 2.2B: Sequence polymorphisms in HV2 subclones based on the revised 
Cambridge Reference Sequence (rCRS). 
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temperature where the average of nucleic acid helicity across an amplicon is 
approximately 75% to 85% (Cooksey et al., 2002; Transgenomic 2003). Under 
these conditions, heteroduplices with a single base mismatch elute from the 
DNASep® column before identical-length homoduplices. 
The mtDNA primer pairs used in the current study yield amplicons within 
a size range that are well suited for DHPLC analysis (i.e., HV1A = 278bp, HV1B = 
271bp, HV2A = 278bp, HV2B = 277bp). Although the appropriate partially 
denaturing temperature for a given amplicon is approximated by the Navigator™ 
software based on nearest neighbor interactions (Fixman and Freire 1977), the 
optimal temperature must be empirically confirmed. This was done by 
monitoring the separation of homo- and heteroduplices in multiple mixed 
samples at temperatures flanking the predicted value. The optimal temperature 
is that at which the greatest chromatographic resolution is achieved. This is 
illustrated in figure 2.1 where the greatest resolution for the mixture of HV1B 
amplicons being assayed is at 59.2°C. This is not to suggest that all mixtures of 
HV1B amplicons will be optimally resolved at this temperature. Rather, this 
represents the optimal initial assay temperature at which mixtures of HV1B 
amplicons of unknown haplotype can be screened. Similarly, the optimal initial 
assay temperatures for the HV1A, HV2A, and HV2B amplicons were determined 
to be 58.0°C, 56.5°C and 57.0°C, respectively.  
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Figure 2.1: Empirical determination of the optimal column temperature for 
comparative sequence analysis of HV1B. While the hetero- and homoduplices 
can be resolved at 58.2°C, optimal resolution is obtained at 59.2°C. At 60.2°C, the 
heteroduplices elute too readily to form distinct peaks.  
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§ 2 - 3.4 Comparative Sequence Analysis of Subcloned mtDNA  
As a preliminary assessment of the accuracy with which DHPLC is able to 
detect sequence differences, a matrix of all possible pair-wise combinations (i.e., 
144 mixtures) of mtDNA fragments (i.e., HV1A, HV1B, HV2A and HV2B) was 
prepared using the subcloned haplotypes as amplification templates. Following 
cross-hybridization and analysis by DHPLC, the resulting chromatograms were 
visually examined.  
Figure 2.2 presents examples of chromatograms obtained from assays of 
27 pair-wise comparisons between non-identical and 9 comparisons between 
identical HV2A amplicons. Sequence differences included a single-base insertion 
situated near the terminus of the amplicon (e.g., all comparisons with sample 5) 
and a variety of single and multiple base substitutions throughout the amplicon. 
Single base substitutions in both GC rich and AT rich regions were also assayed.  
Combinations of each amplicon with itself, and the identical amplicons 
from subclones 2 and 8, yielded chromatograms with a single symmetrical peak 
(i.e., the homoduplex species). For two of the pair-wise combinations, non- 
identity was indicated by the presence of a shoulder on the homoduplex peak 
(e.g., subclones 2 and 4). For 24 of 27 pair-wise combinations of non-identical 
amplicons, sequence non-identity was indicated by the presence of early-eluting 
and easily discernable heteroduplex peaks. In a few comparisons, the 
heteroduplex peak was much smaller than the homoduplex peak (e.g., subclones  
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Figure 2.2: Examples of DHPLC chromatograms from pair-wise hybridization of 
the HV2A fragment amplified from eight mtDNA subclones. (2A) Sequence 
identity is indicated by the presence of a single homoduplex peak. (2B-2E) 
Sequence non-identity is indicated by the presence of more than a single peak. 
Early eluting peaks represent heteroduplices formed by cross-hybridization 
between non-identical amplicons. (2F) Sequence non-identity can also be 
indicated by a shoulder on a homoduplex peak which also indicates the presence 
of heteroduplices. 
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1 and 5) making detection somewhat more challenging. In these cases, the 
presence of a heteroduplex peak was more readily discerned by comparing the 
chromatograms obtained for injections of each amplicon by itself with the 
chromatogram obtained when a mixture of the two amplicons was injected. This 
was done by superimposing these three chromatograms on top of each other.  
Only the comparison between subclones 2 and 3 failed to show sequence 
non-identity by DHPLC at 56.5°C. This was not unexpected since the sequence 
difference between these amplicons (73G vs. 73A) was immediately adjacent to a 
short GC-rich region of predicted 100% helicity. The thermodynamic stability of 
this region is an intrinsic feature of the HV2A amplicon which interferes with the 
detection of base changes at position 73. 
Pair-wise combinations of HV1A, HV1B and HV2B fragments amplified 
from the eight mtDNA haplotype subclones were also assayed for sequence 
identity/non-identity by DHPLC. As seen for the HV2A fragment, sequences that 
differed by one or more bases were successfully identified by DHPLC either by 
the presence of early-eluting heteroduplex peaks or an early-eluting 
heteroduplex shoulder on a homoduplex peak. One sequence difference 
between subclones 3 and 5 (16362T vs. 16362C) was not readily detected 
without overlaying the chromatograms for the individual versus the mixed 
amplicons. This was not unexpected given that HV1B has a biphasic melt profile 
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and position 16362 is within a region of higher GC-content that remains relatively 
stable at the standard assay temperature of 59.2°C.  
§ 2 - 3.5 Comparative Sequence Analysis of mtDNA from Blood 
Samples  
The primary objective of the current study was to evaluate the potential 
utility of DHPLC as a means of screening amplified human mtDNA samples for 
sequence identity/non-identity in the context of a forensic laboratory. Initial 
experiments using subcloned mtDNA haplotypes demonstrated that DHPLC 
accurately detects even single base differences between two mtDNA amplicons. 
Subclones, however, are artificially pure templates which do not reflect the 
molecular complexity of a human tissue-derived DNA extract. Furthermore, the 
eight haplotypes used encompass only a small fraction of known variant 
positions. To more thoroughly assess the reliability of DHPLC as a tool for 
comparative sequence analysis, the approach was tested on blood samples from 
95 research volunteers.  
Exclusive of length polymorphisms associated with the homopolymeric 
cytosine-stretch in HV2, the 95 subjects in the current study represented 83 
distinct haplotypes (Appendix A). Seventy-seven of these were unique within the 
study population. Of the 6 haplotypes which occurred more than once, the most 
common (263G, 315.1C) was observed 8 times while the remaining 5 haplotypes 
each occurred twice. Relative to the revised Cambridge Reference Sequence 
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(rCRS) (Anderson et al., 1981; Andrews et al., 1999), the haplotypes represented 
in the current study encompass 84 polymorphisms in HV1 and 46 polymorphisms 
in HV2, including cytosine-stretch length polymorphisms.  
Based on pair-wise comparisons, individual haplotypes differed from each 
other at 0-22 positions (0-11 in HV1A; 0-13 in HV1B; 0-13 in HV2A; and 0-12 in 
HV2B). On average, there were 8.71 positional differences between haplotypes. 
In toto, the study population encompasses a broad diversity of haplotypes and 
thus is well suited for evaluating the utility of DHPLC for the accurate detection 
of sequence polymorphisms throughout the mtDNA control region. This is 
essential for the validation of DHPLC as a tool for comparative sequence analysis.  
A total of 920 pair-wise combinations of amplicons from the 95 
individuals in this study were prepared, denatured and allowed to gradually 
reanneal. Of these, 72 (22 in HV1A, 8 in HV1B, 17 in HV2A, and 25 in HV2B) 
represented combinations of amplicons that were from different individuals but 
which had identical DNA sequences. DHPLC analyses of these samples all 
produced clear chromatograms consisting of a single symmetrical homoduplex 
peak. This pattern is consistent with sequence identity and is 100% concordant 
with direct sequencing data for these amplicons.  
 To assess the reliability of DHPLC to detect sequence non-identity, 849 
combinations of amplicons (209 in HV1A, 222 in HV1B, 213 in HV2A, and 205 in 
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HV2B) which differed in sequence were assayed. These differences encompassed 
a broad diversity of polymorphisms distributed throughout the HV1 and HV2 
regions including transitions, transversions, insertions and deletions (Table 2.3). 
Positional differences were located internally as well as near the termini of 
amplicons and encompassed regions of varying GC richness. In all, the mixtures 
assayed in this study included sequence variants in HV1A, HV1B, HV2A and HV2B 
at 39, 62, 38 and 30 different positions, respectively. Figure 2.3 illustrates the 
distribution of the variant positions and the frequency with which they were 
assayed.  
Using the aforementioned initial assay temperature for each mtDNA amplicon, 
DHPLC analyses correctly indicated the presence of a mixture of non-identical 
amplicons in 836 (209 in HV1A, 222 in HV1B, 203 in HV2A, and 202 in HV2B) of 
the combinations tested. The remaining 13 mixtures (10 in HV2A and 3 in HV2B) 
of non-identical amplicons, yielded chromatographic traces with a single eluent 
peak, a result erroneously suggesting sequence identity. Careful examination of 
the amplicon mixtures which were not detected by DHPLC reveals that these 
aberrant results are limited to a very small number of challenging positions. 
Mirroring results obtained with subcloned mtDNA, it was not possible to detect 
as non-identical, combinations of HV2A amplicons that differ only at positions 72 
or 73. Taken together, these two positions account for all of the undetected non-
identical mixtures in HV2A.  
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Table 2.3: Sequence polymorphisms assayed by DHPLC in the HV1 and HV2 
regions as deviations from rCRS.  
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Figure 2.3: A histogram showing the distribution of nucleotide positions within 
HV1A, HV1B, HV2A and HV2B amplicons (x-axis) and the number of times that 
sequence polymorphisms at each position were assayed by DHPLC (y-axis). The 
polymorphisms assayed are broadly distributed throughout both GC and AT rich 
regions as illustrated by the light gray line which indicates %GC content across 
each fragment as determined by the surrounding 10 nucleotides.  
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In HV2B, DHPLC was not able to detect as non-identical, combinations of 
amplicons that differed only at position 295. This position lies in a narrow stretch 
of sequence immediately adjacent to a large GC-rich region. Given the 
thermodynamic stability of this region, a single base mismatch may not 
sufficiently destabilize the surrounding helix such that an early eluting peak can 
be discerned. This is a postulate supported by the observation that mixtures of 
amplicons that possess an additional mismatch in this same region are readily 
detected.  
An inverse relationship was generally observed between the number of 
positional differences associated with a given pair of non-identical amplicons and 
the relative heights of the hetero- versus homoduplex peak(s). The height and 
retention time of a heteroduplex peak is a function of the stability and base 
sequence of the helix. The more stable a heteroduplex, the more readily it should 
form relative to the competing homoduplices and thus the greater its peak 
height (indicative of quantity) on the DHPLC chromatograms. The corollary of this 
is that the formation of less stable helices is less favored and should be 
associated with smaller and earlier-eluting peaks on the DHPLC chromatograms. 
In theory, this could compromise the ability of DHPLC to detect as non-identical 
some combinations of amplicons that differ at a large numbers of positions. In 
the current study, however, no examples of such “heteroduplex dropout” were 
observed. 
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§ 2 - 3.6 Heteroplasmy Detection 
As a naturally occurring combination of two haplotypes, heteroplasmy 
represents an important but potentially confounding factor for DHPLC-based 
analyses. Chromatograms obtained from assays of known heteroplasmic samples 
typically show the presence of early-eluting heteroduplices. In these cases, 
DHPLC can often provide an indication of the nature of the heteroplasmy. Using 
either non-denaturing (column temperature = 50°C) or partially denaturing 
conditions, length heteroplasmy results in a chromatogram characterized by a 
markedly broadened peak often characterized by multiple shoulders (Figure 2.4). 
This represents the combination of the various length amplification products and 
the characteristic shape of such peaks makes it possible to readily screen for 
heteroplasmy associated with the cytosine-stretches of HV1 and HV2B. Using 
partially denaturing conditions, point (i.e., base substitution) heteroplasmy can 
also be readily detected. It is typically indicated by the presence of a defined 
heteroduplex peak or a significant shoulder in association with the main 
homoduplex peak.  
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Figure 2.4: An example of length heteroplasmy as detected by DHPLC at a non-
denaturing DNASep® column temperature of 50°C. Secondary and tertiary length 
variants are detected as shoulders prior to the primary length component 
represented by the major peak.  
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When analyzing questioned samples, however, it is not possible to 
reliably distinguish between heteroplasmy and a situational mixture where 
mtDNA has been contributed by two or more individuals. Even so, the presence 
of heteroplasmy does not necessarily preclude the use of a heteroplasmic 
reference sample for comparative sequence analysis by DHPLC. Sequence non-
identity in such cases would be indicated by the presence of additional early 
eluting peaks and/or shoulders that were not evident in the chromatogram 
generated by cross-hybridization of the heteroplasmic sample with itself. 
Conversely, the absence of any additional peaks would be consistent with 
sequence identity.  
Heteroplasmy, however, can reduce the discriminatory power of DHPLC 
in some cases. In the current study, this was most often observed for samples 
with significant length heteroplasmy. The broad chromatographic peak 
associated with these samples can obscure the presence of additional 
heteroduplices formed as a result of cross hybridization between the amplicons 
present in the known sample and additional amplicons in the questioned sample. 
While DHPLC circumvents many of the limitations of alternate approaches 
to mtDNA screening, it is important to consider very carefully the types of 
samples for which such an approach might be indicated. Within an mtDNA 
sequencing laboratory, screening by DHPLC makes it possible to detect samples 
62 
 
that contain mixtures of non-concordant amplicons immediately after PCR 
amplification and without having to sequence them. For both heteroplasmic and 
situational mixtures, this approach would enable the analyst to identify 
potentially challenging samples and mark them for “special handling” – whether 
that be use of alternate sequencing primers to avoid C-stretch polymorphisms or 
the application of emerging technologies for resolving mixed samples (Danielson 
et al., 2005; Andreasson et al., 2006; Danielson et al., 2007). 
§ 2 - 3.7 DHPLC as a Presumptive Screen for Sequence Identity 
It has been reasonably argued by experienced practitioners in the field 
that that it is best to avoid the use of mtDNA screening method on limited or 
irreplaceable evidentiary material (Divne et al., 2005; Melton et al., 2006). A 
presumptive DHPLC screen for mtDNA sequence identity, however, could serve 
as a useful tool for investigators in special situations such as the investigation of 
property crimes. The limited budgets of many law enforcement agencies make it 
extremely difficult for investigators to justify the expense of mtDNA testing in the 
majority of criminal offences that do not involve crimes against persons – 
particularly when there is no assurance a priori that the test results will 
necessarily advance an investigation. A presumptive screen for sequence identity 
between a suspect and an item of evidence, however, could provide sufficient 
justification to submit the sample for confirmatory analysis by direct sequencing. 
Such screening might also help to readily eliminate from consideration such non-
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probative samples as hairs consistent with a victim that were recovered from the 
victim’s home or vehicle in the case of a burglary or auto theft. In short, this 
could help investigators to focus their efforts on the most probative samples and 
thereby maximize the efficient use of investigative resources. 
Employing a presumptive test of mtDNA sequence identity in the manner 
described above shifts the process of DNA extraction from the dedicated mtDNA 
sequencing laboratory to the local law enforcement laboratory. This necessitates 
that additional consideration is given to the handling of these samples. The 
presence of evidentiary material with large quantities of mtDNA (e.g., blood, 
saliva and seminal fluids, etc.) in local laboratories can pose a significant risk of 
cross contamination. Accordingly, an mtDNA sequencing laboratory accepting a 
DNA extract for analysis would almost certainly require the submission of a co-
extracted reagent blank control that could be tested to detect the presence of 
spurious mtDNA contamination. Similarly, the submission of amplified PCR 
products for direct sequencing would also need to be accompanied by the 
appropriate positive and negative PCR controls. 
§ 2 - 4 Conclusion  
The results of the current study have demonstrated that DHPLC analysis 
of pair-wise combinations of identical mtDNA amplicons, accurately and reliably 
produces a single chromatographic peak consistent with sequence identity. 
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These results were 100% concordant with DNA sequence data. Conversely, in 
pair-wise combinations of non-identical amplicons, DHPLC successfully detects a 
diversity of sequence differences throughout the HV1 and HV2 regions. These 
differences, which include a wide variety of base substitutions as well as 
insertions/deletions, are typically indicated by the presence of more than a single 
peak in the resulting chromatogram. As such, DHPLC may have significant 
forensic utility in several areas. These include: a presumptive test of mtDNA 
identity between known and questioned samples; a screen for mixed samples 
prior to direct sequencing and; a preparative tool for the physical fractionation of 
the individual contributors to an mtDNA mixture prior to sequencing.  
Although DHPLC is not a replacement for direct sequencing of mtDNA, it 
does offer some advantages as a potential screening tool. First, the assay is 
relatively simple and fast. It uses raw PCR products thereby avoiding the time 
and expense associated with amplicon cleanup. Following cross-hybridization, 
each assay takes only seven minutes to run and interpretation of the results is 
straightforward. DHPLC provides a comprehensive assessment of sequence 
identity across an entire amplicon without the often challenging task of trying to 
obtain quality base sequence information immediately adjacent to primer 
binding sites. Finally, the presence of heteroplasmy, while a potentially 
confounding variable, does not necessarily preclude comparative sequence 
analysis by DHPLC.  
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Compared to alternate mtDNA screening strategies based on 
oligonucleotide probes or linear arrays, DHPLC consumes less DNA and is not 
limited by the need to design probes for the detection of known mutations at 
predetermined polymorphic sites. This reduces the potential for false inclusions 
and eliminates the need to design custom probes for unique or rare sequence 
variants. Similarly, DHPLC assays are not subject to the “null” or “blank” results 
that arise when hybridization of the target sequence is impeded by other nearby 
polymorphisms. On the contrary, additional sequence variants typically make it 
easier to detect sequence non-identity between two amplicons.  
Forensic laboratory implementation of a commercial DHPLC analysis 
system can be achieved with minimal training and initial equipment cost of just 
over $50K. The $0.50/run operating cost for DHPLC analyses is considerably less 
than that for alternative approaches. Depending on the nature of casework being 
analyzed and level of throughput, the acquisition of a DHPLC system may be a 
fiscally viable option for some forensic laboratories as is already the case in the 
molecular diagnostics arena.  
Finally, the current study has also demonstrated that DHPLC can be used 
to resolve mixtures of non-identical mtDNA amplicons into a series of homo- and 
heteroduplex peaks. Since these can be differentially eluted in time, it should be 
possible to physically recover and concentrate the DNA contained in any given 
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fraction of eluent. Subsequent sequence analysis of the recovered DNA may then 
provide a basis for determining the specific haplotype of each of the contributors 
to the mixture. The feasibility of this approach has already been demonstrated 
(Danielson et al., 2005; Danielson et al., 2007). 
§ 2 - 5 Chapter Summary 
Denaturing High-Performance Liquid Chromatography (DHPLC) was 
evaluated as a means of detecting the presence of sequence differences in pair-
wise mixtures of non-identical amplicons representing hypervariable regions 
(HV1 and HV2) of human mitochondrial DNA (mtDNA). The approach is based on 
the ability to chromatographically distinguish between PCR products on the basis 
of sequence alone. Using forensically-validated primers sets, optimal assay 
parameters (e.g., column temperature and acetonitrile gradient) were 
empirically determined for each of four D-loop amplicons commonly employed 
by forensic mtDNA laboratories. Following extraction of DNA from 95 unrelated 
human volunteers, 920 pair-wise combinations were assayed by DHPLC for 
sequence identity/non-identity. For the 72 combinations of amplicons that were 
from different individuals but which had identical DNA sequences, DHPLC assay 
results consistently indicated the presence of sequence identity between the 
samples. This result was 100% concordant with direct sequencing data for the 
amplicons tested. For the 849 combinations of amplicons which differed in 
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sequence, DHPLC correctly detected the presence of sequence non-identity in all 
but 13 assays to yield 98.5% concordance with direct sequencing. DHPLC can be 
used to detect a diversity of sequence differences (transitions, transversions, 
insertions and deletions) at polymorphic sites distributed throughout the HV1 
and HV2 regions. The current study demonstrates that DHPLC may have forensic 
utility as a presumptive test of mtDNA identity between known and questioned 
samples; as a screen for heteroplasmy or situationally mixed samples prior to 
direct sequencing and; as a preparative tool for the physical fractionation of the 
individual contributors to an mtDNA mixture prior to sequencing. 
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Chapter 3: Validation of Simultaneous Purification and 
Quantification of PCR Yield by High-Performance 
Liquid Chromatography on DNASep® Columns 
§ 3 - 1 Introduction 
High-performance liquid chromatography (HPLC) using an ion-paired 
reversed-phase column allows for the high-resolution analysis of nucleic acid 
fragments. In recent years, this technology has been widely employed for the 
analysis and preparative purification of oligonucleotides; the size fractionation of 
double-stranded DNA molecules; and the detection of sequence polymorphisms 
under partially denaturing conditions - a process known as denaturing HPLC 
(DHPLC). In addition to its use in basic research and molecular diagnostics, the 
forensic potential of DHPLC has also been recognized. DHPLC has been 
investigated as a means of rapid gender determination, STR sizing and the typing 
of Y chromosome biallelic polymorphisms (Underhill et al., 1997; Shinka et al., 
2001; Shi et al., 2007). The greatest forensic interest in DHPLC, however, has 
focused on its potential utility in mitochondrial DNA analysis where it has been 
used to detect heteroplasmy (Lo et al., 2005; Meierhofer et al., 2005; Jiang et al., 
2006), polymorphisms between individuals (Danielson et al., 2005; Wang et al., 
2006) and as a method to resolve mtDNA mixtures into identifiable haplotypes 
(Danielson et al., 2007). Beyond its direct applicability to mtDNA sequence 
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analysis, DHPLC may also help to facilitate two other tasks in the processing of 
mtDNA samples, namely PCR product cleanup and yield determination.  
Following PCR amplification, mtDNA amplicons are purified to remove 
unincorporated nucleotides and oligonucleotide primers. PCR cleanup is critical 
to obtaining quality sequence data and is often accomplished by use of spin 
columns (e.g., Amicon Centricon-50®) (Millipore Corporation, Billerica, MA) or 
enzymatic treatment, (e.g., ExoSAP-IT®) (USB Corporation, Cleveland, OH) (Hanke 
and Wink, 1994; Werle et al., 1994; Dugan et al., 2002). Spin columns effectively 
remove small DNA fragments, such as primers, but are less efficient at removing 
larger extraneous amplification products. Additionally, their use has been 
reported to be prone to inefficient recovery (30% on average) of the target 
amplicon (Dugan et al., 2002). Treatment with ExoSAP-IT® uses exonuclease I to 
digest residual single-stranded DNA (e.g., primers and some extraneous 
amplification products) and shrimp alkaline phosphatase to remove residual 
dNTPs. This enzymatic approach allows for significantly greater rates of product 
recovery (78% on average) (Dugan et al., 2002). Both methods, however, are 
limited by their inability to distinguish between target PCR amplicons and non-
specific double-stranded amplification products of similar size (Gabriel et al., 
2001). Additionally, casework-type samples may vary in number and/or 
extraction volume making it difficult to fully automate the PCR product cleanup 
process on a robotic platform. As a result, analysts may need to set up and 
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process spin columns or ExoSAP-IT® reactions individually. This can require a 
significant amount of hands-on time and corresponding reduction in productivity.  
The accurate determination of DNA yield following sample 
amplification/purification is crucial to generating quality sequence data 
(Kieleczawa, 2006). Excessive DNA input quantities result in sequence 
electropherograms characterized by signal saturation, inconsistent peak heights 
and/or premature signal drop off. Conversely, insufficient quantities of input 
DNA may be associated with signal degradation and decreased S/N ratios. While 
these effects can sometimes be ameliorated by subsequently adjusting 
electrokinetic injection times/voltages or by the concentration/dilution of DNA 
extracts, such remedies are less desirable than simply using an optimal quantity 
of DNA from the start.  
PCR yield can be quantified by a number of approaches including UV 
spectroscopy, gel electrophoresis, or microchip capillary electrophoresis all of 
which have a number of shortcomings. UV spectroscopy cannot distinguish 
between an amplified target and residual primers or spurious PCR amplification 
products. As a result, the amount of amplified target DNA can be easily 
overestimated. Agarose “yield gels”, which are used in many forensic 
laboratories are moderately labor intensive and require that samples be 
compared to a quantification ladder using either the eyes of a trained analyst or 
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pixel counting software. The Agilent 2100 Bioanalyzer Lab Chip capillary 
electrophoresis system (Agilent Technologies, Palo Alto, CA) offers greater 
accuracy and precision but requires investment in expensive dedicated 
equipment, higher consumable costs per sample and a number of sample 
handling steps.  
The ability to fractionate by size, quantify and physically recover 
macromolecules is fundamental to chromatographic techniques (Kalnoski et al., 
1991; Warren and Doniger, 1991; Henninger et al., 1993; Zeillinger et al., 1993; 
Katz, 1996) including ion-pair reversed-phase chromatography. Purification of 
DNA fragments by HPLC should make it possible to recover target amplicons in a 
manner suitable for dye-terminator labeling reactions while circumventing the 
limitations of existing reaction cleanup approaches. Additionally, given that 
chromatographic peaks reflect the quantity of DNA eluted from the HPLC 
column, the height and area of a target DNA peak should provide an accurate 
means of assessing PCR yield for a target amplicon. The current study, therefore, 
sought to evaluate the potential for use of a commercial HPLC system (WAVE® 
3500HT Nucleic Acid Fragment Analysis System, Transgenomic, Inc., Omaha, NE) 
to quantify PCR product yield and simultaneously purify target amplicons for 
downstream applications such as DNA sequencing. In order to demonstrate the 
efficacy of such an approach, the linearity of DNA quantification by HPLC was 
assessed across a range of amplicon sizes and concentrations of potential utility 
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to forensic analysts. Similarly, the suitability of HPLC as a means of amplicon 
purification was assessed in comparison to existing PCR product cleanup 
methods employed by forensic laboratories (i.e., ExoSAP-IT® and Amicon 
Centricon-50® spin columns).  
Given the potential utility of HPLC as a means of detecting and 
fractionating mtDNA mixtures (Danielson et al., 2007), the use of the same 
platform for PCR yield quantification and reaction cleanup is attractive. This 
approach could help to save valuable analyst time, increase productivity and 
streamline the processing of casework-type samples for mtDNA sequencing. 
§ 3 - 2 Materials and Methods 
§ 3 - 2.1 DNA Quantification Standards 
A commercial DNA quantification standard (MassRuler™ Express DNA 
Ladder, LR Reverse, Lot# 00000201) (Fermentas Life Sciences, Hanover, MD) was 
used to assess the correlation between DNA quantity and chromatographic peak 
height/area. This commercial standard is produced in an ISO9001 certified facility 
and the absence of nucleases is confirmed by a direct nuclease activity assay. The 
DNA ladder consisted of a mixture of six chromatography-purified and 
spectrophotometrically quantified DNA fragments (100, 200, 300, 500, 700 and 
1000bp) at a stock concentration of 10ng/µL, 7ng/µL, 5ng/µL, 3ng/µL, 2ng/µL 
and 1ng/µL, respectively. The stock concentration and a series of 2-fold serial 
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dilutions (1:2 to 1:32768) were prepared in nuclease-free water to yield a series 
of quantification standards ranging from 30fg/µL to 10ng/µL. 
§ 3 - 2.2 HPLC Quantification Assays 
All HPLC quantification assays were performed in quintuplicate using a 
DNASep® analytical column packed with alkylated poly(styrenedivinylbenzene) 
resin (Huber et al., 1993) installed in a WAVE® 3500HT Nucleic Acid Fragment 
Analysis System (Transgenomic Inc., Omaha, NE). Stock and each of the serially-
diluted quantification standards were injected (20µl/injection) at a 0.9ml/min 
flow rate and allowed to bind the DNASep® column at 50°C in the presence of 
0.1M triethylammonium acetate (TEAA) pH 7.0 as an ion pairing reagent. DNA 
fragments were sequentially eluted on the basis of size using a gradient of 
increasing acetonitrile produced by differential mixing of buffer A (0.1M TEAA) 
and buffer B (0.1M TEAA:25% ACN). Starting with a mixture of 63% buffer A and 
37% buffer B, the optimal gradient for the quantification assays employed 
stepwise increases to 42.1%, 58.8%, 63.1%, 65.2%, 66.3% and 67.1% of buffer B 
in 3.5 min., 2.0 min., 1.6 min., 1.5 min., 1.5 min., and 1.4 minutes, respectively. 
Eluted DNA fragments were detected by UV absorbance (260nm) and 
fluorescence (ex. 490nm; em. 520nm). Fluorescence detection employed a 
proprietary DNA intercalating dye (WAVE® Optimized HS staining solution I) 
injected downstream of the UV detector using an inline high sensitivity accessory 
(HSX) pump (Transgenomic, Inc.). Due to signal saturation, quantification 
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standards at ≥3.75ng/µL DNA were not assayed by fluorescence. The peak height 
(mV) and peak area (mV*msec) were determined using the Transgenomic 
Navigator™ peak analysis software and DNA quantities based on peak height and 
area were determined by regression analysis. 
§ 3 - 2.3 Mitochondrial DNA Extraction and Purification 
This research was conducted in compliance with U.S. Federal Policy for 
the Protection of Human Subjects (56 FR 28003). Casework-type samples were 
prepared from buccal swabs, peripheral blood, saliva, semen and a variety of hair 
(0.5cm of shaft only) samples collected from individuals who had provided 
informed consent to participate in the study. To test the potential impact of 
different substrates commonly encountered in a forensic context, DNA extracts 
were prepared from biological stains (10μL peripheral blood, semen or saliva) 
applied to nylon fabric, synthetic carpeting, leather, unpainted wood or 
wallboard. To test the potential impact of environmental insult, DNA extracts 
were prepared from 10μL aliquots of peripheral blood, semen or saliva deposited 
on Pur-Wraps® sterile cotton tipped applicators (Hardwood Products, Guilford, 
ME) that had previously been dipped in a slurry of top soil / nanopure water 
(50:50 w/v), laundry detergent, used motor oil, gasoline, 1M sodium hydroxide 
or 1M acetic acid and allowed to dry for 2 hours at room temperature. Finally, 
DNA was extracted from head hairs (natural, dyed dark brown or permed), axial 
hair, pubic hair, a vaginal swab and aged human bone material (bones 
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generously provided by Dr. Randall Skelton, University of Montana, Missoula, 
MT). Bone samples were cleaned twice in 5% Tergazyme™, sonicated for 30-45 
min., rinsed in 95% EtOH, dried overnight at room temperature and then 
pulverized with a SPEX CertiPrep 6850 Freezer/Mill in accordance with 
manufacturers’ recommended protocol for small bone samples. Three, 4-min. 
cycles (2min grinding period, 2min cooling period) yielded a fine bone powder, 
200mg of which mixed with 700µL EDTA (0.5M, pH 8.5) and incubated at 37°C for 
24 - 48 hours. Total human DNA was then extracted from all samples using the 
EZ1 DNA tissue kit on the BioRobot EZ1 DNA extraction robot (Qiagen Inc., 
Valencia, CA); eluted into a final volume of 200μL of nuclease-free water. All 
extracts were stored at -20°C until used.  
Four forensically relevant regions of the human mitochondrial control 
region (i.e., HV1A, HV1B, HV2A and HV2B) were amplified using validated PCR 
primers (Wilson et al., 1995; LaBerge et al., 2003); 2.25U AmpliTaq GOLD® DNA 
polymerase (Applied Biosystems) supplemented with 0.25U Pfu DNA polymerase 
(Stratagene, La Jolla, CA); AmpliTaq GOLD® Buffer with MgCl2 at a final 
concentration of 2mM (Applied Biosystems); 10nmol of each dNTP (Stratagene) 
and 10μL of an approximately 10pg/μL human genomic DNA extract. 
Amplifications were performed on a GeneAmp® 9700 thermocycler (Applied 
Biosystems) with an initial denaturation at 95°C for 10 minutes, followed by 32 
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cycles of 95°C for 20 seconds, 60°C for 30 seconds and 72°C for 45 seconds. The 
final extension at 72°C was for 15 minutes.  
Amplified PCR products were purified in preparation for DNA sequencing 
using one of three methods: Amicon Centricon-50® centrifugal filtration 
(Millipore Corporation, Billerica, MA), ExoSAP-IT® (USB Corporation, Cleveland, 
OH), or HPLC purification on the WAVE® 3500HT Nucleic Acid Fragment Analysis 
System. Column purification employed two washes (2ml each of nuclease-free 
H2O) using the Amicon Centricon-50® spin columns per the manufacturer’s 
protocol. ExoSAP-IT® treatment was performed per manufacturer’s protocol 
using 2µL of proprietary ExoSAP-IT® reagent / 5µL amplified DNA product and 
incubation at 37°C and 80°C for 15 minutes each. HPLC purification employed 
5µL and 20µL injection volumes and an optimized gradient (56.5% to 65.5% 
buffer B increase in 4.5 minutes) for HV1A, HV2A and HV2B and (56.3% to 65.3% 
buffer B increase in 4.5 minutes) for HV1B. Samples were eluted at 0.9ml/min 
flow rate, detected by UV at 260nm and quantified based on a MassRuler™ 
Express DNA Ladder standard curve. Samples containing >200ng were diluted 
and reassayed until the chromatographic peak was within the bounds of the 
standard curve. Eluted peaks were captured using an automated fraction 
collector (Transgenomic, Inc.); dried by vacuum centrifugation for 30 minutes at 
50°C followed by a 20-minute cool down to ambient on a CentriVap® Vacuum 
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Concentrator (Labconco Corporation, Kansas City, MO). Samples were 
resuspended in nuclease-free H2O; and stored frozen until DNA sequencing. 
§ 3 - 2.4 Mitochondrial DNA Sequencing 
Dye-terminator sequencing was performed using the BigDye® Terminator 
v1.1 Cycle Sequencing Kit (Applied Biosystems). Labeling reactions (10µl total 
volume) were prepared in accordance with the manufacturer’s protocol using 
0.8ng of template DNA. Dye-terminated products were purified by Performa® 
DTR V3 96-well short plate purification columns (Edge Biosystems, Gaithersburg, 
MD) and resolved on the PRISM® 310 Genetic Analyzer (Applied Biosystems) 
according to the manufacturer’s protocols using the POP-6™ polymer and 47cm x 
50µm capillaries (Applied Biosystems). The raw electrophoretic traces were 
analyzed using the KB Basecaller (Applied Biosystems) together with the 
appropriate dye set mobility file for the v1.1 kit. Appropriate positive, negative 
controls and reagent blank controls were carried through the entire sample 
handling process to monitor for contamination and reagent integrity.  
The resulting sequence data were displayed using both the Sequencing 
Analysis Software v.5.1.1 (Applied Biosystems) and Sequencher™ v4.2 DNA 
analysis software (Gene Codes Corp, Ann Arbor, MI). QV scores were 
automatically calculated by the Sequencing Analysis Software using the equation 
QV=-10log10(Pe) where Pe is the probability of an error in a base call. While QV 
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scores range from 0 to a theoretical maximum of infinity, the sequence analysis 
software only reports QV scores within a 1-99 range. In general, QV scores of 1-
20 at pure base positions generally indicate a low-quality base call while those of 
20-50 or higher (i.e., QV20+) indicate a high-quality base call. Mixed base 
positions typically have lower QV scores than non-mixed positions Sequence 
quality was evaluated on the basis of both QV20+ Scores and Trace Scores – the 
latter being the average of all QV scores across the entire post-trimmed 
sequence. (Biosystems, 2003). 
§ 3 - 3 Results 
§ 3 - 3.1 Quantitation of PCR Yield on a DNASep® Column 
Using a non-denaturing column temperature of 50°C, double-stranded 
DNA can be readily fractionated to yield a trace in which the height and area of a 
chromatographic peak reflect the quantity of eluted DNA. To evaluate the 
accuracy and reproducibility of using these peak parameters to calculate PCR 
yield, a commercial double-stranded DNA quantification standards and a series 
of serial dilutions were fractionated by HPLC using a DNASep® column. Each of 
the resulting chromatographic traces was characterized by the presence of six 
DNA peaks representing double-stranded fragments ranging in size from 100bp - 
1000bp, as described above. Based on the quantification standards used, the 
lower limit (Mean±SD) for reproducible UV and fluorescence detection was 
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1.85±0.56ng and 30.9±1.4pg, respectively based on automated peak detection by 
the Navigator™ analysis software (Transgenomic, Inc.).  
Figure 3.1 displays the regression between an injected DNA quantity and 
either the height or area of the resulting chromatographic peak based on UV 
detection at 260nm. The linear regressions for each size standard based on peak 
height (figure 3.1A) had coefficients of determination which ranged from 0.960 
(1000bp fragment) to 0.999 (100bp and 200bp fragments). The linear regressions 
for each size standard based on peak area (figure 3.1B) had coefficients of 
determination ranging from 0.908 (1000bp fragment) to 0.999 (100bp, 200bp 
and 300bp fragments). 
As presented in figure 3.2, a second degree polynomial regression was 
found to best delineate the relationship between an injected DNA quantity and 
the height or area of the resulting chromatographic peak based on fluorescence 
detection data. The coefficients of determination for the polynomial regressions 
based on peak height for each size standard (figure 3.2A) ranged from 0.991 
(200bp fragment) to 0.999 (700bp and 1000bp fragments). When based on peak 
area (figure 3.2B), the coefficients of determination for the resulting polynomial 
regressions were 0.998 (100bp and 200bp fragment) to 0.999 (300bp, 500bp, 
700bp and 1000bp fragments). 
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Figure 3.1: Linear regression analysis of (A) peak height and (B) peak area data 
collected by UV detection at 260nm. 
 
A 
B 
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Figure 3.2: A second degree polynomial regression analysis of (A) peak height 
and (B) peak area data collected by fluorescence detection using a proprietary 
DNA intercalating dye and the HSX high sensitivity accessory.  
A 
B 
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§ 3 - 3.2 Efficiency of PCR Product Recovery and Sequence Quality 
To determine the efficiency of PCR product recovery associated with 
DNASep® column purification, 100ng, 70ng, 50ng, 30ng, 20ng and 10ng of the 
commercial quantification standards (100bp, 200bp, 300bp, 500bp, 700bp and 
1000bp, respectively) were assayed in triplicate. For each size fragment, the DNA 
represented by the resulting chromatographic peak was detected by UV, 
physically recovered by an automated fraction collector, dried and then 
reassayed by HPLC on a DNASep® column and quantified by comparison to the 
MassRuler™ Express DNA Ladder standard curve. The average±SD recovery 
efficiencies were found to be 72.68±2.6%, 70.05±7.9%, 63.58±5.9%, 69.6±7.7%, 
64.9±7.2%, 60.76±8.3% for the 100bp, 200bp, 300bp, 500bp, 700bp and 1000bp 
fragments, respectively.  
To compare the quality of sequence data obtained from templates 
purified by HPLC on a DNASep® column versus alternate cleanup methods 
currently used in many forensic laboratories, mtDNA was amplified from extracts 
of five dried 10µL spots of whole blood. Aliquots (40µL) of the crude post-
amplification product were purified by either HPLC using a DNASep® column, 
ExoSAP-IT® treatment or Amicon Centricon-50® spin columns. Detail from 
examples of sequencing electropherograms generated from dye-terminator 
labeling of 0.8ng of purified PCR product are presented in figure 3.3. All three 
post amplification cleanup methods yielded full-length sequences (257 bp) with  
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Figure 3.3: Examples of sequencing electropherograms generated using the 
BigDye® Terminator v1.1 Cycle Sequencing Kit and 0.8ng input DNA. HPLC 
purification shows higher signal-to-noise ratio than either Spin column or 
ExoSAP-IT® purification methods. Y-axis (max 2000 RFU) is the same for all three 
purification methods. 
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high quality base calls. Averaged across the five replicate sequencing reactions 
for each purification method, the overall trace scores (i.e., average QV for all 
bases) were 55.6, 54.6 and 54.4 and the QV20+ scores were 252.4, 251.2, and 
251.2 for the samples purified by HPLC, ExoSAP-IT® treatment, and Amicon 
Centricon-50® spin columns, respectively. The ratio of sequence signal to 
baseline noise across each trace was also assessed as an indicator of sequence 
quality. Averaged across the five replicate sequencing reactions for each 
purification method, total baseline noise accounted for 4.86±0.69%, 6.04±1.68% 
and 6.52±0.54% of total signal for the samples purified by HPLC, ExoSAP-IT® 
treatment, and Amicon Centricon-50® spin columns, respectively.  
§ 3 - 3.3 Casework type Samples  
A diversity of casework type samples (Table 3.1) were employed to assess 
the accuracy of using HPLC on a DNASep® column to simultaneously quantify and 
purify post-amplification products in preparation for DNA sequencing. For each 
sample, the amount of post-amplification product (ng) was determined based on 
area of the chromatographic peak. This value was used to determine the volume 
of sterile water in which to resuspend the purified mtDNA fragment (1.0µL 
ddH2O per 0.8ng of DNA) for dye-terminator labeling. The robustness of this 
approach was evaluated on the basis of the quality of the resulting sequence 
data. Pristine reference type samples were prepared from dried peripheral blood 
or buccal cells on sterile cotton swabs. Recognizing that PCR amplification of  
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Table 3.1: Summary of casework-type samples used in the study. Samples were 
isolated from a variety of substrates and exposed to a variety of environmental 
degradation. DNA yield depended on HPLC injection volumes as well as inhibition 
to amplification. QV and QV20+ scores obtained were highly consistent. 
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reference samples is typically robust, only 5µL injection volumes were used for 
HPLC purification. The amount of purified post-amplification product ranged over 
nearly an order of magnitude from 8.6ng (Item 1, buccal swab) to 81.0ng (Item 4, 
blood swab). The resulting sequence data were characterized by QV20+ scores of 
241 to 256 for sequences having 251 to 258 called bases and high trace scores of 
49 to 59 representing an average basecalling confidence level of 99.9987% to 
99.99987% across the post-trimmed sequence.  
The potential impact of a diversity of substrates (i.e., carpet, blue denim, 
leather, nylon fabric, wallboard and wood) from which biological stains (blood, 
saliva, and semen) could be collected was also tested. Not knowing the extent to 
which a given substrate might influence PCR amplification, 20µL injection 
volumes were used for HPLC purification. Following quantification and 
purification by HPLC, the recovered post-amplification products were labeled and 
sequenced as described above. All samples amplified successfully with yields 
ranging from 63.1ng (Item 7, blood on leather) to 443ng (Item 13, saliva on 
carpeting). Regardless of the yield of the PCR reaction, the resulting sequence 
data generated from DNA quantified and purified by HPLC were of uniformly high 
quality. Trace scores ranged from 44 to 50 (i.e., 99.996% to 99.999% confidence) 
and QV20+ scores ranged from 233 to 249 for sequences having 251 to 258 
called bases.  
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To assess the potential impact of common environmental insults (i.e., 
laundry detergent, gasoline, used motor oil, soil, 1M sodium hydroxide and 1M 
acetic acid), biological stains intermixed with these contaminants were extracted 
and amplified. As before, 20µL injection volumes were used for HPLC 
quantification and purification. All samples amplified and yielded from 11.5ng 
(Item 27, blood with soil) to 462.6ng (Item 24, blood with acetic acid). 
Sequencing of the recovered post-amplification products yielded high quality 
results. Trace scores ranged between 45 and 50 (i.e., 99.997% to 99.999% 
confidence) and QV20+ scores were between 237 and 250 for sequences having 
a total of 251 to 258 called bases.  
To test the utility of HPLC quantification and purification with challenging 
samples more typically encountered in a forensic mtDNA context, a diversity of 
hair shafts (natural, dyed and permed), aged bone samples and vaginal swabs 
were also tested (Table 3.2). Vaginal swabs generally yielded the highest 
quantities of post amplification product on average and the resulting sequence 
quality was excellent with trace scores between 46 and 49 (i.e., 99.9974% to 
99.9987% confidence) and QV20+ scores of 248 to 251 out of 257 to 258 bases 
called. As expected, amplification yields with hair and bone samples were 
frequently lower than with DNA extracts of blood, saliva or semen. Using a 20µL 
injection volume, the amplification yield from hair shaft extracts range from 
32.9ng (Item 49, permed head hair) to 394.3ng (Item 46, untreated head hair).  
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Table 3.2: Summary of hair, bone and vaginal swab samples used to validate 
HPLC as a tool for single step purification and quantification. HPLC and dye-
terminator sequencing detected mixtures in 4 of 5 bone samples and length-
heteroplasmy in 6 of 19 hair samples.  
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Using a 5µL injection volume, the yield of HPLC purified DNA ranged from 
14.2ng (Item 42, dyed head hair) to 59.9ng (Item 41, dyed head hair). The lowest 
yields were seen with bone samples where a 20µL injection volume yielded as 
little as 2.7ng of amplified DNA (Item 33, aged bone) for labeling. Regardless of 
the tissue employed, the amplification yield or the injection volume purified, all 
post-amplification products that were quantified and purified by HPLC yielded 
high quality sequence data characterized by trace scores which, except for 
heteroplasmic samples, ranged from 44 to 57 (i.e., 99.996% to 99.9998% 
confidence). Similarly, the QV20+ scores for the same samples ranged from 241 
to 252 for sequences in which 256 to 258 base calls were made. Although 
sequence results from four of five aged bone samples presented as mixtures, the 
overall quality of these sequences was still high with trace scores of 46 to 48 (i.e., 
99.9974% to 99.9984% confidence) and QV20+ scores 243 to 248 out of 256 to 
258 base calls.  
§ 3 - 3.4 HPLC Purification and Length Heteroplasmy 
Mitochondrial DNA length heteroplasmy most commonly occurs in 
association with the C-stretch motifs in HV1 and HV2B. Length heteroplasmy 
arising from insertion/deletion events at other positions may also be 
encountered when processing either reference or casework type samples. In the 
current study, length heteroplasmy was readily identified during HPLC 
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purification and quantification. As illustrated in figure 3.4, each single-base 
length variant forms a clearly discernible shoulder adjoining the chromatographic 
peak of the primary amplification product (figure 3.4, buccal swab). In cases 
where the quantity of a length variant approaches that of the major product, a 
separate chromatographic peak forms before or after the major product peak 
with shorter or longer variants, respectively (figure 3.4, blood stain). Non-length 
(i.e., substitution) variants were not distinguishable from the major product 
under non-denaturing conditions used for post-amplification quantification and 
purification.  
Using casework-type samples, length heteroplasmy was observed in the 
chromatographic traces for either the HV1A or HV2B fragment of 6 out of 19 
hairs tested. In each case, the resulting sequence electropherograms confirmed 
the length heteroplasmy. In no case was heteroplasmy detected by sequencing 
but not by HPLC. In terms of sequence quality, heteroplasmic samples tended 
toward slightly lower trace scores which ranged from 38 to 48 (i.e., 99.984% to 
99.9984% confidence) even for data outside of the region directly impacted by 
the length polymorphism. The same was seen in the QV20+ scores which ranged 
from 194 to 239 for sequences where 257-258 base calls were made.  
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Figure 3.4: An example of length heteroplasmy as detected by HPLC at a non-
denaturing DNASep® column temperature of 50°C. Secondary and tertiary length 
variants are detected as shoulders prior to the primary length component. 
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§ 3 - 4 Discussion 
Reaction cleanup and yield quantification prior to dye-terminator labeling 
is an essential part of obtaining accurate and high quality sequencing 
electropherograms. Validation of a highly automated system for quantification, 
purification and characterization (i.e., length heteroplasmy) of amplified PCR 
products has, therefore, been conducted in order to streamline the processing of 
casework-type mtDNA samples. Results of validation studies presented, show 
that quantification and purification of crude PCR products can be performed in a 
highly automated manner while also differentiating target PCR amplicons from 
non-specific double-stranded amplification products.  
Quantitation results of PCR yield by HPLC under non-denaturing 
conditions are highly consistent across all six tested fragment ranges for both UV 
and fluorescence detection. While reported detection limits were determined 
using the Navigator™ analysis software’s automated peak detection and analysis, 
manual determination of peak appearance and analysis of peak height and peak 
area yielded detection limits in accordance with manufacturer’s specifications 
(UV: approx. 0.5ng and fluorescence: <10pg, www.transgenomic.com, data not 
shown). Regression analyses of both peak height and peak area show that 
determination of DNA quantity is highly consistent, although determination of 
peak area is more consistent across multiple fragment sizes. With the occurrence 
of a secondary peak (due to length heteroplasmy of mtDNA samples) or peak 
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broadening, the use of peak height can underestimate the total quantity of PCR 
product present in the sample. Realizing that peak height determination is not 
always possible, due to various length variants within the same amplification 
product, quantity determination using peak area is, therefore, a more reliable 
method for quantity determination. 
Efficiency of PCR product recovery using DNASep® column purification 
was determined to be similar to results reported for ExoSAP-IT® and the 
QIAquick PCR Purification columns in Dugan et al., The benefit, however, is that 
DNASep® column purification yields information regarding PCR efficiency (e.g., 
target quantity, presence of spurious amplification products, length variants, 
etc.) in a single fully automated step. 
Sequence quality obtained by dye-terminator labeling using the BigDye® 
v1.1 Cycle Sequencing Kit for dried blood spots was slightly higher when purified 
by HPLC on a DNASep® column versus alternate cleanup methods. All purification 
methods yield high quality electropherograms (with average QV20+ scores above 
250 for a 257bp product), although only the HPLC purification allows for definite 
determination of low level heteroplasmy at position 292 as compared to the 
Cambridge Reference Sequence (Figure 3.3). This is due to the overall greater 
signal-to-noise ratio of basecalls for the HPLC purified samples.  
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The quality of sequencing electropherograms extends into the casework 
type samples employed in this study. Results obtained from a diversity of 
casework type samples employed in this study and the overall high quality scores 
(QV and QV20+) of electropherograms obtained show that purification of crude 
PCR reactions and simultaneous determination of PCR yield by HPLC is a reliable 
and consistent platform for obtaining quality mtDNA sequencing 
electropherograms. Additionally, the ability to accurately determine and 
standardize the DNA input quantity and not having to subsequently adjust 
sequencing run parameters to obtain good quality electropherograms saves 
valuable analyst time and increases productivity. 
The ability of HPLC to detect length variants expands on the ability of 
purification and quantification of crude PCR products. Traditionally, this critical 
information is only obtained following direct sequence analysis and requires 
additional labeling reactions and often the use of C-stretch flanking primers. By 
gaining knowledge of length variants prior to dye-terminator sequencing, the 
analyst can setup the sequencing analyses accordingly. This significantly 
increases turnaround of challenging mtDNA samples and alleviates repetition of 
result analysis.  
The current study has validated the utility of HPLC to purify and quantify 
mtDNA amplicons in a single step. As an additional step in streamlining mtDNA 
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analysis, HPLC also yields length characteristics of mtDNA amplicons prior to dye-
terminator sequencing. The quality of mtDNA sequences obtained in this study 
show that HPLC purification and quantification outperforms current standards in 
mtDNA sample processing. 
§ 3 - 5 Summary 
High-Performance Liquid Chromatography (HPLC) using a DNASep® 
column was evaluated as a means of quantifying PCR product yield and 
simultaneously purifying target amplicons for downstream applications such as 
DNA sequencing. The approach is based on the inherent ability of HPLC to 
fractionate by size, quantify and physically recover macromolecules. Using a 
commercial six fragment DNA quantification standard, a standard curve was 
generated for both UV and fluorescence detection, followed by recovery, 
quantification and sequence analysis of a variety of casework and reference-type 
samples. Samples purified by HPLC were compared to commonly used forensic 
purification methods (i.e., ExoSAP-IT® and Spin column) and yielded improved 
sequencing results. Samples purified and quantified by HPLC yielded significantly 
improved QV and QV20+ scores over data reported in the general forensic 
literature. Determination of length-heteroplasmy within mtDNA amplicons 
yielded additional and important pre-sequencing data not seen by other 
methods. The current study demonstrates that HPLC has tremendous utility in 
96 
 
streamlining purification and quantification of target amplicons for downstream 
applications and in the same step determining length-heteroplasmy of mtDNA 
amplicons. 
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Chapter 4: Peak Height Reproducibility as an Indicator of 
Mitochondrial DNA Sequence Quality for Forensic 
Analyses 
§ 4 - 1 Introduction 
Dye-terminator sequencing is one of the most widely used methods in 
modern molecular genetics and medical diagnostics. This approach has also been 
established as the technology of choice for typing hypervariable regions 1 and 2 
(HV1 and HV2) of the control region of the human mitochondrial DNA (mtDNA) 
genome by forensic laboratories. In this context, mtDNA sequencing has been 
used to analyze a diversity of evidentiary materials including hair shafts, saliva 
and bone even in cases where the biological source material has undergone 
significant decomposition or environmental insult (Hagelberg and Clegg, 1991; 
Hagelberg et al., 1991; Holland et al., 1993; Allen et al., 1994; Ivanov et al., 1996; 
Allen et al., 1998).  
Positive, negative and reagent blank DNA amplification/labeling controls 
are typically included in the standard operating procedures of forensic mtDNA 
laboratories for quality assurance/quality control purposes. These serve to 
demonstrate that the reagents used in this process are functional and free of 
extraneous contaminating DNA. The resulting DNA sequence data are then 
assessed primarily on the basis of basecalling quality scores and the watchful eye 
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of trained forensic analysts. A variety of sequence vicissitudes, however, can 
often compromise what would otherwise be the straight forward process of 
basecalling. These include, differential mobilities of DNA fragments due to 
chemical differences among the dye-terminators, differential dye-terminator 
incorporation efficiencies (Parker et al., 1996), excessive “noise” from 
unincorporated dye-terminators, sequence compressions - especially in area of 
GC-richness (Sanger and Coulson, 1975), and a general loss of peak-to-peak 
signal resolution with poor signal-to-noise ratios toward the end of long 
electropherograms.  
Basecalling software programs processes DNA sequence 
electropherogram files and assign a base quality score to each call using the 
equation QV=-10log10(Pe) where Pe is the probability of an error in a base call 
(Biosystems, 2003). Based on an examination of peak spacing, the ratio of the 
largest uncalled to the smallest called peak and the degree of peak resolution 
expected in a given window, it is typically possible to distinguish between errors 
and correct base-calls. The “KB” Basecaller from Applied Biosystems (Foster City, 
CA) employs such an algorithm.  
While base quality scores indicate the confidence with which individual 
base calls have been made relative to theoretical optimum, they do not 
necessarily serve as a measure of the extent to which the quality of a sequencing 
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reaction deviates from what would be seen for an actual reference sample. It is 
thus conceivable that base quality scores alone might not readily reflect subtle 
differences in the reproducibility of sequencing reactions. Such differences can 
be significant in a forensic context when comparing sequence data generated 
from different laboratories, different DNA extracts, different input DNA 
quantities or different labeling kits. Similarly, base quality scores do not 
necessarily compensate for reproducible anomalies (e.g., deviations from the 
theoretically optimal base spacing) that are commonly seen in sequence 
electropherograms. 
In cycle sequencing reactions, the efficiency with which dye-labeled 
terminators are incorporated can be highly variable between any two positions 
reflecting both the chemical differences between the dye-terminators and the 
influence of sequence context (Khan et al., 1999). The resulting 
electropherograms, therefore, are typically characterized by a pattern of peaks 
that are often significantly uneven in their heights relative to each other. Such 
variability can have a negative impact on basecalling confidence with existing 
basecalling algorithms. The ability to predict relative differences in peak heights, 
however, could be used to improve sequence accuracy. Moreover, if the pattern 
of peak height variability were highly reproducible, the pattern itself could be 
employed as a parameter for assessing the quality of a given sequencing reaction 
relative to an actual reference standard. This has important implications for 
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laboratory validation and quality assurance efforts since it would enable analysts 
to automatically spot check a sequence to determine whether the global 
“electrophoretic pattern” is within an acceptable range of sample-to-sample 
variability for a specific amplicon and the instrumentation in a specific 
laboratory.  
Quantifying the reproducibility of an “electrophoretic pattern” may also 
facilitate the analysis of mixed samples including heteroplasmic as well as 
situational mixtures of more than one individual. This is based on the reasonable 
expectation that after accounting for spectral differences in dye terminator 
fluorochromes, relative differences in peak heights are fundamentally a function 
of the underlying difference in the quantity of terminated DNA molecules. Thus, 
any significant change in the relative height of a given peak should reflect a 
change in the underlying quantity of DNA at that position. Some researchers 
have attempted to quantify the level of heteroplasmy by comparing the relative 
heights of overlapping electrophoretic peaks (Sekiguchi et al., 2003). In the 
absence of data on peak height reproducibility, however, such measures are only 
rough approximations. In an effort to achieve greater quantitative accuracy, 
some researchers have relied on alternative approaches such as quantitative 
real-time PCR (Bai and Wong, 2004), pyrosequencing (White et al., 2005) or 
endpoint assays that employ densitometry (Tengan et al., 1997). These 
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approaches, however, consume additional sample while often being laborious or 
requiring instrumentation not typically found in a forensic laboratory.  
The first objective of the current study, therefore, was to assess the 
quantitative reproducibility of electrophoretic peak heights for the HV1 and HV2 
regions of human mtDNA as a function of DNA input quantity, base location and 
sequencing chemistry. The second objective was to determine whether a 
quantitative pattern of relative peak height differences across a high-quality 
reference electropherogram could be used to accurately assess the quality of 
DNA sequencing results from subsequent sequencing reactions.   
§ 4 - 2 Materials and Methods 
§ 4 - 2.1 Mitochondrial DNA Extraction and Purification 
This research was conducted in compliance with U.S. Federal Policy for 
the Protection of Human Subjects (56 FR 28003). Samples were collected from 
subjects who were unrelated and had provided informed consent to participate 
in the study. Mitochondrial DNA was extracted from buccal swabs using the EZ1 
DNA tissue kit on the Qiagen BioRobot EZ1 DNA extraction robot (Qiagen Inc., 
Valencia, CA) according to the manufacturer’s protocol. Briefly, whole swabs 
were immersed in 190µL of Qiagen’s proprietary “G2 Buffer” and 10µL of 
proteinase K solution (600mAU/mL), vortexed for 10 sec. and incubated at 56°C 
for 15 min. The digested supernatant was transferred to a sterile 2mL sample 
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tube and loaded onto the BioRobot EZ1 where samples were automatically 
extracted using paramagnetic beads and eluted into 200µL DNA free water. 
Validated primer pairs and PCR amplification conditions (Wilson et al., 1995; 
Budowle et al., 2000) were used to amplify four forensically relevant regions of 
the human mitochondrial control region (i.e., HV1A, HV1B, HV2A and HV2B 
amplified by primer sets, A1/B2, A2/B1, C1/D2 and C2/D1, respectively) except 
that AmpliTaq GOLD® DNA polymerase (Applied Biosystems) was used and 
supplemented with high-fidelity Pfu DNA polymerase (Stratagene, La Jolla, CA) at 
a 9:1 ratio. 
Amplification reactions were purified by denaturing high-performance 
liquid chromatography (Huber et al., 1993; Kuklin et al., 1997) on a WAVE® 
3500HT Nucleic Acid Fragment Analysis System (Transgenomic Inc., Omaha, NE). 
Briefly, unpurified PCR products were bound to a DNASep® analytical column at 
50°C in the presence of 0.1M triethylammonium acetate (TEAA) pH 7.0 as an ion 
pairing reagent. Target PCR amplicons were selectively eluted using a linear 
gradient of increasing acetonitrile produced by differential mixing of buffer A 
(0.1M TEAA) and buffer B (0.1M TEAA: 25% ACN). The optimal gradients 
employed a 56% to 65% buffer B increase in 3.5 minutes for HV1A, HV2A and 
HV2B and a 55% to 64% buffer B increase in 3.5 minutes for HV1B. All samples 
were eluted at 0.9ml/min flow rate and detected by UV at 260nm. Eluted peaks 
were captured using an automated fraction collector; dried by vacuum 
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centrifugation (30 minutes at 50°C, followed by a 20-minute cool down to 
ambient temperature); resuspended in ddH2O; quantified by 260/280nm UV 
spectrophotometry and stored frozen until dye-terminator labeling. 
§ 4 - 2.2 Mitochondrial DNA Sequencing 
DNA sequencing reactions were prepared for each of four control region 
amplicons. Use of the eight aforementioned PCR primers for labeling allowed 
each amplicon to be sequenced in both the forward and reverse directions. 
Reactions prepared using the BigDye® Terminator v1.1 Cycle Sequencing Kit 
(Applied Biosystems) used five different DNA input quantities (0.1ng, 0.2ng, 
0.4ng, 0.8ng and 1.6ng) while those prepared using the BigDye® Terminator v3.1 
Cycle Sequencing Kit (Applied Biosystems) used three different DNA input 
quantities (0.4ng, 0.8ng and 1.6ng). For all samples and conditions tested, five 
independently-labeled replicate 10µl reactions were prepared in accordance 
with the manufacturer’s protocol. Appropriate positive and negative controls 
were carried through the entire sample handling process to monitor for 
contamination and reagent integrity.  
Dye-terminated products were purified by Performa® DTR V3 96-well 
short plate purification columns (Edge Biosystems, Gaithersburg, MD) per the 
manufacturer’s protocol and resolved on a PRISM® 310 Genetic Analyzer 
(Applied Biosystems) using POP-6™ polymer and 47cm x 50µm capillaries 
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(Applied Biosystems). The raw electrophoretic traces were analyzed using the KB 
Basecaller together with the dye set mobility files indicated for the labeling kit 
used. The resulting sequence data were displayed using the Sequencher™ DNA 
analysis software (Gene Codes Corp, Ann Arbor, MI). 
Quantitative data on peak heights for statistical analyses of 
electrophoretic patterns were obtained by first analyzing raw electrophoretic 
data using the KB Basecaller which is part of the PRISM® 310 Sequencing Analysis 
Software version 5.1 (Applied Biosystems). The resulting .scf output file was then 
ported to the CEQ™ 8000 Genetic Analysis System version 8.0 software package 
(Beckman-Coulter, Fullerton, CA) to allow output of the electrophoretic peak 
height data for each channel and time point as a .txt file. Text files were then 
opened in Microsoft Excel for subsequent statistical analyses. The height of each 
peak in relative fluorescence units (RFU) was compared across the five replicates 
for each amplicon, sequencing primer, input DNA quantity, and sequencing 
chemistry tested. 
§ 4 - 3 Results 
The reproducibility of electrophoretic traces across the mtDNA HV1 and 
HV2 region was evaluated. A total of five different DNA template input quantities 
(0.1ng - 1.6ng); encompassing a range frequently encountered by forensic 
practitioners were used. For these analyses, each of four forensically-relevant 
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mtDNA amplicons was sequenced in both the forward and reverse directions. 
The resulting eight dye-terminator labeling reactions were independently 
replicated five times each for statistical purposes.  
Figure 4.1 presents an example of peak height and statistical variability 
data (RFU ± SD) for nucleotide positions 140 - 180 of HV2A at labeling reaction 
DNA input quantities of 0.4ng, 0.8ng and 1.6ng. Across these DNA input 
quantities, the heights of individual electrophoretic peaks and, therefore, the 
overall “pattern of relative peak height differences” was highly reproducible. This 
is exemplified by the consistently low peaks for 147C and 164C versus the 
consistently high peaks for 143G and 160A. Although the data presented in figure 
4.1 represent a small portion of the HV2A amplicon, they are consistent with the 
results that have been obtained for the entire HV1 and HV2 region. The 
sequencing traces obtained using lower DNA input quantities (0.1ng and 0.2ng) 
were similarly consistent (Appendix B). 
§ 4 - 3.1 Impact of DNA input quantity on peak height reproducibility 
Shown in Table 4.1 are peak height variability data for each of the eight 
labeling reactions used to sequence the HV1 and HV2 regions. These values 
reflect the variability in peak height averaged across all the peaks in the amplicon 
sequenced. Also shown is the combined peak height variability average of all 
sequencing reactions at each of five DNA input quantities. In order to 
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compensate for the often significant differences in peak heights between any 
two positions, variability data were expressed as a percentage of peak height 
(i.e.,. Coefficient of variation = SD/mean x 100%). 
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Table 4.1: Total variability (coefficient of variation with standard deviation 
normalized to individual peak heights) associated with direct sequence 
electropherograms for each of the four forensically relevant mtDNA amplicons 
which encompass HV1 and HV2. 
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Using the BigDye® Terminator v1.1 Cycle Sequencing Kit, 0.8ng of input 
DNA yielded the lowest overall variability (±4.0%) across all amplicons. The 
lowest input DNA quantity tested (0.1ng) had the highest average peak height 
variability at ±6.4%. At lower input DNA quantities (0.1ng and 0.2ng), there was a 
marked decrease in the signal-to-noise ratio particularly at the beginning of an 
electropherogram. Conversely, electropherograms generated using 1.6ng of 
input DNA were frequently characterized by fluorescence signal saturation, 
especially of G and T peaks and/or a marked degradation in peak resolution near 
the end of the trace.   
§ 4 - 3.2 Impact of positional location and sequence context on peak 
height reproducibility  
To determine whether a base’s positional location within an amplicon has 
an influence on electropherogram reproducibility, peak height variability was 
compared across the length of each sequenced amplicon at five DNA input 
quantities. Although the average variability across an amplicon (Table 4.1) ranged 
from ±1.4% (HV2A sequenced using the D2 primer at 0.4 - 0.8ng input DNA) to 
±10.0% (HV2B sequenced using the D1 primer at 0.1ng input DNA), variability 
was found to be very position dependent. As illustrated by an analysis of HV1A 
amplicon sequenced using the B2 primer (Figure 4.2), peak height variability is 
typically greatest immediately adjacent to the primer binding site. Variability 
decreases steadily towards the center of the amplicon; normally  
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Figure 4.2: Variability of electrophoretic peak heights across the HV1A amplicon 
sequenced using the B2 primer. To compensate for relative differences in peak 
heights, variability data (averaged for groups of ten bases) are expressed as a 
percentage of peak height. Values are based on five independent labeling 
reactions for each of the three DNA input quantities. Variability which is greatest 
adjacent to the primer binding site decreases towards the center of the amplicon 
and then rises toward the end of the labeled product. This pattern is more 
pronounced at input DNA quantities of 0.1ng and 1.6ng.  
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reaching a minimum 85-114bp downstream of the primer binding site. Variability 
then rises steadily as one approaches the end of the labeled product. This 
phenomenon is generally more pronounced at either low (0.1 - 0.2ng) or high 
(1.6ng) input DNA quantities (Appendix B).  
Nearest neighbor interactions are important to the thermodynamic 
stability of base pairing in nucleic acids.  To determine whether this has a 
significant impact the efficiency of nucleotide incorporation during dye-
terminator labeling, peak height variability was examined as a function of the 
preceding base for all HV1 and HV2 amplicons at all five input DNA quantities. 
Analysis of the resulting data by two-way non-parametric Kruskal-Wallis test 
showed no significant influence or interaction on peak height variability as a 
result of the preceding base at any DNA input quantity (H=0.0913, df=8, 
P=0.999).    
§ 4 - 3.3 Impact of sequencing chemistry on peak height 
reproducibility  
To determine whether peak height reproducibility is influenced by 
sequencing chemistry, two DNA input quantities (0.8ng and 1.6ng) were tested 
across the four labeling reactions used to sequence the HV1 region. Peak height 
variability averaged across an amplicon was found to be more variable with the 
BigDye® Terminator v3.1 than the v1.1 Cycle Sequencing Kit. At 0.8ng of input 
DNA, peak height variabilities for HV1 sequencing reactions ranged from 2.5% - 
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16.4% with the v3.1 chemistry versus 1.6% - 9.9% with the v1.1 chemistry. Similar 
results were obtained at 1.6ng of input DNA where the average peak height 
variabilities for HV1 sequencing reactions ranged from 2.6% - 21.5% with the v3.1 
chemistry versus 1.4% - 7.5% with the v1.1 chemistry. In addition to being more 
consistently reproducible, the v1.1 chemistry also yielded higher quality 
sequence data at lower DNA input quantities; provided sequence information 
immediately adjacent to the primer binding site and; more clearly resolved peaks 
throughout the electropherogram (Figure 4.3). 
§ 4 - 3.4 Evaluating sequence data relative to a “reference 
electropherogram” 
Given the overall reproducibility of “electrophoretic patterns”, it should 
be possible to use relative differences in the heights of adjoining peaks to assess 
how closely a “questioned electropherogram” conforms to a “reference 
electropherogram” and thereby to identify electrophoretic irregularities of 
potential interest in a questioned sequence. As an initial test of this approach, 
the electropherogram for HV1A (0.8ng of input DNA; A1 primer; the v1.1 
chemistry) was selected as a reference sequence. Using a prior moving average 
equation: 
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Figure 4.3: Examples of DNA sequence electropherograms obtained using 
BigDye® Cycle Sequencing chemistries. (3A) The v3.1 chemistry results in 
electropherograms characterized by lower quality scores and reduced resolution 
between adjoining peaks especially in regions of homopolymeric sequence. (3B) 
The v1.1 chemistry results in electropherograms characterized by higher quality 
scores and optimal resolution between adjoining peaks.  
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where “Q” and “R” are peak heights (RFU) in the questioned and reference 
samples, respectively, “P” is the predicted peak height and “n” is the base 
position in the electropherogram it is possible to generate a “predicted peak 
height pattern” for any questioned electropherogram based on a reference 
electropherogram. By comparing the “expected heights” to the actual peak 
heights in the questioned sample, it is possible to assess how closely the 
questioned electrophoretic pattern corresponds to the reference pattern.  
Figure 4.4 illustrates the use of this approach for comparative pattern 
analysis between the HV1A reference sequence mentioned above and the 
electropherogram for the HV1A region of a questioned sample. Deviations from 
the expected peak heights are readily indicated by the presence of “pattern 
perturbation spikes” in the comparison plot. In figure 4.4, there are a total of five 
spikes which represent deviations from the expected “reference pattern.” Three 
of these spikes (16086, 16129 and the compound spike from 16182 - 16186) are 
due to the fact that the questioned sample was a two-component (80:20 ratio) 
DNA mixture. The spikes reflect changes in the height of the major component 
peak where the underlying minor component differs in primary sequence (i.e., 
mixed based positions: 16086C/T, 16129A/G, 16182A/C, 16183A/C and 
16184T/C). The spike at 16089 reflects deviations from expected peak heights 
due to the proximal influence of the T→C base substitution at position 16086 in 
the minor component of this DNA mixture. Similarly, the spike at position 16185  
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- 16186 results from the proximal influence of the neighboring substitutions at 
positions 16182 - 16184. The spike at position 16048 cannot be traced to the 
direct/proximal influence of a base substitution and thus represents an “atypical 
perturbation spike”. Because they are unattributable to base substitutions, 
atypical spikes represent potential sequence electropherogram anomalies of 
particular interest. These phenomena will be addressed in the following sections.  
In a broader test of comparative electrophoretic pattern analyses, forty 
non-identical questioned samples (ten each for HV1A, HV1B, HV2A and HV2B) 
were compared to the cognate reference electropherograms pattern. Table 4.2 
shows the number of pattern perturbation spikes for each amplicon. These 
spikes were categorized as either “base substitution”, “proximal substitution” or 
“atypical” spikes. For all amplicons, base substitutions present in the questioned 
amplicons accounted, directly or through proximal effect, for 289 of 321 (90.0%) 
pattern perturbation spikes. Atypical spikes were less common, accounting for 32 
of 321 (10.0%) spikes.  
§ 4 - 3.5 Impact of base substitution on proximal peak heights 
To assess the impact of base substitution on the overall “pattern” of 
relative peak heights, sequencing traces representing each of four mtDNA 
amplicons were compared. Each amplicon was sequenced in both the forward 
and reverse directions at five different DNA input quantities (0.1ng - 1.6ng). 
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Table 4.2: Total number and causal distribution of peak perturbation spikes 
detected in pairwise analyses of 40 non-identical samples relative to the cognate 
reference sample for each amplicon and labeling primer. 
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A base substitution may influence the peak heights of surrounding bases. 
Based on analyses of 150 base substitution sites, the height of peaks within a 
range of -2 to +5 bases of the substitution site are most typically affected. This is 
not to suggest, however, that every peak within this window will necessarily be 
affected nor that such proximal effects cannot occur beyond it. Figure 4.5 
illustrates this for a T→C base substitution at position 16086. In addition to the 
expected change in channel in which the dye terminator fluorochrome is 
detected and height of the electrophoretic peak at the substitution point, the 
heights of the nearby peaks also showed a reproducible change in height. The 
largest changes were seen at 16084G, 16088T and 16089G. The heights of 
16084G and 16088T decreased while that of 16089G increased following the 
base substitution at 16086. The intervening peak heights for 16085C and 16087A, 
by contrast were unchanged.  
§ 4 - 3.6 Other anomalous impacts on peak heights 
Although the majority of pattern perturbation spikes are attributable to 
base substitutions, atypical spikes appear to have a different etiology. Among 
atypical spikes in the current study, 75.0% could be traced to poor signal quality 
typically at the beginning or end of a sequencing electropherogram. The 
remaining 25.0% of atypical spikes, however, were present in regions of high 
quality signal. In an effort to elucidate the underlying cause of the remaining  
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Figure 4.5: Superimposed electropherograms for a region of HV1A sequenced 
using the A1 primer illustrated the influence of a 16086T→C base substitution on 
the heights of proximal peaks. The largest changes involved decreases in peak 
heights at 16084G and 16088T and an increase at 16089G. This proximal effect 
did not impact the heights of the intervening peaks at 16085C or 16087A.  
120 
 
“atypical spikes”, raw and analyzed electropherograms were compared for these 
anomalous positions which were present in all four mtDNA amplicons. 
Figure 4.6 shows the analyzed electrophoretic traces for five replicate 
sequencing reactions of part of the HV1A amplicon sequenced with the B2 
primer. While there is almost complete consistency in the height for each peak 
across these independent reactions, the peak corresponding to 16182T has a 
significantly reduced height in the fifth replicate sample. This results in an 
atypical spike when compared to a reference sequence. Analyses of other 
atypical spikes in regions of good signal quality revealed a similar pattern (e.g., 
positions 16182 in HV1A; 16267 and 16284 in HV1B; and 158 in HV2A). In each 
case, the anomalous peak was nearly always the second base of a 3 - 5 base 
homopolymeric A- or C-stretch; reduced in height relative to the reference 
pattern; and did not appear to have any influence on the heights of neighboring 
bases. 
§ 4 - 4 Discussion 
Electrophoretic peak heights reflect the underlying quantity of DNA 
molecules terminated at a given position during the labeling process. The current 
study provides an evaluation of the reproducibility of peak heights in sequence 
electropherograms for human mtDNA amplicons commonly employed for 
forensic analyses. A thorough understanding of specific factors that may impact  
121 
 
 
Figure 4.6: Replicates of five sequencing reactions from HV1A sequenced with 
the B2 primer and the overall peak height consistency for each peak across 
multiple independent reactions. Note that the 16182T peak (arrow) of the last 
replicate is significantly lower than the corresponding peak in the preceding four 
replicates.  
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the reproducibility of a given electrophoretic trace can make it possible to rapidly 
identify genuine sequence irregularities thereby facilitating more efficient and 
accurate interpretation of mtDNA sequence data by lab analysts. 
DNA template quantities have a significant influence on peak height 
reproducibility and sequence quality. Across all four forensically-validated 
mtDNA amplicons, 0.4 - 0.8ng of input DNA yielded the lowest average peak 
height variability. Electropherograms generated using these optimal input 
quantities showed minimal noise associated with unincorporated dyes at the 
beginning of the sequence and minimal signal deterioration at the end of the 
sequence. Elevated peak height variability and lower signal-to-noise ratios were 
frequently seen with low DNA input (0.1 - 0.2ng) while signal saturation at high 
input (1.6ng) produced “phantom peaks” due to spectral pull up.  
Deconvolution of saturated electrophoretic peaks, which is required for 
basecalling, results in both an underestimation of a peak’s true height and 
greater peak height variability. Signal saturation also produces pull-up of the 
overlapping dye spectra. This artifact remains following application of the dye 
matrix and typically results in the appearance of false “phantom peaks” 
immediately before or after the saturated peak. Figure 4.7 illustrates this in a 
comparison of a 43bp stretch of HV1A sequence data for two DNA input 
quantities (1.6ng and 0.8ng). Signal saturation seen in the raw data for the 1.6ng  
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Figure 4.7: Comparison of raw and analyzed electrophoretic sequence data for 
HV1A sequenced using the A1 primer at two DNA input quantities. (7A) Use of 
1.6ng of template DNA in a dye-terminator labeling reaction was associated with: 
signal saturation of the raw data; phantom peaks produced by spectral pull-up in 
the analyzed data and; frequent low basecall quality scores. (7B) Use of 0.8ng of 
template DNA in a labeling reaction eliminated these anomalies in the analyzed 
data and resulted in basecall quality scores that were consistently high.  
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reaction (Figure 4.7A) resulted in the appearance of five clearly defined phantom 
peaks in the analyzed data – three of which were erroneously called by the 
sequencing software. In the absence of signal saturation, these were eliminated 
as illustrated by the analyzed data for the 0.8ng reaction (Figure 4.7B). This 
underscores the importance of accurate template quantification prior to dye-
terminator labeling. 
Given the sequence dependent folding characteristics of a DNA molecule, 
the context specificity of a base might be expected to influence the 
reproducibility of dye-terminator incorporation. Although small differences in 
peak height reproducibility were seen as a function of the preceding base, these 
differences did not approach statistical significance. The degree of 
electropherogram reproducibility was, however, found to vary as a function of 
location within an amplicon. Peak height variability was elevated both in the 
region immediately downstream of the labeling primer and at the end of the 
amplicon leaving the most reproducible peak heights clustered toward the center 
of the amplicon. Although this was seen at all DNA input quantities, use of 
optimal input DNA quantities (0.4 - 0.8ng) minimized the phenomenon. 
Two BigDye® Terminator Cycle Sequencing chemistries (v1.1 and v3.1) are 
commercially available for forensic applications. Although most forensic 
laboratories employ the v1.1 chemistry for mtDNA sequencing, the v3.1 
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chemistry has also been used for forensic casework (Cruz et al., 2004). On the 
basis of both reproducibility and peak quality, the v1.1 kit demonstrated superior 
performance. Quantitatively, electropherograms produced using the v1.1 kit 
were nearly twice as reproducible. Qualitatively, interpretable sequence reads 
typically began almost immediately after the primer and the resolution between 
peaks was greater – especially in homopolymeric regions (Figure 4.3). More 
critically for forensic laboratories, the v1.1 kit yields high quality sequence 
information at half the DNA input quantity required with the v3.1 kit. This is an 
advantage in cases where only minute quantities of DNA are recovered (e.g., 
degraded biological material). 
Given the reproducibility of sequencing electropherograms and having 
characterized the impact of DNA input quantity, positional location and 
sequencing chemistry, it may be possible to develop algorithms capable of 
assessing sequence quality relative to a reference electropherogram. In the 
current study, reproducible differences in the heights of neighboring 
electrophoretic peaks were used as a basis for comparison. When the height of 
an electrophoretic peak was either significantly higher or lower than what was 
expected based on the electropherogram from a corresponding reference 
sample, that peak resulted in the formation of a “pattern perturbation spike” as 
described previously. A number of factors, many of potential interest to a 
forensic analyst, can cause an electropherogram to deviate from the expected 
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reference pattern. These include base substitutions, mixed base positions and 
changes in the heights of peaks in the vicinity of a base substitution (i.e., 
“proximal affects”).  
The approach may also facilitate the detection of subtle sequence 
anomalies that are not evident from base quality scores. In the current study, for 
example, the occurrence of some “atypical spikes” revealed the presence of 
anomalies that were not linked to base substitutions, mixed base positions or 
regions of elevated peak height variability. Figure 4.8 highlights two bases 
(16267C and 16284A) which were found to be independently associated with 
atypical spikes. In figure 4.8A, the height of the 16267C peak is consistent with 
expectations based on the reference electrophoretic pattern while 16284A is 
abnormally low. Conversely, in figure 4.8B, this relationship is reversed such that 
16267C is abnormally low while the 16284A peak is consistent with the reference 
electrophoretic pattern. These anomalously low peaks, however, showed no 
corresponding indication of an anomalously low fluorescence signal in the raw 
data. Rather, the raw data appears indistinguishable between “normal” traces 
and those in which an atypical spike was seen. Furthermore, there does not 
appear to be an increase in noise or an obvious change in peak morphology that 
could account for this anomaly. Re-analysis of the same data set using a 
difference basecaller (i.e., ABI basecaller) eliminated the anomaly, suggesting a 
software problem. In consultation with software engineers at Applied 
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Figure 4.8: Illustration of the independent occurrence of two peak height 
anomalies within the same region of two of five replicates sequencing reactions. 
(8A) A low peak height anomaly is present at position 16267C while the peak 
height for 16284A is within expected values. (8B) A low peak height anomaly is 
present at position 16284A while the peak height for 16267C is within expected 
values. Although the anomalies are clearly evident in the analyzed data, 
comparison of the corresponding peaks in the raw data traces show no 
significant difference in peak height suggesting that the anomaly is due to a 
factor other than a reduction in fluorescence signal.  
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Biosystems, the consensus opinion is that the anomaly is likely the result of an 
unidentified bug within the KB Basecaller (Applied Biosystems, personal 
communication). The potential for this to adversely impact basecalling accuracy 
has not been determined. The fact that its occurrence can be detected through 
pattern analysis may assist analysts by focusing their attention on potentially 
problematic sequence data. 
The algorithm employed for the current study represents only one 
possible approach to the quantitative comparison of electrophoretic patterns. 
The results presented, while encouraging should not be interpreted at indicating 
that alternative algorithms might not provide superior detection of regions of 
sequence data that deviate from that of a reference pattern. The development 
and validation of an optimal algorithm was beyond the scope of the current 
study but represents an important focus for future research.  
Comparative analysis of electrophoretic patterns may have important 
potential as an added computational tool for forensic analysts working with 
mtDNA. First, the entire process can be readily automated and as a result may 
help to more readily direct an analyst’s attention to regions of sequence data 
worthy of heightened scrutiny. By using a known sample as the reference 
electropherogram, it could enable an analyst to more quickly and confidently 
include or exclude a questioned sample. From a laboratory QA/QC perspective 
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this approach may be useful as a rapid and reliable means of monitoring 
sequencing kit integrity and instrument performance based on pattern 
concordance with a laboratory reference standard. 
§ 4 - 5 Conclusion 
DNA sequencing analysis is among the most comprehensive genetic 
analysis tools currently used in molecular biology. For forensic applications, it 
remains the gold standard for mtDNA haplotyping. To date, however, the 
assessment of DNA sequence quality has relied almost exclusively on the 
experienced eye of forensic analysts and the use of base quality scores. The 
results of the current study have evaluated the reproducibility of sequencing 
electropherograms and quantitatively characterized the impact of DNA input 
quantity, peak location, sequencing chemistry and base substitution on peak 
height variability. This study has potential benefits for forensic practitioners in 
that the data presented may facilitate the development of computational 
approaches to aid in the laborious process of reviewing mtDNA sequence 
electropherograms. This can speed the turnaround of mtDNA samples while 
allowing for greater confidence in base calls and quicker disposition of forensic 
cases. Ongoing studies seek to develop and ultimately validate statistically 
grounded algorithms in conjunction with software for automated data analysis. 
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§ 4 - 6 Summary 
The review of dye-terminator sequencing electropherograms is central to 
forensic mtDNA haplotyping. The assessment of DNA sequence quality relies 
heavily on the experienced eye of the forensic analyst and the use of basecall 
quality scores. The current study sought to assess the quantitative reproducibility 
of electrophoretic peak height patterns for forensically relevant regions of 
human mtDNA. The impact of DNA input quantity, base location and sequencing 
chemistry on peak height variability and the potential utility of comparative 
electrophoretic pattern analysis was evaluated. DNA template quantities used in 
dye terminator labeling reactions were found to significantly influence sequence 
quality and reproducibility. DNA input quantities of ≤0.2ng resulted in elevated 
peak height variability and lower signal-to-noise ratios while input ≥1.6ng 
produced signal saturation associated with false peaks. Peak height variability 
was position dependent across all amplicons being lowest in the center and 
highest adjacent to the primer binding site. With regard to sequencing 
chemistries, the BigDye® Terminator v1.1 Cycle Sequencing chemistry 
demonstrated superior performance on the basis of peak height reproducibility, 
electropherogram quality and optimal DNA input quantity.  
The reproducibility of “electrophoretic patterns” makes it possible to use 
relative differences in the heights of adjoining peaks to assess how closely a 
“questioned electropherogram” conforms to a “reference electropherogram” 
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and thereby to identify electrophoretic irregularities of potential interest in a 
questioned sequence. A comparative analysis of forty, non-identical samples 
representing the HV1A, HV1B, HV2A and HV2B amplicons accurately identified 
deviations from reference electrophoretic patterns which resulted directly or 
indirectly from base substitutions, the presence of mixed base positions in 
situational mixtures and a possible anomaly in the basecalling software. 
Comparative analysis of electrophoretic patterns may have important potential 
as computational tool for forensic analysts. Such an approach may help analysts 
to more rapidly identify sequence irregularities; thereby facilitate more efficient 
and accurate interpretation of mtDNA sequence data. 
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Chapter 5: Quantitative Determination of Mixed Nucleotide 
Populations in Mitochondrial DNA Sequencing 
§ 5 - 1 Introduction 
There has been significant discussion regarding mtDNA and the 
importance of characterizing heteroplasmy and situational mixtures in the 
forensic and other scientific literature (Ivanov et al., 1996; van Den Bosch et al., 
2000; Melton et al., 2005). Much of the discussion has focused on the basic 
detection of heteroplasmy; the potential value of being able to quantitatively 
assess heteroplasmic ratios. It has been proposed that the availability of 
quantitative information might aid human identification (Gill et al., 1994), 
disease diagnostics (Harrigan et al., 1998; Nurpeisov et al., 2003) and the ability 
to determine the individual mtDNA haplotypes of the contributors to a mtDNA 
mixture (Danielson et al., 2005). Dye-terminator sequencing has through the 
years been considered to be the most accurate method of DNA sequence 
analysis in molecular genetics and molecular diagnostics. As new terminator 
chemistries have been developed, consistency in peak height and reliability of 
base calls have become a major focus of scrutiny in dye-terminator sequencing. 
Individual peak heights across a sequencing electropherogram are highly variable 
relative to one another. This is due to differences in the incorporation rates of 
individual dye-terminator nucleotides at a given base position and the spectral 
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properties of their associated fluorochromes. For any specific base position, 
however, peak heights are highly consistent across multiple sequencing reactions 
(Chapter 4). 
In dye-terminator sequencing, the appearance of a heterozygous loci or a 
mixture of two or more DNA molecules is characterized by one or more 
overlapping electrophoretic peaks. This typically results in ambiguous basecalls at 
mixed sites. In the case of a length variant, a completely unreadable sequencing 
electropherogram is produced starting at the point where the two variants fall 
out of register with each other. The quantitative ratio of the contributors to a 
mixture should be reflected by differences in the peak heights at mixed-base 
positions. Since peak height is governed in part by the relative incorporation 
efficiencies of individual nucleotides, the ratio of one peak to another at a mixed-
base position is not a direct reflection of the relative DNA quantity contribution 
of two or more contributors to a mixture. (Danielson et al., 2007). As a result, 
mixed-base positions in sequencing electropherograms from forensic casework 
samples are generally omitted from the reported haplotype analysis. This 
exclusion of data decreases the power of discrimination of the analyzed sample. 
In spite of these limitations, some researchers have attempted to use 
peak height data to follow the spread of drug resistant mutations associated with 
human immunodeficiency virus type 1 (HIV-1) (Harrigan et al., 1998; Nurpeisov et 
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al., 2003) and the spread of mutations in hepatitis B virus polymerase (Olivero et 
al., 2006). This approach relies on a comparison of relative peak heights for the 
variants of interest at mixed-base positions from samples taken at different time 
points. An increase in nucleotide peak height associated with the 
resistant/disease strain along with a corresponding decrease in peak height 
associated with the wild type nucleotide suggests an increase in the prevalence 
of the resistant/disease strain between the samples being assayed.  
Additional methods for the detection of these mutations have been 
developed. These include line probe assays (Stuyver et al., 1997) (Innogenetics, 
Gent, Belgium) and detection by real-time PCR (Affigene, Sangtec Molecular 
Diagnostics AB, Bromma, Sweden). Although these approaches work well when 
dealing with known genetic markers, they require the design of new nucleotide 
specific probes whenever a new sequence variant is discovered. An added 
concern is that line probe assays are associated with a high level of false negative 
results (Servais et al., 2001). Real-time PCR assays are accurate and highly 
reproducible but the detection of mutations at multiple different sites 
necessitates the design and costly optimization of numerous assays. In a forensic 
context, these methods can consume a significant amount of often precious 
evidentiary material.   
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The ability to extract quantitative information on DNA mixtures from the 
direct analysis of peak height ratios at mixed-base positions in sequencing 
electropherograms would make it possible to circumvent these limitations. Such 
an approach would allow for analysis of known and novel polymorphisms 
regardless of location within an amplicon. Furthermore, quantitation analyses 
could be conducted without the need for any additional sample manipulation. 
Finally, sequencing analyses require significantly lower template quantities than 
a single line probe assay and can be completed at significantly lower cost than 
either of the aforementioned method. 
Although dye-terminator sequencing has, in general, been very successful 
for accurate DNA haplotyping of single source samples, the interpretation of DNA 
heteroplasmy and the analysis of mixtures of two or more individuals have 
proven to be significantly more difficult. Due to context specificity of nucleotide 
incorporation efficiencies, the reliable determination of relative DNA quantity 
associated with each component of a mixture has until now been unattainable. 
The ability to accurately interpret DNA mixtures would have significant benefits 
for basic research, disease diagnostics and forensic investigations involving 
mtDNA or other sequence-based analyses such as those based on biallelic 
markers. The objective of the current study was, therefore, aimed at determining 
the extent to which a change in the relative quantities of input DNA for two 
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amplicons correlated with a change in ratio between the resulting 
electrophoretic peak heights across a range of mixed-base positions. 
§ 5 - 2 Materials and Methods 
This research was conducted in compliance with U.S. Federal Policy for 
the Protection of Human Subjects (56 FR 28003). Individual buccal swabs were 
collected from 45 unrelated subjects of diverse ethnicity who had previously 
provided informed consent to participate in the study. All samples were stored at 
-20°C until DNA extraction. 
§ 5 - 2.1 Mitochondrial DNA Extraction and Purification 
Mitochondrial DNA was extracted from buccal swabs using the EZ1 DNA 
tissue kit on the Qiagen BioRobot EZ1 (Qiagen Inc., Valencia, CA) according to the 
manufacturer’s recommended protocol. Four forensically relevant regions of the 
human mitochondrial control region (i.e., HV1A, HV1B, HV2A and HV2B) were 
amplified in 50μL reactions, using 50pmol each of forensically-validated PCR 
primers (Wilson et al., 1995; LaBerge et al., 2003); 2.25U AmpliTaq GOLD® DNA 
polymerase (Applied Biosystems, Foster City, CA) supplemented with 0.25U Pfu 
DNA polymerase (Stratagene, La Jolla, CA); AmpliTaq GOLD® Buffer (Applied 
Biosystems); 10nmol of each dNTP (Stratagene) and 10μL of an approximately 
10pg/μL human DNA extract. Amplifications were performed on a GeneAmp® 
9700 thermocycler (Applied Biosystems) with an initial denaturation at 95°C for 
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10 minutes, followed by 32 cycles of 95°C for 20 seconds, 60°C for 30 seconds 
and 72°C for 45 seconds. The final extension at 72°C was for 15 minutes. PCR 
amplicons were purified and quantified at 50°C on a WAVE® 3500HT DNA 
Fragment Analysis System (Transgenomic Inc., Omaha, NE) containing a DNAsep® 
analytical column packed with alkylated poly(styrenedivinylbenzene) resin 
(Huber et al., 1993) using previously established methods (Chapter 3). 
§ 5 - 2.2 Mitochondrial DNA Sequencing 
Mixture templates were prepared at thirteen stepped quantity ratios 
ranging from 99:1-1:99 (i.e., 99:1, 95:5, 90:10, 80:20, 70:30, 60:40, 50:50, 40:60, 
30:70, 20:80, 10:90, 5:95, 1:99) at 0.4ng/µl. Sequencing reactions were prepared 
in triplicate 10µl reactions, using the previously mentioned forensically-validated 
primers. For each labeling reaction, 0.8ng of input DNA was used in order to 
obtain optimal peak height consistency as described previously (Chapter 4). 
Samples were extended using the BigDye® v1.1 Dye Terminator Cycle Sequencing 
kit (Applied Biosystems) according to the manufacturer’s protocol. Dye-
terminated products were purified using Performa® DTR V3 96-well Short Plate 
Kit (Edge BioSystems, Gaithersburg, MD) according to the manufacturer’s 
protocol and resolved on the PRISM® 310 Genetic Analyzer (Applied Biosystems). 
Appropriate positive and negative controls were carried through the entire 
sample handling process to minimize cross contamination and to monitor 
amplification efficiency.  
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Sequence data was analyzed with Sequencing Analysis Software v.5.1.1 
(Applied Biosystems). The resulting .scf output file was then ported to the CEQ™  
8000 Genetic Analysis System version 8.0 software package (Beckman-Coulter, 
Fullerton, CA) to allow output of the electrophoretic peak height data as a .txt 
file. Text files were then opened in Microsoft Excel for statistical analyses or 
displayed using the Sequencher™ v4.2 DNA analysis software (Gene Codes Corp, 
Ann Arbor, MI). 
§ 5 - 3 Results and Discussion 
§ 5 - 3.1 Reproducibility of Peak-Height Ratios 
Representatives of each of the four forensically validated mtDNA 
amplicons (i.e., HV1A, HV1B, HV2A and HV2B) that collectively encompassed 100 
variant sites across these regions were originally examined. During the course of 
theses analyses, it was noted that the relationship between relative quantities of 
input DNA and the ratio of the resulting electrophoretic peak heights at mixed-
base positions was not identical when sequenced in the forward and reverse 
directions. In discussions with forensic practitioners, a more rigorous approach 
was taken to demonstrate the relationship between relative quantities of input 
DNA and the ratio of electrophoretic peak heights at mixed-base positions by 
including an additional 102 mixed-base positions in the reverse sequencing 
direction (i.e., a total of 202 mixed-base positions, Table 5.1). In addition, 5  
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Table 5.1: Sequence polymorphisms in the HV1 and HV2 regions assayed in two-
component mixtures at 13 different DNA quantity ratios. Nucleotide differences 
are noted as deviations from the revised Cambridge Reference Sequence. 
 
  
140 
 
mixtures assayed that represented different combinations of mixed-bases within 
the 202 positions included in the study. 
Given the reproducibility of inter-individual differences in relative peak 
heights, it is reasonable to suggest that a change in the relative molar ratio of 
one component to another in a mixture will be reflected by a corresponding 
change in ratio of overlapping fluorescence signals at all mixed-base positions. 
The relationship between different molar ratios of two contributors to a mixture 
and the corresponding electrophoretic peak height ratios at mixed-base positions 
(182 T/C; 186 A/C; 189 C/A; 195 C/T; 198 T/C; 200 G/A) is illustrated in figure 5.1. 
As the molar ratio between the two contributors in this HV2A mtDNA mixture 
was varied in a stepwise manner, from a 90:10 to a 50:50 ratio of contributor 1 
to contributor 2, there was a coordinated shift in the ratio of overlapping 
electrophoretic peaks at nucleotide positions where the two contributors differ 
from each other. In this example, six peaks representing nucleotides associated 
with contributor 1 (182 T; 186 A; 189 C; 195 C; 198 T; 200 G) display a 
coordinated decrease in fluorescence intensity relative to the peaks associated 
with contributor 2 (182 C; 186 C; 189 A; 195 T; 198 C; 200 A). Figure 5.2 
illustrates the excellent peak height reproducibility within overlapping 
electrophoretic peaks. Shown are the peak heights and associated error bars for 
mixed-base position 182 T/C across nine of the DNA quantity ratios tested in 
triplicate. As expected, peak height consistencies, for this and the other 201  
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Figure 5.1: Fluorescence peak height ratios at six mixed-base positions as a 
function of stepwise changes in the quantity DNA input to the dye-terminator 
labeling reaction. Shown are mixture ratios ranging from a 90:10 mixture to a 
50:50 mixture of two HV2 DNA amplicons.  
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Figure 5.2: Peak height reproducibility at nt182 for three replicate labeling 
reactions at nine contributor DNA quantity ratios. Both components of the 
mixture show highly reproducible peak heights (as represented by the error bars) 
across all input quantity ratios tested.  
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mixed base positions included in this study, were highly consistent across three 
replicates. This confirms previously reported data on the global consistency of 
peak heights in sequencing electropherograms (Chapter 4). Furthermore, these 
results indicate that it should be possible to deconvolve the individual haplotypes 
of two-component mixtures. 
§ 5 - 3.2 Correlation Between DNA Quantity and Fluorescence 
Intensity Ratios 
The analyzed peak height data for 347 nucleotide mixtures revealed a 
highly significant correlation between changes in DNA input quantity ratio for a 
DNA mixture and changes in electophoretic peak height ratios. Consistent with 
the high degree of reproducibility that was observed previously for relative 
differences in electrophoretic peak heights (Chapter 4), a change in the molar 
ratio of one contributor to another was found to correlate nearly perfectly (R = 
0.9998) with the change in relative fluorescence of overlapping peaks at mixed-
base positions (Figure 5.3). This is not to suggest that all mixed-base positions are 
identical with respect to the relationship between a given peak height ratio and a 
given DNA quantity ratio. Instead, the relative peak height ratios observed at 
different nucleotide positions displayed highly reproducible context-specific peak 
height relationships.  
This is best demonstrated by the highly reproducible differences seen in 
electrophoretic peak height ratios at a variety of nucleotide positions where  
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Figure 5.3: A graph illustrating the strong correlation (R = 0.9998) between a 
change in the molar ratio of DNA amplicons input to a dye-terminator labeling 
reaction and a change in peak height ratios at mixed-base positions. The plot 
consists of averages obtained from 74,952 data points (changes in peak height 
fluorescence). A total of 347 mixed nucleotide positions were assayed at 9 molar 
ratios of mixed mtDNA templates. The dashed line indicates the statistical line of 
best fit to the data.  
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equivalent DNA input quantities were assayed. Figure 5.4 illustrates the broad 
range of fluorescent peak height ratios observed at mixed-base positions in 
sequencing electropherograms when an equimolar mixture of two DNA 
amplicons is used for the labeling reaction. The displayed histogram shows the 
fluorescence contribution of the lower of the two peaks detected at each mixed-
base position to the combined fluorescence signal of the overlapping peaks. Also 
shown is the frequency that each level of fluorescence was detected in the 347 
assays of mixed-base positions that were analyzed. In the majority of cases 
(69.5%), the labeling of an equimolar DNA mixture was associated with a 
fluorescent peak height ratio that fell within ±10% of the ideal 50:50 ratio. There 
were a large number of cases that displayed significant discordance between an 
equimolar DNA input to the labeling reaction and the resulting fluorescence ratio 
at a mixed-base position. In the most extreme cases, the fluorescence ratio was 
strongly and reproducibly skewed to yield a 21:79 peak height ratio. Accordingly, 
for the 202 positions analyzed, one may reasonably assign a major and minor 
contributor on the basis of peak heights alone at mixed base positions providing 
that the major component peak exceeds 80% and the minor peak base call is less 
than 20% of the total fluorescence at a mixed base position. 
§ 5 - 3.3 Impact of Peak Overlap on Fluorescence Intensity Ratio 
Direct sequence analysis of mixed mtDNA templates yields overlapping 
peaks in the analyzed electropherogram at all positions where the templates  
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Figure 5.4: Frequency of minor peak contribution to total fluorescence at an 
equimolar (i.e., 50:50) ratio of two contributors to a DNA mixture. In 69.2% of 
equimolar mixtures, the contribution of the minor peak to the total fluorescence 
at mixed base positions was within 10 percentage points of the idealized 50% 
value. In 30.8% of cases, however, the minor peak accounted for only 21% to 
39% of total fluorescence at mixed base positions even though an equimolar 
mixture of amplicons was labeled. This phenomenon was highly reproducible 
across replicate reactions.  
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differ in primary sequence. In most cases, peaks representing these mixed base 
positions overlap completely (i.e., peak maxima occur at the same sampling 
point). However, on occasion the minor peak at a mixed base position may be 
shifted significantly upstream or downstream of the major peak. When analyzed, 
this shift can result in an underestimation of the height of the minor component 
peak. At affected positions, this phenomena is highly consistent across all ranges 
of DNA input quantities (e.g., position 200G/A in Figure 5.1) and has been noted 
to a varying degree at a number of different locations.  
Figure 5.5A illustrates an extreme example of apparent minor component 
peak shifting for the 239A nucleotide of the minor component in a 60:40 mixture 
of 239G/A sequenced with the D2 primer. The sequence analysis algorithm 
places the 239A minor component peak between the 238T and 239G peaks 
creating an erroneous insert in the electrophoretic trace. The practical 
implications of this are significant. In a putative single-source DNA sample, such a 
peak shift could mistakenly be reported as an insertion. The risk of making such 
erroneous base calls underscores the importance of sequencing templates in 
both directions since this phenomenon has yet to be demonstrated in both 
directions. One possible explanation for this shift may be reproducible anomalies 
that exist in the spacing of some dye terminated chains. Figure 5.5B, illustrates 
this by showing that even in the absence of a 239A peak, the 239G peak is still 
shifted asymmetrically toward the 240T peak. It could be postulated that this  
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Figure 5.5: Positional shifting of a minor contributor peak relative to the major 
component peak in the HV2A amplicon sequenced with the D2 primer. 5A 
illustrates a phantom insertion of 239A prior to the genuine 239G peak and an 
ambiguous base call (239K) a result of the inserted minor component peak. 5B 
illustrates the peak spacing in the same region obtained with a single source 
sample. This demonstrates that even in a single source sample, 239G is 
positioned asymmetrically toward 240T. This could predispose mixtures at this 
position to phantom insertions. 
  
A 
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asymmetry predisposes this position to such phantom insertions. Accordingly, 
analysts may be able to use base spacing in some cases as a potential indicator of 
whether a questioned insert is genuine or not.  
§ 5 - 3.4 Minor contributor identification in low level mixtures 
Direct sequence-based mixture determinations have generally been 
classified as any secondary/minor peak having a fluorescence intensity >10% of 
that of the major component. Although generally true, a number of factors can 
cause a mixed-base position to either under- or over-represent the relative 
quantity of DNA contributed by the secondary component. Analysis of 202 
unique low-level mixed-base positions by direct DNA sequencing yielded a shift 
in fluorescence intensities for several tested positions. A total of 694 
comparisons were performed at each of thirteen quantity ratios (i.e., the 
aforementioned 99:1 through 1:99 range). At a quantity ratio of 20:80, 3.6% of 
minor component peaks yielded a fluorescence intensity ratio lower than the 
cutoff for calling mixed nucleotide positions (>10% major component peak 
height). At the 30:70 quantity ratio, however, no minor component peaks fell 
below the 10% mixture call threshold. As a result, some mixtures in which the 
minor contributor represents less than 30% of the total DNA quantity will be 
associated with selective peak dropout in the analyzed electrophoretic data even 
though the minor component itself accounts for >10% of the total input DNA 
quantity. In other words, some low level mixtures may yield a minor component 
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haplotype where one or more nucleotide substitutions are not detected. This has 
significant implications for haplotype determination of the minor component in 
mtDNA mixtures. In these cases, fractionation of cross hybridized PCR products 
by denaturing high performance liquid chromatography (DHPLC) can be 
employed to enrich for the minor contributor so as to avoid erroneous peak 
dropout (Danielson et al., 2007). 
These results beg the contrary question of how often a two-contributor 
mixture with a DNA input quantity ratio of 5:95 yields a fluorescence intensity 
ratio for the minor component that is greater than the 10% cutoff for mixed 
nucleotide detection. Out of 694 comparisons performed, 15.6% of minor 
components yielded a fluorescence intensity ratio greater than the 10% cutoff. 
While a small fraction of these can be traced to sequencing noise, the observed 
deviation between the DNA input quantity ratios and the corresponding 
fluorescence intensity ratio accounts for the majority of these cases. The obvious 
implication of this phenomenon is that a sample which may appear to be 
heteroplasmic at a single site, in reality, contains a low-level secondary 
component. Again, employing DHPLC fractionation can aid in detecting these 
types of low-level mixtures by enriching for the minor component. This will make 
it possible, in many cases, to determine the complete haplotype of the minor 
contributor. Alternatively, DHPLC could be used to purify away the minor 
component/contaminant to yield a clean sequence for the major contributor. In 
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all cases, knowledge of nucleotide incorporation rates associated with mixture 
determination is imperative. 
§ 5 - 3.5 Additional Considerations 
Previous published studies on relative peak height ratio determinations 
presented data from mixtures generated prior to PCR amplification (Harrigan et 
al., 1998; Nurpeisov et al., 2003). This assumes that both contributors to the 
mixture will amplify at equal efficiency regardless of template quantities present 
from each contributor. Where near equimolar quantities of each contributor are 
used it is probably reasonable to assume that the amplification efficiency of each 
contributor’s amplicon will be approximately equivalent. This may not be as 
reasonable an assumption in cases where there is a great difference in the 
relative input quantities of two contributors. In fact, there may potentially be 
significant differences in amplification efficiency due to a relative scarcity of the 
minor component amplicon. This may skew the apparent contributor ratio 
towards the major contributor giving an inaccurate representation of the actual 
ratio that existed in the original mixture.  
To demonstrate the extent to which this may present a point of concern, 
several two-contributor mixtures were prepared. Half of these mixtures were 
prepared before PCR amplification, and the remainder was prepared by mixing 
together stocks of DNA that had already been PCR amplified and quantified from 
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individual contributors. These mixtures were then dye-terminator labeled and 
the resulting relative peak height fluorescence ratios at 9 mixed base positions 
were analyzed. Figure 5.6 illustrates the results obtained at the mixed-base 
position 195C/T. The pre-amplification generated mixture shows a steeper slope 
across the mixture ratios assayed than was observed for the post-amplification 
generated mixture. The results obtained for the other 8 mixed base positions 
formed between these amplicons yielded similar results. 
The results show that a bias in amplification efficiency exists toward the 
major component in non-equimolar ratio mixtures. Therefore, these results 
suggest that when determining peak height ratios in actual forensic mixture 
samples, these will nearly always tend to overestimate the major contributor to 
the mixture and underestimate the minor contributor. 
§ 5 - 4 Concluding Remarks 
The current study provides a comprehensive analysis of changes in 
relative peak heights at mixed base positions as a function of changes in relative 
DNA input quantities to dye-terminator labeling reactions. Previous studies have 
demonstrated the highly reproducible nature of peak height patterns in 
sequencing electropherograms (Chapter 4). Due to the sequence context 
dependence of electrophoretic peak height at individual base positions, peak 
height alone cannot generally be used to accurately determine the relative  
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Figure 5.6: A range of DNA quantity ratios generated from pre- and post PCR 
amplification mixtures. Mixtures prepared prior to PCR amplification (solid lines) 
showing a steeper slope than mixtures prepared after PCR amplification of the 
contributors individually. This may be due to amplification bias against the less 
abundant of the target amplicon (i.e., minor contributor) during PCR.  
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quantity of individual amplicons when present in a mixture. However, the strong 
statistical correlation between changes in the relative quantity of two amplicons 
and changes in the resulting ratio of overlapping fluorescent peaks at mixed base 
positions provides a potential means for accurately determining the relative 
quantities and thus the haplotypes of individual amplicons in a mixed sample. 
This is of particular utility to some efforts aimed at monitoring disease 
progression, the onset and spread of drug resistant strains of pathogens and 
mtDNA mixture analysis in forensics. 
As an example of how changes in relative peak height ratios at mixed-
base positions can be used to indentify individual haplotypes, consider the 
following. Given a change in the quantity of one contributor relative to another 
(e.g., from a 90:10 ratio to a 70:30 ratio of contributor “1” to contributor “2”), a 
decrease will be observed in the peak height of all bases associated with 
amplicon “1” relative to amplicon “2”. Conversely, an increase will be observed in 
the peak height of all bases associated with amplicon “2” relative to amplicon 
“1”. By analyzing such shifts in relative peak heights at mixed-base positions, it 
should be possible to clearly and reproducibly determine the primary DNA 
sequence of (e.g., the haplotype in the case of mtDNA) for each contributor to 
the mixture. Especially in cases where the minor contributor accounts for 20% or 
less of a mixed sample, accurate haplotype determination is often not possible 
due to potential peak dropout. In these cases, fractionation and enrichment of 
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individual contributors by DHPLC is indicated (Danielson et al., 2007). It is 
expected that this approach will allow for the accurate determination of the 
linkage phase (i.e., the DNA sequence) for individual contributors. 
Using the mixture analysis strategy presented here, it should be possible 
to accurately deconvolve the DNA sequences of virtually all two-contributor 
mixtures. Moreover, the extensive body of information that is presented in this 
study in conjunction with the results of previous studies on peak height 
reproducibility as a function of DNA input quantity will facilitate the development 
of statistically supported interpretation guidelines for the analysis of mixed DNA 
samples. 
§ 5 - 5 Summary 
In dye-terminator sequencing, the appearance of a heterozygous locus or 
a mixture of two or more DNA molecules is characterized by overlapping 
electrophoretic peaks at all positions where the amplicons in a mixture differ in 
primary sequence. This results in ambiguous basecalls at mixed sites or 
unreadable sequencing electropherogram, in the case of indel-associated length 
variations between DNA molecules. The ability to accurately resolve DNA 
mixtures will have significant benefits for basic research, disease diagnostics and 
forensic investigations involving mtDNA analysis. 
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In mixed amplicon populations, the ratio between overlapping 
electrophoretic peaks at mixed base positions shifts as the molar ratio of the 
input DNA between individual contributors changes. If shown to be 
quantitatively reproducible, this phenomenon may provide a means of 
deconvolving the sequence electropherograms generated by sequencing DNA 
mixtures.  
The objective of the current study, therefore, was to determine the 
extent to which a change in the relative quantities of input DNA from two 
amplicons correlated with a change in the ratio between overlapping 
electrophoretic peaks at mixed base positions. The current study presents peak 
height ratio data for 202 mixed base positions at thirteen different DNA quantity 
ratios. The base positions analyzed were distributed across the region of the 
human mtDNA genome most often examined by forensic analysts. Analyses of 
peak height ratios revealed a highly significant correlation (R = 0.9998) between 
a change in the molar ratio of contributor DNA in a mixture and a change in peak 
height ratios in the resulting electropherogram. This strong correlation supports 
the use of comparative sequence analysis to determine the linkage phase (i.e., 
the primary DNA base sequence) of the individual amplicons in a mixture. 
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Chapter 6: Separation of Mitochondrial DNA Mixtures by 
Denaturing High Performance Liquid 
Chromatography and Linkage Phase Analysis 
§ 6 - 1 Introduction 
Dye-terminator sequencing of DNA from hypervariable regions 1 and 2 
(HV1/HV2) of human mtDNA is the current method of choice for the analysis of 
human mtDNA. A mixture of different mtDNA molecules in a single sample, 
however, presents a significant obstacle to successful mtDNA analyses by 
standard forensically validated methods. For example, an individual can naturally 
possess more than one mtDNA haplotype (i.e., heteroplasmy) (Lightowlers et al., 
1997). Alternately, forensic analysts often encounter mixtures of DNA-containing 
samples from separate individuals (i.e., a “situational” mixture). The ability to 
accurately determine the specific haplotypes of individual contributors to a DNA 
mixture can provide valuable investigative information.  
While the size variation of short tandem repeats can facilitate the 
interpretation of nuclear DNA mixtures, this is not the case with mtDNA 
haplotypes differ primarily by base substitution or by only very small differences 
in length - most often arising from the insertion or deletion of a single base pair. 
Such subtle variations in sequence typically produce ambiguous base calls due to 
overlapping electrophoretic peaks. Similarly, variations in the length of mtDNA 
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molecules, such as those commonly associated with the cytosine stretches in 
both HV1 and HV2 result in long stretches of unreadable electropherograms. This 
reflects the fact that dye-terminated chains fall out of register with each other 
starting at the position of the insertion or deletion responsible for the length 
variant. In these cases, additional sequencing primers targeted to flank the 
heteroplasmic cytosine stretch must be used to obtain readable sequence. 
Unfortunately, this reduces the total amount of sequence data that can be used 
to characterize a given mitochondrial amplicon (Holland and Parsons, 1999). The 
ability to accurately resolve and interpret these types of samples in a timely and 
cost efficient manner would substantially increase the power of mtDNA analysis 
by allowing its use in cases where the current approach yields results that are of 
limited or no utility. 
There are a number of molecular strategies that have been proposed to 
separate DNA mixtures. These include denaturing gradient gel electrophoresis 
(DGGE), single-strand conformational polymorphism (SSCP) analysis and 
subcloning into bacterial vectors (Hanekamp et al., 1996; Barros et al., 1997; 
Steighner et al., 1999). Both DGGE and SSCP require manual recovery of 
fractionated DNA from polyacrylamide gels and PCR reamplification to generate 
enough template for DNA sequencing. Subcloning represents an even more time 
and labor-intensive approach. Furthermore, it would require forensic scientists 
to screen and sequence DNA from multiple transformed bacterial colonies to 
159 
 
ensure that observed sequence differences reflect genuine contributors to the 
starting template rather than artificial variants that were introduced as a result 
of DNA nucleotide misincorporation by Taq polymerase. Taken together, these 
shortcomings pose significant obstacles to the adoption of these technologies by 
forensic laboratories.  
Pyrosequencing™ has recently been proposed as an alternate method for 
mixture analysis (Andreasson et al., 2006). Pyrosequencing™ relies on the 
sequential addition of nucleotides to the reaction mixture resulting in light 
emission of the incorporated nucleotide (Ronaghi, 2001). In a mixed sample, a 
complicated pattern of peaks may allow for the determination of individual 
components of a mixture. Concerns regarding pyrosequencing™, however, 
include limited sequence reads (approx. 60-70bp) and, therefore, significant 
consumption of valuable sample in order to obtain complete coverage of the 
hypervariable region. 
By comparison, denaturing high performance liquid chromatography 
(DHPLC) as described previously (Chapter 1) is a rapid and cost-effective method 
for physically fractionating mtDNA mixtures and then recovering amplicons for 
characterization by direct DNA sequencing (Emmerson et al., 2003; Etokebe et 
al., 2003). While doing so, DHPLC addresses the limitations of alternative 
strategies.  
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The underlying principle of DHPLC that is central to any effort to resolve 
an mtDNA mixture is Temperature Modulated Heteroduplex Analysis (TMHA) 
(Hou and Zhang, 2000). Briefly, when a mixture of two (or more) DNA amplicons 
is heat denatured and then allowed to slowly reanneal a combination of homo- 
and heteroduplices are formed. The homoduplices represent the original 
components of the mixture while the heteroduplices are generated by cross-
hybridization of DNA strands from the different contributors to the mixture. 
Under partially denaturing conditions and an increasing gradient of a non-polar 
solvent (e.g., acetonitrile), it is possible to physically separate the heteroduplices 
and the homoduplices from each other (Huber et al., 1993). Heteroduplices, are 
inherently less stable as the result of one or more base pair mismatches and thus 
they appear as early eluting peaks in the chromatographic trace of an DHPLC 
assay (Huber et al., 1995; O'Donovan et al., 1998). The sensitivity of DHPLC to the 
thermodynamic stability of a DNA amplicon ensures that even very subtle 
sequence differences (i.e., single nucleotide substitutions, insertions, deletions) 
between components of a mixture will be readily detected and fractionated in 
time (Kuklin et al., 1997; Underhill et al., 1997). 
Analysis of PCR products by DHPLC integrates seamlessly into the 
established protocols for mtDNA sequencing used by the forensic community. 
Once fractionated, the recovered DNA requires no PCR reamplification, post PCR 
cleanup or quantitation by yield gel since PCR yield can be directly determined 
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from the height of the chromatographic elution peak (Chapter 3). Samples 
fractionated by DHPLC yield highly purified amplicons void of PCR amplification 
primers, enzymes or salts. Finally, sequencing results obtained from DHPLC 
purified samples result in highly reproducible electrophoretic peak patterns 
(Chapter 4), essential for accurate determination of DNA sequence identity. 
Previous studies (Danielson et al., 2007) have reported a correlation 
between the change in ratio of two contributors to a DNA mixture and the 
corresponding change in the ratio of electrophoretic peak heights at mixed-base 
positions. In the current study, the efficacy of DHPLC for the fractionation of 
mtDNA mixtures and automated recovery of sequence-ready DNA is 
investigated. Furthermore, a statistical analysis-based approach has been 
developed, which allows for the accurate determination of coordinated shifts in 
peak height ratios at mixed base positions (i.e., linkage phase analysis). This 
serves as the basis for the determination of the haplotypes of the individual 
contributors to an mtDNA mixture. 
§ 6 - 2 Materials and Methods 
§ 6 - 2.1 Mitochondrial DNA Extraction and Quantification 
This research was conducted in compliance with U.S. Federal Policy for 
the Protection of Human Subjects (56 FR 28003). Individual buccal swabs were 
collected from 46 unrelated subjects of diverse ethnicity who had previously 
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provided informed consent to participate in the study. Individual buccal swabs 
were incubated for 15min. in 10µL proteinase K (600mAU/ml) (Qiagen Inc., 
Valencia, CA) at 37°C, followed by DNA extraction using the EZ1 DNA Tissue kit on 
the BioRobot EZ1 DNA extraction robot (Qiagen Inc.) in accordance with the 
manufacturers’ recommended protocol. Purified DNA was eluted into 200µL of 
nuclease free ddH2O and following visual inspection and subsequent removal of 
residual paramagnetic beads, which have the potential to interfere with 
quantitative real-time PCR (qRT-PCR), samples were stored at -20°C. 
All samples used in this study were quantified by qRT-PCR using 
previously published amplification primers and probe (Andreasson et al., 2002) 
on a PRISM® 7900HT Sequence Detection System (Applied Biosystems, Foster 
City, CA). Quantification standards were prepared by serial dilution in 
T10E0.1/Glycogen buffer (10mM Tris-HCl pH 8.0; 0.1mM EDTA; 20µg/mL glycogen) 
of a previously subcloned 143bp mtDNA fragment encompassing the primer and 
probe binding sites. Seven serial dilutions ranging from 2.16x107 – 2.1x101 in ten-
fold increments were used. Optimization of reaction conditions yielded a 
quantification assay in a total volume of 10µL containing 5µL TaqMan® Universal 
Master Mix – AmpErase® UNG (Applied Biosystems), 2µL DNA extract, 130nM 
probe and 100nM each primer. Samples were loaded onto MicroAmp® Optical 
96-Well reaction plates and sealed using Optical Adhesive Covers (Applied 
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Biosystems). PCR amplification was initiated with 10 min incubation at 95°C 
followed by 45 cycles of 95°C for 15 sec and 60°C for 1 min. 
All standards were assayed in triplicate and all experimental samples 
were assayed in duplicate for statistical accuracy. Standard curves were 
generated and amplification plots were used to compare individual PCR reaction 
consistency, efficiency, and results. No-template DNA and reagent blank controls 
were also included in each assay. 
§ 6 - 2.2 Mitochondrial DNA Amplification and Purification 
Two-contributor mitochondrial DNA mixtures prepared at various 
quantity ratios ranging from 95:5-5:95 as determined by quantitative real-time 
PCR. Four forensically relevant regions of the human mitochondrial control 
region (i.e., HV1A, HV1B, HV2A and HV2B) were amplified in 50μL reaction 
volumes. Each reaction was was prepared using 50pmol each of forensically-
validated PCR primers (Wilson et al., 1995; LaBerge et al., 2003); 2.25U AmpliTaq 
GOLD® DNA polymerase (Applied Biosystems) supplemented with 0.25U Pfu DNA 
polymerase (Stratagene, La Jolla, CA); AmpliTaq GOLD® Buffer (Applied 
Biosystems); 10nmol of each dNTP (Stratagene) and 10μL of an approximately 
10pg/μL human DNA extract. Amplifications were performed on a GeneAmp® 
9700 thermocycler (Applied Biosystems) with an initial denaturation step at 95°C 
for 10 minutes, followed by 32 cycles of 95°C for 20 seconds, 60°C for 30 seconds 
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and 72°C for 45 seconds. The final extension at 72°C was for 15 minutes. PCR 
amplicons were purified and quantified at 50°C on a WAVE® 3500HT DNA 
Fragment Analysis System (Transgenomic Inc., Omaha, NE) containing a DNASep® 
analytical column (Transgenomic Inc.) packed with alkylated 
poly(styrenedivinylbenzene) resin (Huber et al., 1993). DNA quantity was 
determined using peak area standard curve obtained from a dilution series of a 
six fragment quantitiation ladder (Chapter 3). 
§ 6 - 2.3 DHPLC Mixture Fractionation 
Cross-hybridization of mixed mtDNA amplicons was performed by 
denaturation at 95°C for 4 minutes and renaturation by gradual cooling 
(1.5°C/min) over a 45 minute period to reach a final temperature of 25°C 
(LaBerge et al., 2003). Cross-hybridized mixtures were analyzed by Temperature-
Modulated Heteroduplex Analysis (TMHA) (Kuklin et al., 1997) at empirically 
predetermined optimal temperatures for each of the four forensic mtDNA 
amplicons (HV1A, 58°C; HV1B, 59.2°C; HV2A, 56.5°C and HV2B, 57°C.) The 
optimal acetonitrile linear gradients, generated from differential mixing of buffer 
A (0.1M TEAA) and buffer B (0.1M TEAA, 25% ACN), were 56% to 65% buffer B 
increase in 3.5 minutes for HV1A, HV2A and HV2B and a 55% to 64% buffer B 
increase in 3.5 minutes for HV1B. All samples were eluted at 0.9ml/min flow rate 
and detected by UV absorbance at 260nm. Eluted peaks were captured using an 
automated fraction collector (Transgenomic, Inc.); dried by vacuum 
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centrifugation for 30 minutes at 50°C followed by a 20-minute cool down to 
ambient on a CentriVap® Vacuum Concentrator (Labconco Corporation, Kansas 
City, MO). Samples were resuspended in nuclease-free H2O; and stored frozen 
until DNA sequencing. Standard DHPLC controls included: zero-volume injections 
to screen for residual DNA carryover from the column matrix, no-template PCR 
controls to check for amplification contamination and manufacturer-supplied 
mutation control standards for buffer and column quality control. 
§ 6 - 2.4 Mitochondrial DNA Sequencing 
Sequencing reactions were prepared using the appropriate forensically-
validated amplification primers. For greatest peak height consistency as 
previously determined (Chapter 4), 0.8ng total input DNA quantities were used 
for all labeling reactions and amplicons were extended according to the 
manufacturer’s protocols using the BigDye® v1.1 Dye Terminator Cycle 
Sequencing kit (Applied Biosystems). Dye-terminated products were purified by 
Performa® DTR V3 96-well short plate purification columns (Edge BioSystems, 
Gaithersburg, MD) according to the manufacturer’s protocol and resolved on a 
PRISM® 310 Genetic Analyzer (Applied Biosystems). Appropriate positive and 
negative controls were carried through the entire sample handling process to 
minimize cross contamination and to monitor amplification efficiency. The 
resulting sequence data were analyzed using the Sequencing Analysis Software 
v.5.1.1 (Applied Biosystems). The resulting .scf output file was then ported to the 
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CEQ™ 8000 Genetic Analysis System version 8.0 software package (Beckman-
Coulter, Fullerton, CA) to allow output of the electrophoretic peak height data as 
a .txt file. Text files were then opened in Microsoft Excel for statistical analyses or 
displayed using the Sequencher™ v4.2 DNA analysis software (Gene Codes Corp, 
Ann Arbor, MI). 
§ 6 - 3 Results 
§ 6 - 3.1 Statistical Analyses of Mixture Ratios 
A near perfect correlation (R = 0.9998) exists when mixtures are analyzed 
for changes in relative DNA quantities between two contributors versus changes 
in electrophoretic peak height ratios at mixed base positions (Chapter 5). This 
demonstrates that a change in peak height ratio of two components in a mixture 
is a reflection of an underlying change in relative DNA quantity at any mixed base 
position. 
In these analyses, the relative shift in peak height fluorescence was 
calculated by comparing triplicate fluorescence intensity ratios across thirteen 
DNA quantity ratios (99:1 – 1:99) for each of 202 mixed nucleotide positions. 
Based on these data, exhaustive statistical analyses were performed using 
Tukey’s honestly significant differences (HSD) test:  
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where,  and  are the mean of each group,  is the mean square 
within for the group and  is the number of samples per group. Using “R”, “a 
language and environment for statistical computing and graphics” 
(http://www.r-project.org/), confidence levels were obtained for the 27,066 
probability values. 
The results of these analyses indicate an even tighter statistical 
correlation than presented above and have made it possible to precisely 
determine the level of statistical confidence associated with any detectible shift 
in electrophoretic peak height ratios. The calculated significance values for 
27,066 comparisons of peak height fluorescence ratios illustrate the reliability of 
this relationship (Figure 6.1, Table 6.1). Based on these statistical calculations, as 
little as a 6% shift in fluorescence intensity of one contributor relative to the 
other makes it possible to accurately determine the linkage phase of the 
questioned mixture with a >99% confidence. Enrichment by 17% increases the 
statistical confidence of linkage phase to >99.9%. 
§ 6 - 3.2 Linkage Phase Analysis of a Two-Component mtDNA Mixture 
Because of the strong correlation between a change in the ratio of DNA 
quantities within a mixture and a change in the ratio of overlapping 
electrophoretic peaks, the linkage phase of individual amplicons present in a 
two-component mixture can be readily determined. This holds true even in cases  
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Figure 6.1: Tukey HSD confidence associated with changes in electrophoretic 
peak height ratios at mixed base positions. Shown are average and minimum 
confidence values (left y-axis) as a function of the percentage change in peak 
height fluorescence (x-axis) along with the number of data points behind each 
calculation (right y-axis). Greater than 99% confidence is obtained for a ≥6% shift 
in fluorescence while greater than 99.9% confidence is obtained for a ≥17% shift 
in fluorescence. 
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Table 6.1: Peak height enrichment and corresponding Tukey HSD confidence 
values. Shown for peak height enrichment level (measured as a percent) are the 
corresponding average and minimum Tukey HSD statistical confidence levels for 
linkage phase determination (i.e., confidence that the shift represents an actual 
amplicon enrichment rather than stochastic peak height variation) as well as the 
number of comparisons performed for each enrichment percentage level. 
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where complete separation of individual components of a mixture cannot be 
achieved. In such cases, the linkage phase of each component of the mixture is 
determined by tracking the ratio of overlapping fluorescent peaks at all mixed 
base positions between two or more DHPLC fractions. The observation of 
coordinated shifts in the relative fluorescence ratios for a given set of nucleotides 
is consistent with them being in the same linkage phase and thus representing 
the same amplicon. Figure 6.2 represents the complete process of DHPLC 
fractionation followed by linkage phase analysis (LPA) of mixed nucleotide 
positions detected as a result of dye-terminator sequencing. A two-component 
mixture of HV2A amplicons containing ten mixed nucleotide positions (73G/A, 
151T/C, 152T/C, 182T/C, 186A/C, 189C/A, 195C/T, 198T/C, 200G/A and 247A/G) 
was purified and fractionated into 16 individual fractions by DHPLC (Figure 6.2A). 
Five of the captured fractions (10-14) were sequenced and the mixed nucleotide 
positions were analyzed for relative peak height shifts (Figure 6.2B). 
Subsequently, these fractions were analyzed by LPA for determination of 
nucleotides corresponding to each contributor (Figure 6.2C). Separation of mixed 
nucleotides based on LPA identified the individual haplotypes of each of the two 
contributors to the mixture with greater than 99.99% average basecalling 
confidence.  The haplotype of contributor 1 was 73A, 151C, 152T, 182C, 186C, 
189A, 195T, 198C, 200A and 247G while that of contributor 2 was found to be 
73G, 151T, 152C, 182T, 186A, 189C, 195C, 198T,  
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Figure 6.2: (A) Denaturing HPLC chromatogram, showing collected fractions, 
including those fractions used for dye-terminator sequencing (i.e., fractions 10-
14). (B) Radar graphs showing relative quantitation of fluorescence peak height 
ratios (y-axis) for 10 mixed base positions from sequence electropherograms 
representing DNA recovered from five DHPLC fractions (x-axis). (C) Linkage phase 
analysis determination and identification of individual contributors to a two-
component mixture. Results are based on shifts in relative fluorescent intensity 
at all mixed base positions between DHPLC fractions 11 and 14. 
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200G and 247A. Although figures 6.2B and 6.2C illustrate only results obtained in 
the forward sequencing direction, confirmatory results were obtained when the 
same samples were sequenced in the reverse direction. 
§ 6 - 3.3 Linkage Phase Analysis of Minor-Component mtDNA 
Mixtures 
In forensic casework, mtDNA samples are not generally considered 
mixtures unless two or more nucleotide positions yield a secondary peak having 
a height of >10% that of the major component nucleotide. Based on results 
described in chapter 5, a 10% secondary peak height, however, can represent a 
molar mixture ratio of two contributors ranging anywhere from a 95:5 to 70:30 
due to context specific incorporation of dye-terminators. 
A known 95:5 mixture of HV2A, which appeared to be a single-source 
sample with a single heteroplasmic site, as determined by direct DNA 
sequencing, was separated into ten fractions by DHPLC and analyzed by LPA. Two 
of the isolated fractions yielded no mixture at all, while 5 yielded apparent 
heteroplasmy at one site as determined by the 10% threshold for secondary peak 
height. However, two of the fractions yielded 8 mixed-base positions where the 
height of the secondary peak ranged from 15% - 53% of that of the major peak. 
LPA analysis confirmed the existence of a mixture at all eight sites with an 
average confidence of 99.985%. 
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§ 6 - 3.4 Two-Component mtDNA Mixtures Analyzed by LPA 
Individual mtDNA haplotypes for all samples used in this study were 
determined by dye-terminator sequencing prior to mixture generation. Thirteen 
samples, each of which represented a unique haplotype, were used to determine 
the accuracy of LPA for HV2A, (Table 6.2). Two-component mixtures were 
generated at multiple molar ratios ranging from 50:50 to 95:5 of contributor 1 to 
2, respectively. All mixtures generated were PCR amplified and then fractionated 
by DHPLC. Selected fractions were then dye-terminator sequenced and the 
resulting electropherograms were then used for LPA. In every case, the results 
were in complete concordance with the known sequences from each 
contributor. Across all mixtures assayed, amplicon enrichment by DHPLC (as 
measured at individual mixed base positions) ranged from as little as a 2.1% to as 
much as a 92.3% shift in peak height fluorescence between individual DHPLC 
fractions (Table 6.3). 
§ 6 - 3.5 Three- or More Component Mixtures 
Mitochondrial DNA mixtures comprising three or more contributors are 
readily detected by DHPLC but yield significantly more complicated 
chromatographic traces than two-component mixtures. This reflects the 
significant increase in the number of heteroduplices that can be formed with 
each additional contributor. A total of 32 mixtures containing three to five 
distinct amplicons at various molar DNA input ratios were fractionated by  
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Table 6.2: The HV2A control region sequences of the samples used in the current 
study, shown as deviations from the revised Cambridge Reference Sequence 
(rCRS) (excluding 263A/G since all samples used in the study are 263G). 
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Table 6.3: Summary of HV2A mtDNA mixtures analyzed by DHPLC illustrating 
nucleotide enrichment and Tukey HSD-derived confidence ranges of mixed- 
nucleotide positions detected. Contributors identified in each mixture refer to 
the sequences characterized in table 6.2. 
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DHPLC. These multi-component mixtures yielded 4 to 10 clearly discernible 
chromatographic peaks.  
Sequencing results and subsequent LPA of three component mixtures 
have shown that determination of one or two contributors can be achieved. 
However, application of statistical analyses for these samples remains difficult 
since shifting in peak height fluorescence ratio can be skewed as a result of 
multiple overlapping nucleotide contributions at any one mixed site. Reliable 
protocols for the resolution of three to five component mixtures by LPA, 
therefore, have not been developed. 
§ 6 - 3.6 Identification of Heteroplasmic Components by LPA  
Identification of heteroplasmy in mtDNA sequencing analysis has been 
proven to be of tremendous utility for human identification (Ivanov et al., 1996). 
Due to the nature of DNA sequencing, low level heteroplasmic identification can 
often prove difficult to distinguish from underlying sequence chatter and noise. 
Utilizing DHPLC fractionation and LPA, identification of these can be made 
significantly easier, allowing for confirmation of suspected heteroplasmy in 
difficult samples. One sample displaying a broadened DHPLC profile revealed low 
level heteroplasmy at 16183. This sample was subjected to DHPLC fractionation 
and LPA, resulting in 25.6% and 24.0% enrichment of the minor component, 
depending on the direction of sequencing. This confirmed the existence of a 
177 
 
heteroplasmic 16183C/A with an average confidence of 99.973±0.091% and 
99.968±0.077% depending on sequencing direction. 
§ 6 - 4 Discussion 
Based on aforementioned studies (Chapter 2) the accuracy of mixture 
screening by DHPLC is fully concordant with the detection of mixtures by direct 
sequencing. Furthermore, DHPLC may facilitate the detection of mixtures at 
ratios that might be missed by direct sequencing, i.e., in cases where the quantity 
of the minor component is less than 10% that of the major component. The 
current study illustrates the potential utility of DHPLC in combination with LPA to 
resolve detected mixtures involving mtDNA amplicons commonly used by 
forensic analysts. DHPLC fractionation of a two-component mixture is 
independent of the initial screening of a sample to determine whether or not it 
consists of a mixture of non-identical amplicons.  
DHPLC, allows an analyst to fractionate any DNA sample, regardless of 
whether it is a mixture or not. Subsequent sequencing analysis of the isolated 
fractions then allows for identification of the linkage phase of individual 
contributors and/or the detection of sequencing anomalies, e.g., unincorporated 
dye blobs or suboptimal signal to noise ratio.  Although fragment resolution by 
DHPLC, is a function of amplicon length and/or differences in primary sequence, 
it is difficult to predict a priori the characteristics of the chromatographic trace 
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that will result from DHPLC analysis of a specific mixture. Optimal separation and 
recovery is achieved when a two-component mixture can be resolved into four 
discernible peaks (i.e., fully separated homo- and heteroduplices). This minimizes 
co-elution of incompletely resolved amplicons. When this is achieved, 
subsequent electropherograms are generally of good quality and are free of 
underlying electrophoretic signal from a second contributor. In practice, 
however, optimal chromatographic resolution is uncommon, and this typically 
results in the co-elution of target and non-target DNA amplicons. This produces a 
series of DHPLC fractions that are enriched for one contributor versus the other 
but which are not free of the second contributor. In the absence of complete 
separation, sequence electropherograms show signal from both contributors. As 
a consequence of this, overlapping electrophoretic peaks are produced at those 
nucleotide positions where the two amplicons differ in primary sequence. 
Based on statistical analyses using Tukey’s HSD test as little as a 6% shift 
in relative peak height fluorescence at mixed nucleotide positions is required to 
obtain a 99% statistical confidence in the linkage phase determination while a 
17% shift in peak height ratio yields 99.9% confidence. Therefore, only a slight 
shift in peak height fluorescence is required in order to obtain a highly 
statistically significant linkage phase determination of a mixture. It is worth 
noting that the majority of mixtures analyzed to date show a >17% enrichment of 
one contributor over the other based on peak height shifts; thereby allowing for 
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>99.9% confidence in the resolution of the haplotypes of the individual 
contributors to two-component mtDNA mixtures. In the current study, all 
mixtures analyzed by LPA, including those showing as little as 2% enrichment, 
were accurately resolved albeit with reduced statistical confidence levels. 
In the HV2A amplicon, two nucleotide positions within a single mixed 
sample were found after DHPLC fractionation to yield a <6% shift in peak height 
fluorescence. Even in this case however, LPA correctly determined the 
haplotypes of the two contributors. While, the average enrichment levels for the 
other three amplicons (HV1A, HV1B and HV2B) were lower than that of the HV2A 
amplicon, only 4 mixed-nucleotide positions, out of a total of 182 assayed, were 
resolved by LPA at a calculated confidence level of <99% (data not shown). In all 
cases, these represented mixtures where the ratio of the major to the minor 
contributor was 95:5, demonstrating that separation of these types of low-level 
mixtures cannot be obtained with high statistical confidence in every case. As a 
standard safeguard, therefore, enrichment of amplicons yielding a <6% (i.e., 
<99% confidence) shift in peak height ratios should be treated with caution. 
The tremendous value of DHPLC in combination with LPA is further 
demonstrated by the use of this approach to identify low level mixtures that 
might not be evident based on direct sequencing alone. By using DHPLC to 
selectively detect and enrich for minor contributors, it is possible to determine 
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not only that the original sample was a mixture, but also to determine the 
haplotype of the minor contributor to a high degree of statistical significance. 
One of the most important impacts of this in a forensic context is that samples 
thought to be of a single source or only slightly heteroplasmic as determined 
solely by direct DNA sequencing might actually contain low levels of a secondary 
contributor’s DNA that can be enriched by DHPLC to provide potentially 
probative information. Until now, it has only been possible to identify the 
presence of additional contributors in these types of cases by the laborious 
process of subcloning mixed templates – a process that has not been forensically 
validated nor passed legal muster for courtroom admissibility. Based on the 
current studies, however, DHPLC represents the first reliable and forensically-
validated method available to address low-level mixtures. 
Studies to date on the use of DHPLC in combination with LPA for the 
deconvolution of three or more component mixtures make it possible in some 
cases to determine one and sometimes two major contributors. Because of 
skewed peak heights at mixed base positions, however, it has not been possible 
to reliably assign a concrete level of statistical confidence to the haplotype 
determinations in these cases. Further validation studies and development of 
more advanced LPA algorithms to handle multicomponenet mixtures are 
ongoing. DHPLC analysis of these types of mixtures, however, can yield 
significant information on the overall complexity of a mixture. From these 
181 
 
results, a forensic analyst can then determine whether to proceed with DHPLC 
fractionation and downstream sequencing. By giving analysts an early indication 
of the molecular complexity of a sample, it enables them to make informed 
decisions on whether or not to proceed with the more time, labor and cost 
intensive direct sequencing analyses and interpretation. 
Although mtDNA analyses are generally only resorted to in cases where 
nuclear DNA analyses fail, DHPLC and LPA of mtDNA mixtures can be used to 
compliment short tandem repeat (STR) typing results obtained from mixtures. In 
cases where the minor contributor to a mixture only displays a partial profile, 
mtDNA mixture separation will yield confirmatory information regarding the two 
contributors to the mixture, regardless of their ratio. This can provide 
investigators with greater confidence in STR typing results from mixed 
populations. 
Mixtures of mtDNA molecules have traditionally been viewed as 
irresolvable by the forensic community. The development of DHPLC fractionation 
of PCR products followed by LPA as a means of assigning a level of statistical 
confidence in the results obtained will have significant benefits for forensic 
practitioners. Courtroom admissibility of this approach, however, will rest upon 
exhaustive validation studies, including analyses of mixtures: consisting of DNA 
from a variety of tissue sources; recovered from a broad diversity of substrates 
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and; subjected to environmental insults likely to be encountered in a forensic 
context. Finally, the computationally tedious nature of LPA analyses have 
prompted the development of automated computer software for the 
identification and quantization of mixed nucleotide positions and the application 
of LPA statistics. 
§ 6 - 5 Summary 
A mixture of different mtDNA molecules in a single sample presents a 
significant obstacle to successful mtDNA analyses by standard forensically 
validated methods. The ability to accurately resolve and interpret these types of 
samples in a timely and cost efficient manner would substantially increase the 
power of mtDNA analysis by allowing its use in cases where the current approach 
yields results that are of limited or no utility. DHPLC is a rapid and cost-effective 
method for physically fractionating mtDNA mixtures; thereby allowing for 
amplicon recovery and subsequent characterization by direct DNA sequencing. 
This is achieved without the need for additional purification or re-amplification. 
The current study illustrates the efficacy of this approach. Further, a statistical 
analysis-based approach is presented (i.e., linkage phase analysis), which allows 
for accurate determination of coordinated shift in peak height fluorescence at 
mixed base positions. This allows for identification of individual contributors to 
an mtDNA mixture with a high degree of statistical significance. The development 
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of linkage phase analysis in conjunction with DHPLC and direct DNA sequencing 
will have significant benefits for forensic practitioners working on mtDNA 
mixtures and will thereby increase the potential probative value of this class of 
physical evidence. 
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Chapter 7: Validation of Mitochondrial DNA Mixture 
Separation by Linkage Phase Analysis 
§ 7 - 1 Introduction 
The use of mitochondrial DNA sequencing has been proven to be of 
tremendous utility in forensic investigations and has been admitted to court on 
several occasions (See www.denverda.org). Until recently, however, mixtures of 
two or more contributors would have complicated mitochondrial DNA haplotype 
analysis and would have often yielded uninformative sequencing data. This has 
limited the statistical power of discrimination of mtDNA analyses. Fractionation 
of mtDNA mixtures by Denaturing High Performance Liquid Chromatography 
(DHPLC) and subsequent Linkage Phase Analysis (LPA) has demonstrated the 
reliability and effectiveness by which mixed samples can be resolved.  
The use of DHPLC has been shown to facilitate the fractionation and 
recovery of PCR amplicons and in some cases has yielded complete separation of 
the individual components of mixtures of two mtDNA contributors. This is 
achieved without reamplification or excessive processing of PCR products as to 
minimize cross contamination or amplification of contaminating components. In 
cases where only partial separation of the individual contributors to a mixture is 
achieved, LPA can be used to deconvolve mixed nucleotide positions. This allows 
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for the identification of individual haplotypes in the mixture (Chapter 6). The 
method also allows for a statistical weight to be assigned to base calls associated 
with the separated mixtures. 
The aim of the current study, therefore, was to validate the use of DHPLC 
fractionation and LPA of sequencing results obtained from these fractions as a 
combined method for mtDNA mixture analysis. This study was performed using a 
variety of commonly encountered forensic samples as well as environmentally 
insulted samples to facilitate the use of this technology in a forensic context. This 
study was in accordance with the DNA Advisory Board (DAB) developmental 
validation standards for sensitivity, reproducibility, accuracy, etc. Furthermore, 
recognizing that Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 593-
94 (1993), Frye’s “general acceptance” test, Frye v. United States, 293 F. 1013, 
1014 (D.C. Cir. 1923) and federal rules of evidence specifically Rules CRE 403 and 
CRE 702 provide the standard for admitting scientific evidence in the federal 
courts. The experimental design of the validation assays was planned with both 
the Frye and Daubert standards in mind. 
The current study shows that mtDNA mixture fractionation by DHPLC and 
sequence analysis by LPA is a valid, highly reliable and rapid method for mtDNA 
mixture separation and subsequent haplotype determination of individual 
contributors to a mixed sample. 
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§ 7 - 2 Materials and Methods 
§ 7 - 2.1 Sample Preparation and DNA Extraction 
This research was conducted in compliance with U.S. Federal Policy for 
the Protection of Human Subjects (56 FR 28003). Individual samples, including 
blood, saliva, semen and hair were collected from unrelated subjects who had 
previously provided informed consent to participate in the study. The mtDNA 
haplotypes of all sample donors were determined separately by sequencing of 
individual buccal swabs. No two donors had identical mtDNA sequences for the 
hypervariable regions used in the study. 
Combinations of undiluted body fluid mixtures (i.e., blood, saliva and 
semen) (5µL each) were used to stain a variety of substrates including denim, 
leather, wood, carpet, nylon and wallboard. All samples were aged for four 
weeks at room temperature, prior to DNA extraction. In order to assess the 
potential impact of environmental contaminants, combinations of undiluted 
body fluid mixtures, (i.e., blood, saliva and semen) (5µL each) were applied to 
Pur-Wraps® sterile cotton tipped applicators (Hardwood Products, Guilford, ME) 
that had previously been dipped in gasoline, a slurry of sterile water and soil, 
used motor oil, laundry detergent, 1N sodium hydroxide and 10% glacial acetic 
acid and allowed to dry for 2 hours.  
Hair samples (natural, dyed dark brown or permed, axial hair, pubic hair; 
2cm; without root) were mixed with 10µL whole blood, semen or saliva prior to 
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two 56°C, six hour incubations. Aged human bones (generously provided by Dr. 
Randall Skelton, University of Montana, Missoula, MT) were cleaned twice in 
25ml of 5% Tergazyme™ and sonicated for 30-45 min.. After rinsing in 95% EtOH 
the bones were allowed to dry overnight at room temperature. All bone samples 
were then pulverized using the SPEX CertiPrep® 6850 Freezer/Mill in accordance 
with manufacturers’ recommended protocol for small bone samples. Briefly, 
samples were placed in SPEX CertiPrep® 6751 grinding vials and frozen in liquid 
nitrogen for 10min. Samples were then pulverized in three 4min. cycles (2min 
grinding period, 2min cooling period). Following retrieval from the grinding vial, 
200mg of bone powder was mixed with 700µL EDTA (0.5M, pH 8.5) and 
incubated at 37°C for 24 - 48 hours. Equal amounts of bone powder (200g) 
obtained from additional samples or 20µL of whole blood were mixed together 
along with 20µL proteinase K (600mAU/mL) (Qiagen, Inc.) and incubated at 56°C 
for at least 3 hours. 
All DNA samples were extracted on the BioRobot EZ1 using the EZ1 DNA 
tissue kit (Qiagen Inc., Valencia, CA) in accordance with the manufacturers’ 
recommended protocol for DNA extraction from trace samples. In order to 
maximize DNA recovery, all samples used in this study were incubated for 15min. 
at 56°C in 190µL of G2 Buffer and 10µL proteinase K (600mAU/mL) (Qiagen, Inc.) 
prior to extraction, unless otherwise noted. Extracted DNA was eluted into 200µL 
of nuclease free ddH2O and stored at -20°C until PCR amplification. 
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§ 7 - 2.2 Mitochondrial DNA Amplification and Purification 
Mitochondrial DNA hypervariable region amplification reactions (50μL) 
were prepared using 50pmol each of forensically-validated PCR primer pairs for 
relevant regions of the human mitochondrial control region (i.e., HV1A, HV1B, 
HV2A and HV2B amplified by primer sets, A1/B2, A2/B1, C1/D2 and C2/D1, 
respectively) (Wilson et al., 1995; Budowle et al., 2000). For each reaction, 2.25U 
AmpliTaq GOLD® DNA polymerase (Applied Biosystems, Foster City, CA) 
supplemented with 0.25U Pfu DNA polymerase (Stratagene, La Jolla, CA); 
AmpliTaq GOLD® Buffer (Applied Biosystems); 10nmol of each dNTP (Stratagene) 
and 10μL of an approximately 10pg/μL DNA extract were used. Amplifications 
were performed on a GeneAmp® 9700 thermocycler (Applied Biosystems) with 
an initial denaturation at 95°C for 10 minutes, followed by 32 cycles of 95°C for 
20 seconds, 60°C for 30 seconds and 72˚C for 45 seconds. The final extension at 
72°C was for 15 minutes. PCR amplicons were purified and quantified at 50°C on 
a WAVE® 3500HT DNA Fragment Analysis System (Transgenomic Inc., Omaha, 
NE) containing a DNAsep® analytical column packed with alkylated 
poly(styrenedivinylbenzene) resin (Huber et al., 1993) using previously 
established methods (Chapter 3). 
§ 7 - 2.3 DHPLC Mixture Fractionation 
Cross hybridization of mixed amplicons was performed by denaturation at 
95°C for 4 minutes and renaturation by gradual cooling (1.5°C/min) over a 45 
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minute period to reach a final temperature of 25°C (LaBerge et al., 2003). Cross 
hybridized mixtures were then analyzed by Temperature-Modulated 
Heteroduplex Analysis (TMHA) (Kuklin et al., 1997) using a DNASep® column in 
the presence of 0.1M triethylammonium acetate (TEAA) pH 7.0 as an ion pairing 
reagent. Empirically predetermined optimal temperatures for each of the four 
forensic mtDNA amplicons (HV1A, 58°C; HV1B, 59.2°C; HV2A, 56.5°C and HV2B, 
57°C) were used for each assay. The optimal acetonitrile linear gradients 
generated from differential mixing of buffer A (0.1M TEAA) and buffer B (0.1M 
TEAA, 25% ACN) were 56% to 65% buffer B increase in 3.5 minutes for HV1A, 
HV2A and HV2B and a 55% to 64% buffer B increase in 3.5 minutes for HV1B. All 
samples were eluted at a 0.9ml/min flow rate and detected by UV absorbance at 
260nm. Eluted peaks were captured using an automated fraction collector 
(Transgenomic, Inc.); dried by vacuum centrifugation for 30 minutes at 50°C 
followed by a 20-minute cool down to ambient temperature on a CentriVap® 
Vacuum Concentrator (Labconco Corporation, Kansas City, MO). Samples were 
resuspended in nuclease-free H2O; and stored frozen until DNA sequencing. 
Standard DHPLC controls included: zero-volume injections to screen for residual 
DNA carryover from the column matrix, no-template PCR controls to check for 
amplification contamination and manufacturer provided mutation control 
standards for buffer and column quality control. 
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§ 7 - 2.4 Mitochondrial DNA Sequencing 
DNA sequencing reactions were prepared using the appropriate 
forensically-validated amplification primers. For greatest peak height consistency 
as previously determined (Chapter 4), 0.8ng total input DNA quantities were 
used for all labeling reactions and amplicons were extended according to the 
manufacturer’s protocols using the BigDye® Terminator v1.1 Cycle Sequencing Kit 
(Applied Biosystems). Dye-terminated products were purified by Performa® DTR 
V3 96-well Short Plate Kit (Edge BioSystems, Gaithersburg, MD) according to the 
manufacturer’s protocol and resolved on a PRISM® 310 Genetic Analyzer 
(Applied Biosystems) using POP-6™ polymer and 47cm x 50µm capillaries 
(Applied Biosystems). Appropriate positive and negative controls were carried 
through the entire sample handling process to minimize cross contamination and 
to monitor amplification efficiency. Raw electrophoretic traces were analyzed 
using the KB Basecaller (Applied Biosystems) together with the appropriate dye 
set mobility file for the v1.1 kit using Sequencing Analysis Software v.5.1.1 
(Applied Biosystems). The resulting sequence data were analyzed using the 
Sequencher™ v4.2 DNA analysis software (Gene Codes Corp, Ann Arbor, MI) and 
individual peak height values obtained using the CEQ™ 8000 Genetic Analysis 
System version 8.0 software package (Beckman-Coulter, Fullerton, CA) 
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§ 7 - 2.5 Linkage Phase Analysis 
Mixed nucleotide positions were considered to be any positions 
characterized by a primary peak and an underlying secondary peak having a 
height >10% that of the major peak as determined by inspection of the relative 
fluorescent units (RFU) in the analyzed data. Corresponding mixed nucleotide 
positions were analyzed between fractions and LPA was used to resolve mixtures 
based on a comparison of those fractions showing the greatest average change in 
fluorescence ratio across all mixed base positions. For each mixed nucleotide 
position, the change in the base fluorescence ratio corresponds to a change in 
amplicon quantity between the two components that make up the mixture. The 
statistical confidence of this relationship was derived from statistical analyses of 
data gathered during the developmental validation study. These data were 
obtained from 347 comparisons of 13 different contributor ratios at 202 unique 
nucleotide positions across the hypervariable region of the mtDNA genome, for a 
total of 27,066 data points (Chapter 6). 
§ 7 - 3 Results and Discussion 
§ 7 - 3.1 Efficiency of Component Identification as a Function of 
Chromatographic Trace Characteristics 
As a reflection of chromatographic separation of non-identical amplicons, 
DHPLC trace characteristics should be correlated with the efficiency of mixture 
resolution. Mixture analysis by TMHA, yields chromatographic traces ranging 
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from a major peak complimented by a significant shoulder, to multiple peaks 
representing each of the homo- and heteroduplices formed during denaturation 
and subsequent renaturation of the DNA present in the sample. In a two-
component mixture, the optimal DHPLC trace displays complete separation of 
each homo- and heteroduplex peaks. 
Two-component mixtures which display optimal four peak resolution, 
where the two homoduplices resolve into two distinct peaks of close or equal 
height, generally yield fractions that, when sequenced, display the most 
pronounced coordinated shift in peak height fluorescence ratios. Figure 7.1 
illustrates the fractionation and LPA analysis of a two-component mixture with 
four peak resolution. The two homoduplices were captured by automated 
fraction collection (Figure 7.1A) and peak height ratios determined by dye 
terminator sequencing (Figure 7.1B). Pair-wise comparison of fluorescence ratios 
at mixed base positions across all fractions (66 comparisons among the 12 
fractions recovered), yielded an average peak height ratio shift of 34.2 ± 21.1%. 
Of these, the comparison of fractions 7 and 11 yields the greatest coordinated 
shift in peak height fluorescence ratios across all mixed bases, with an average of 
81.8 ± 1.5%. This was associated with linkage phase determination where the 
base calling confidence was greater than 99.99% for all mixed base positions 
(Figure 7.1C). Comparison of fractions 11 and 12 yields the least shift in peak 
height fluorescence ratios, with a mixed base average of 0.77 ± 0.47%. The  
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Figure 7.1: (A) Denaturing HPLC chromatogram, showing the twelve collected 
fractions all of which were used for dye-terminator DNA sequencing. (B) Relative 
quantitation of fluorescence peak height ratios (y-axis) for eight mixed base 
positions from sequence electropherograms representing DNA recovered from 
all DHPLC fractions collected (x-axis). (C) Use of linkage phase analysis to 
determine the haplotypes of the individual contributors to this two-component 
mixture. This analysis is based on shifts in peak height ratios at mixed base 
positions between DHPLC fractions 7 and 11. 
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particularly low shift in peak height ratio between fractions 11 and 12 is due to 
the fact that both of these fractions represent the near complete isolation of a 
single contributor to the mixture – the same contributor in both cases. A 
comparison between these two fractions, therefore, adds no value to the overall 
analysis of the mixture. Furthermore, the shift in peak height between fractions 
11 and 12 is comparable to the internal variability noted in replicate sequencing 
reactions of mixtures consisting of the same amplicon ratios (Chapter 5) as well 
as the inherent peak height variability of individual peaks in any sequencing 
reaction (Chapter 4).  
Although fractions 7 and 11 yielded the greatest amount of fluorescence 
ratio shift across all mixed nucleotides, LPA of the majority of fraction 
comparisons (49 out of 66) yielded linkage phase determinations with an average 
base calling confidence greater than 99.9%. The remaining 17 fraction 
comparisons, where average base calling confidence was less than 99.9%, 
reflected two phenomena. The first of these is the comparison of adjoining 
fractions containing very similar molar ratios of mixed amplicons (e.g., fractions 6 
and 7), or fractions flanking the same peak which again would be expected to 
possess similar amplicons ratios (e.g., fractions 5 and 8). 
Table 7.1 illustrates the results obtained from 51 two-component 
mixtures at component molar ratios ranging from 50:50 to 95:5. These samples  
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Table 7.1: Summary of mtDNA mixtures ratios analyzed by DHPLC including 
change in peak height ratios attained and base calling confidence ranges for 
linage phase determination at mixed nucleotide positions. 
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display a range of DHPLC trace characteristics, from one major peak and a 
corresponding shoulder, to complete separation of all four homo- and 
heteroduplex peaks. All amplified samples were fractionated accordingly by 
DHPLC under partially denaturing conditions. Three to twelve fractions for each 
sample were then labeled for direct sequencing. All sequenced fractions were 
analyzed for mixed base positions. These were compared across fractions by LPA 
in order to identify those bases that displayed coordinated shifts in peak height 
fluorescence ratios. Eighty-two percent of analyzed mixtures yielded linkage 
phase determinations with average base calling confidence of greater than 
99.9%, when the fractions that were compared were those that displayed the 
greatest shift in peak height fluorescence. Of the nine remaining mixtures, only 
two yielded linkage phase determinations with an average base calling 
confidence of less than 99% (CS-38; 98.922% and CS-49; 98.557%).  
Analysis of sample CS-38 by DHPLC using TMHA (Figure 7.2) was 
characterized by separation of the homoduplices into a major peak and a trailing 
shoulder (separated into six 50µL fractions). The heteroduplices (not captured) 
formed to only a minimal degree as evidence by their low elution peak heights. 
The major reason for this lack of apparent separation for CS-38 when analyzed by 
LPA is that the trailing edge of the shoulder was not sequenced (fractions 5 and 
6). When compared to sequencing results obtained from the opposite 
sequencing primer (CS-42; where fractions 1-5 were sequenced), the shift in  
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Figure 7.2: Analysis of sample CS-38 by TMHA, showing separation of individual 
homoduplices into a major peak (fractions 1-3) and a trailing shoulder (fractions 
5 and 6).  Also shown is the formation of minor heteroduplices (not captured) at 
a retention time of approximately 3.9 minutes. Linkage phase analysis of 
fractions 1 and 4 yielded separation of the two contributors to the mixture with 
an average base calling confidence of 98.922%. Analysis of fractions 1 and 5 
yielded an average confidence of 99.976%.  
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peak height fluorescence was significantly greater. These results illustrate that, 
while blind fraction sequencing yields significant information as to the 
haplotypes comprising the mixture, considerably improved results are attained 
when strategic fraction sequencing is performed. 
Analysis of sample CS-49 by TMHA (Figure 7.3) shows the separation and 
capture of a single broad homoduplex peak (fractions 4-7) preceded by a single 
heteroduplex peak (fractions 1-2). This was primarily due to the nature of the 
mixture itself (a 95:5 component ratio) in which the major contributor peak 
masks the minor contributor peak. As a result, comparisons of mixed base 
positions in the sequencing data obtained from these fractions revealed only 
small shifts in peak height ratios. Of these, the largest coordinated shift in peak 
height fluorescence ratios was seen between fractions 4 and 7. LPA of these 
fractions, allowed for the determination of the linkage phase of each of the two 
contributors to this mixture. This illustrates, that the broad nature of the 
homoduplex peak is due to a slight difference in the retention times between the 
two homoduplices present in the mixture. The LPA results clearly indicate that 
even when retention time differences are not readily apparent (as the minor 
component homoduplex is hidden by the major component peak), the subtle 
variation in retention time can be detected by LPA of the sequences obtained 
from these fractions. 
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Figure 7.3: Analysis of sample CS-49 by TMHA, showing separation and capture 
of a single broad homoduplex peak (fractions 4-7). This major peak is preceded 
by a separate single heteroduplex peak (fractions 1-2). Based on analyses of the 
sequencing electropherograms, the greatest shift in peak height ratios was 
between fractions 4 and 7. LPA of these fractions made it possible to determine 
the haplotypes of the individual contributors to this mixture with an average 
basecalling confidence of 98.557%.  
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Of the samples displayed in table 7.1, those displaying two, three and 
four peak resolution by DHPLC account for 29.4%, 21.6% and 47.1% of the 
samples tested. Comparison to a larger study of 849 mixtures subjected to 
DHPLC profiling across all four forensically relevant regions of the human mtDNA 
(Chapter 2) reveals a slight decrease in the amount of samples yielding two and 
three peak resolution. In that study, samples displaying two, three and four peak 
resolution comprised 50.3%, 36.6% and 11.6% of all samples tested, respectively. 
This discrepancy may reflect differences in the specific sequences analyzed and 
the number of each sequence analyzed. In the current validation study, 
sequences were selected to incorporate a broad diversity of mixed base positions 
across the HV1 and HV2 regions. The larger study included numerous more 
similar amplicons which may be less likely to yield cross hybridization products 
capable of being fractionated into four clearly discernible chromatographic 
peaks. 
§ 7 - 3.2 Efficiency of Component Identification as a Function of 
Mixture Ratio 
Comparison of multiple mixture ratios for a two-component mixture 
yielded information on which fraction comparisons generate the most 
informative and consistent coordinated shifts in peak height fluorescence. 
Analysis of samples CS-8, CS-20, CS-21, CS-38 and CS-39 sequenced with the C1 
primer and samples CS-15, CS-25, CS-26, CS-42 and CS-43 sequenced with the D2 
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primer made it possible to determine which fraction comparisons yielded the 
largest and the smallest coordinated shifts in the fluorescence ratios of linked 
bases. In all cases, the homoduplicies formed during cross hybridization of the 
amplified PCR products resolve into two distinct peaks, each representing one 
contributor. If the first peak is the tallest, the greatest coordinated shift in peak 
height fluorescence is achieved by comparing the lagging edge of the second 
peak to the top of the first peak (Figure 7.1A; fractions 7 and 11). If the second 
peak is the tallest, the same can be achieved by comparing the leading edge of 
the first peak to the top of the second peak. As described above, comparison of 
adjacent fractions tends to yield only limited shifts in peak height fluorescence 
ratios due to the fact that adjacent fractions are likely to be characterized by 
smaller changes in the underlying molar ratios of one contributor to the other. 
When homoduplices are not resolved into separate peaks, comparisons 
between the heteroduplex peaks and the top or lagging edge of the homoduplex 
peak generally yields the greatest coordinated shift in peak height fluorescence. 
This can be illustrated when comparing fractions sequenced for CS-29 (Figure 7.4; 
fractions 1-3 compared to fractions 11-13). Here, a large shift in peak height 
fluorescence ratio was consistently observed when comparing a number of 
fractions on the lagging side of the heteroduplex peak to the top or lagging side 
of the homoduplex peak. When this is done, a consistent 20% - 30% coordinated 
shift is noted for all fraction comparisons performed between the homo- and  
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Figure 7.4: Analysis of sample CS-19 by TMHA, showing separation and capture 
of a single very broad homoduplex peak (fractions 6-13) preceded by a separate 
single heteroduplex peak (fractions 1-3). A consistent 26% - 32% coordinated 
shift in peak height fluorescence ratio is observed when comparing fractions on 
the lagging side of the heteroduplex peak (fractions 2 or 3) to the homoduplex 
peak (fractions 7-13). Based on analyses of the sequencing electropherograms, 
the greatest shift in peak height ratios was between fractions 2 and 8. LPA of 
these fractions made it possible to determine the haplotypes of the individual 
contributors to this mixture with an average basecalling confidence of 99.982%. 
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heteroduplex peaks. Only when fluorescence ratios were compared between 
fractions from the same peak was there a low shift in peak height fluorescence 
ratios. 
§ 7 - 3.3 Body Fluid Mixtures 
Thirty six two-component body fluid mixtures were stained onto a variety 
of substrates intended to simulate forensic casework. These included denim, 
fabric, leather, wood, synthetic carpeting, nylon and wallboard. Samples were 
aged at room temperature for four weeks followed by DNA extraction. No two 
donor samples used in this study had identical mtDNA haplotypes as previously 
determined by sequencing analysis of known buccal swabs (Table 7.2). 
Amplification of HV1 and HV2 region fragments was performed on a subset of 
questioned mixtures using forensically validated primer sets and conditions. All 
amplified samples were then fractionated by DHPLC under partially denaturing 
conditions. Five to nine fractions for each sample were analyzed by direct 
sequencing, followed by LPA of mixed base locations. DNA sequencing yielded 
clean base calls for all but mixed nucleotide positions, which were characterized 
by overlapping fluorescent peaks. Identification by LPA of the haplotypes of the 
individual contributors that comprised each of the 18 mixtures tested was 
achieved in all cases for a success rate of 100%. All identified haplotypes were in 
full concordance with sequence data obtained from sequencing of single source 
representative samples from each contributor. The linkage phase of individual  
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Table 7.2: The mtDNA control region sequences of the body fluid samples used in 
the current study. Sequences are shown as deviations from the revised 
Cambridge Reference Sequence (rCRS). 
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contributors was determined with a high degree of base calling confidence. 
Depending on substrate and the nucleotide position, the mean confidence of 
base calling by linkage phase analysis ranged from an average of 99.926% to 
99.994% (Table 7.3). In all cases, linkage phase analysis was performed on those 
DHPLC fractions which showed the greatest shift in peak height fluorescence 
ratios. 
Comparison of all fractions sequenced yielded an average change in peak 
height fluorescence ratio ranging from 7.7% - 24.5%, with fractions neighboring 
each other yielding the lowest shift in peak height fluorescence (0.2% - 2.7%). 
The largest shift in peak height fluorescence ratio ranged from 16.3% - 51.5%. 
Those fraction comparisons that tended to yield the most optimal results were 
consistent with the aforementioned results of the studies in this chapter that 
examined the relationship between DHPLC trace characteristics and the 
efficiency of mixture resolution by DHPLC in combination with LPA. 
§ 7 - 3.4 Environmental Insult Mixtures 
Thirty six two-component body fluid mixtures were subjected to a variety 
of environmental insults designed to simulate forensic casework type samples. 
These included gasoline, soil, laundry detergent, used motor oil, sodium 
hydroxide and acetic acid. Following DNA extraction, amplification of mtDNA HV1 
and HV2 regions was performed on a subset of mixtures using forensically  
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Table 7.3: Casework-type mtDNA samples analyzed by DHPLC and LPA including 
changes in peak height ratios attained and base calling confidence ranges for 
linkage phase determination at mixed nucleotide positions. 
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validated primer sets and amplification conditions. All amplified samples were 
fractionated by DHPLC under partially denaturing conditions. Five to nine 
fractions for each sample were then analyzed by direct sequencing, followed by 
LPA of all mixed base positions.  
DNA sequencing yielded good quality base calls for all but mixed 
nucleotides positions which, as anticipated, were characterized by overlapping 
fluorescent peaks. For each of the 18 amplified mixtures, the haplotypes of the 
individual contributors was determined by LPA of the sequence 
electropherograms. All identified haplotypes were in full concordance with 
sequencing results obtained from single source reference samples of the same 
contributors. Thus a success rate of 100% was achieved for the resolution of the 
18 mixtures that were fractionated. Moreover, the average base calling 
confidence (depending on substrate and nucleotide position) ranged from 
99.926% to 99.993% (Table 7.3). This was achieved when the DHPLC fractions 
that were compared were those that displayed the greatest shifts in peak height 
fluorescence.  
Pairwise comparisons of all fractions sequenced yielded an average 
change in peak height fluorescence ratio across all mixed base positions ranging 
from 8.0% - 23.2%.  As expected and as demonstrated previously, adjoining 
fractions yielded the lowest shift in peak height fluorescence ratios (0.3% - 1.7%). 
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The largest shifts in peak height fluorescence ratios ranged from 12.2% - 49.9%. 
Those fraction comparisons that tended to yield the most optimal results were 
consistent with the aforementioned results of the studies in this chapter that 
examined the relationship between DHPLC trace characteristics and the 
efficiency of mixture resolution by DHPLC in combination with LPA. 
§ 7 - 3.5 Hair and Bone Mixtures 
Hair shafts as evidentiary material are commonly encountered in forensic 
contexts. Because of the paucity of nuclear DNA typically recovered from these 
samples mtDNA analysis often represents an investigator’s most promising 
opportunity to obtain potentially probative biological information. Accordingly, 
31 hair samples were contaminated with various body fluids. Head, axial and 
pubic hairs were immersed in blood, semen and saliva and allowed to air dry. 
DNA was extracted from all samples, yielding a total of 9 hair shaft body fluid 
mixtures which were detected and subsequently fractionated by DHPLC. 
Sequence data from the recovered DNA fractions were subjected to LPA in an 
effort to determine the haplotypes of the individual contributors to the mixtures. 
For each of the 9 mixtures that were fractionated and analyzed, LPA correctly 
identified the contributor haplotypes in 100% of the cases. All identified 
haplotypes were in full concordance with sequencing results obtained from 
single source reference samples of the same contributors. Haplotypes were 
determined with a high base calling confidence which (depending on the specific 
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mixture and nucleotide position) ranged from an average of 99.84% to 99.99% 
(Table 7.3). This was achieved when the DHPLC fractions that were compared 
were those that displayed the greatest shifts in peak height fluorescence. 
Pairwise comparison of all fractions sequenced yielded an average change 
in peak height fluorescence ratio ranging from 5.2% - 18.5%. As before, adjoining 
fractions yielded the lowest shift in peak height fluorescence (0.2% - 2.5%). The 
largest shifts in peak height fluorescence ratios ranged from 11.0% - 44.5%. As 
has been seen with all other mixed samples, the fraction comparisons that 
tended to yield the most optimal results were consistent with the 
aforementioned results of the studies in this chapter that examined the 
relationship between DHPLC trace characteristics and the efficiency of mixture 
resolution by DHPLC in combination with LPA. 
Human bone samples obtained from the University of Montana’s 
Department of Anthropology were pulverized and then processed to extract 
amplifiable mtDNA. One bone sample yielded no amplifiable product even 
following a second round of extraction and amplification, while two of the 
samples yielded a mixed mtDNA profile. The lack of amplifiable product for one 
of the bone samples was most likely due to a number of factors. These may 
include but are not limited to extensive degradation of the DNA present in the 
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bones which had been stored for years at room temperature and/or chemical 
treatments used to prepare the material for storage.  
A second bone (Item-37) did yield amplifiable mtDNA. As is typical, the 
porous nature of many aged bone samples makes them conducive to 
contamination by extraneous DNA, e.g., from comingling with other remains or 
excessive handling by unrelated individuals. Initial analysis of the amplified 
mtDNA by DHPLC under partially denaturing conditions suggested that the 
amplified product consisted of a mixture of two non-identical amplicons. 
Fractionation of this sample by DHPLC yielded six fractions from which DNA could 
be recovered and sequenced. Pairwise comparisons of the resulting sequence 
data from these fractions revealed a two-component mixture with five mixed-
nucleotide positions. The largest shift in the peak height ratios among the 
fractions compared was 48.7% - 61.6% depending on the mixed nucleotide 
position being examined. LPA of the sequence data from these fractions resulted 
in an average base calling confidence of greater than 99.99% across all five mixed 
base positions. 
A third bone (Item-38), also presented as a likely two-component mixture 
upon examination of the DHPLC trace characteristics under partially denaturing 
conditions. Fractionation of this sample by DHPLC yielded six fractions from 
which DNA could be recovered and sequenced. Shifts in peak height fluorescence 
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ratios that were evident in pairwise comparisons of sequence data from these six 
fractions revealed a total of five mixed-base positions. Subsequent LPA, of the 
mixed-base positions however, revealed that while shifts in peak height ratios 
made it possible to determine the linkage phase of one contributor, there was 
not a corresponding linkage phase at these same positions for the second 
contributor. Rather, coordinated shifts in peak height ratios at only two of the 
five mixed nucleotide sites appeared to constitute the linkage phase of a second 
contributor (average base calling confidence >99.9%). Shifts in peak height ratios 
at the remaining three mixed base position appeared to constitute the linkage 
phase of a third contributor (average base calling confidence >99.9%). While the 
third component was not identified in the initial screen by DHPLC, this was most 
likely due to the low concentration of the third contributor in this mixture. The 
presence of the third contributor, however, was evident in the DNA sequencing 
electropherograms and was resolved through LPA.  
Although a three-contributor mixture was discovered and resolved for 
this particular sample during LPA, extensive studies on three or more component 
mixtures at varying contributor ratios remain a significant challenge. This is due 
to the difficulty that is typically encountered in attempting to deconvolute mixed 
nucleotide positions where all three contributors differ (Chapter 6). 
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Neither chromatographic trace characteristics nor the number of variant 
positions between the amplicons comprising a mixture revealed any significant 
trends in the efficiency of separation for any of the samples tested in this study. 
In fact, two-peak DHPLC traces yielded both the lowest and greatest averages 
with regard to the observed shifts in peak height ratios. It is recognized, 
however, that based on an inspection of the results reported from this study, 
mixtures of amplicons sequenced using the C1 primer tended to yield a lower 
shift in peak height ratios and therefore a lower efficiency of mixture separation. 
This trend, however, is most likely due to the specific mixtures employed in this 
study. This is supported by the results obtained for the control samples 
presented in Table 7.1 and data previously reported on concentration and 
sequencing reproducibility (Chapter 4) where this trend was not evident. 
§ 7 - 4 Conclusion 
Mitochondrial DNA sequencing analysis is now a widely used 
methodology for the identification of sequence polymorphisms both in the 
medical and forensic communities. While mtDNA sequencing analyses of samples 
containing single contributors have been rigorously tested and validated, 
analyses of the electrophoretic trace characteristics of mtDNA mixtures have, 
until now, never been thoroughly studied. Alternative methods for mixture 
separation (e.g., DGGE, pyrosequencing) have previously been proposed as 
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means for separating mtDNA mixtures. Use of DGGE, however, is extremely labor 
intensive, requires significant sample manipulation, re-amplification of captured 
PCR products and is not easily amenable to automation (Danielson et al., 2005). 
Pyrosequencing yields very short sequence reads (~70bp) and consumes 
significant amounts of sample due to multiple synthesis reactions. Further, 
mixture separation capabilities of pyrosequencing have yet to be put through the 
rigors of forensic validation and pyrosequencers remain more of a research 
novelty than a realistic option for forensic practitioners. The significant cost of 
the requisite instrumentation presents an additional barrier. 
Although mtDNA sample contamination by even minor extraneous 
sources of human DNA remains high due to its environmental persistence and 
abundance in terms of copy number, proper handling procedures and vigorous 
quality control measures can significantly reduce the occurrence of cross 
contamination. In the current study, no mixture component was traced back to 
individuals not originally added to the mixture. Not even in the case of Item-38, 
was the third component traced back to any individual present in the 
laboratory’s internal exclusion database. This database includes not only all 
laboratory employees, but also all human DNA samples located in the laboratory. 
In the current study, the analysis of mtDNA mixtures from two-
contributor samples was evaluated using DHPLC fractionation and LPA of 
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sequencing results obtained from captured fractions. Using this approach, a total 
of 101 mixtures have been analyzed and the haplotypes determined for 
individual contributors to each mixture. In all cases, linkage phases at mixed-base 
positions were determined with a high degree of base calling confidence. 
Nucleotides determined to be in linkage phase with each other were, in all cases, 
fully concordant with sequencing results obtained from non-mixed reference 
samples. Results from the current study therefore, demonstrate the usefulness 
and reliability of this approach through the use of both control and simulated 
casework samples. 
§ 7 - 5 Summary 
Mixtures of two or more contributors decrease the reliability and 
usefulness of mtDNA haplotyping, due to the unavoidable generation of 
ambiguous and often uninformative sequencing data. Fractionation and recovery 
of PCR amplicons by DHPLC has made it possible to separate and identify 
individual contributors to a mixture without reamplification or excessive 
processing of PCR products. Statistical analysis using linkage phase analysis adds 
statistical weight to separated mixtures allowing for the confidence of mixed 
nucleotide separation to be determined. This study presents results of mixture 
resolution by DHPLC in combination with LPA using a variety of commonly 
encountered and environmentally insulted samples as well as hair, bone etc. 
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designed to simulate evidentiary material consistent with forensic casework. 
These validation studies have been designed to facilitate the adoption of this 
technology by forensic practitioners. The current study shows that mtDNA 
mixture fractionation by DHPLC and sequence analysis by LPA is a rapid, highly 
reliable and forensically valid method for mtDNA mixture separation and 
subsequent haplotype determination of individual contributors to a mixed 
sample. 
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Chapter 8: Validation of Denaturing High-Performance Liquid 
Chromatography for Forensic mtDNA Casework 
Analysis 
§ 8 - 1 Introduction 
Denaturing high-performance liquid chromatography (DHPLC) is a rapid 
ion-paired reversed-phase HPLC method used to detect variations in DNA 
sequence in identical length amplicons. The use of DHPLC has in recent years 
been proposed as a method for a variety of forensic applications. These methods 
include but are not limited to detection of single nucleotide polymorphisms (Shi 
et al., 2001), sex identification (Shinka et al., 2001), heteroplasmy determination 
(van Den Bosch et al., 2000; Biggin et al., 2005), short tandem repeat (STR) 
analysis (Zhu et al., 2006) and mtDNA screening and mixture resolution 
(Danielson et al., 2007). 
In DHPLC, cross-hybridized PCR products interact with the hydrophobic 
column matrix through a triethylammonium acetate buffer and are eluted 
through an increasing gradient of acetonitrile (Huber et al., 1993). Under partially 
denaturing conditions less stable heteroduplices elute prior to the more stable 
homoduplices allowing for identification of sequence variation (O'Donovan et al., 
1998; Hou and Zhang 2000). Under non-denaturing conditions, samples of 
varying length are easily separated, allowing for sample purification and 
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determination of amplicon size and quantity in a similar manner as other HPLC 
systems (Warren and Doniger 1991; Henninger et al., 1993; Zeillinger et al., 1993; 
Katz 1996). 
While new protocols for analysis and processing of evidentiary material 
employing DHPLC analysis have been reported (Danielson et al., 2003; Danielson 
et al., 2005; Danielson et al., 2007), forensic validation studies of the WAVE® 
3500HT DNA Fragment Analysis System (Transgenomic, Inc., Omaha, NE) 
employed for DHPLC analysis have until now not been carried out. This has 
limited DHPLC use to non-caseworking applications. The aim of the current study 
was, therefore, to demonstrate the reliability, sensitivity and consistency of the 
WAVE® 3500HT DNA Fragment Analysis System in combination with the 
DNASep® column (Transgenomic, Inc.). The results of this study demonstrate that 
the combination of WAVE® 3500HT DNA Fragment Analysis System and DNASep® 
column provides a platform for consistent and reliable analysis of cross-
hybridized PCR products with unparalleled detection sensitivity. 
§ 8 - 2 Materials and Methods 
§ 8 - 2.1 Mitochondrial DNA Extraction 
All aspects of this research were conducted in compliance with U.S. 
Federal Policy for the Protection of Human Subjects (56 FR 28003). Individual 
buccal samples were collected from unrelated subjects who had previously 
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provided informed consent to participate in the study. Total human DNA was 
extracted using the EZ1 DNA tissue kit on the Qiagen BioRobot EZ1 DNA 
extraction robot (Qiagen Inc., Valencia, CA) according to the manufacturer’s 
protocol. Samples were eluted into 200µl of nuclease-free water and then stored 
at -20°C until PCR amplification. 
§ 8 - 2.2 Mitochondrial DNA Control Region Amplification 
Forensically validated protocols (Wilson et al., 1995; LaBerge et al., 2003) 
were used to amplify the four forensically relevant regions (HV1A: 278bp; HV1B: 
271bp; HV2A: 278bp; HV2B: 277bp) of the human mitochondrial genome. 
Amplification reactions (50μL) were prepared using 50pmol each of forensically-
validated PCR primers at final concentration of 1μmol/L (Wilson et al., 1995; 
LaBerge et al., 2003); 0.45 U/10μL AmpliTaq GOLD® DNA polymerase (Applied 
Biosystems, Foster City, CA); 0.05 U/10μL PFU DNA polymerase (Stratagene, La 
Jolla, CA); 10X AmpliTaq GOLD® Buffer (Applied Biosystems) and 200μmol/L of 
each dNTP (Stratagene) with 2μL of an approximately 10pg/μL DNA extract. 
Amplifications were carried out on a GeneAmp® 9700 thermocycler (Applied 
Biosystems) with an initial denaturation at 95˚C for 10 minutes, followed by 32 
cycles of 95˚C for 20 seconds, 60˚C for 30 seconds and 72˚C for 45 seconds, 
followed by a final extension at 72˚C for 15 minutes. 
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§ 8 - 2.3 DHPLC-Based Temperature-Modulated Heteroduplex 
analysis (TMHA) 
Amplified fragments were combined at a 1:1 molar ratio to generate a 
series of pair-wise mixtures which were cross-hybridized by denaturation at 95°C 
for 4 minutes and gradual cooling (1.5°C/min) to a final temperature of 25°C 
(LaBerge et al., 2003). Cross-hybridized amplification reactions were assayed by 
DHPLC (Kuklin et al., 1997) on a WAVE® 3500HT DNA Fragment Analysis System 
(Transgenomic Inc., Omaha, NE) containing a DNASep® analytical column (Huber 
et al., 1993). Products were bound to the resin in an aqueous buffer containing 
0.1M triethylammonium acetate (TEAA) pH 7.0 as an ion-pairing reagent. Cross-
hybridized mixtures were analyzed under partially denaturing conditions at the 
empirically determined optimal temperatures for each of the four mtDNA 
amplicons (i.e., HV1A, 58°C; HV1B, 59.2°C; HV2A, 56.5°C and HV2B, 57°C). All 
samples were eluted at 0.9ml/min flow rate and detected by UV absorbance 
(260nm). The optimal acetonitrile linear gradient generated from differential 
mixing of buffer A (0.1M TEAA) and buffer B (0.1M TEAA, 25% ACN) were 56% to 
65% buffer B increase in 3.5 minutes for HV1A, HV2A and HV2B and a 55% to 
64% buffer B increase in 3.5 minutes for HV1B. Eluted peaks were captured by 
automated fraction collection and then evaporated by vaccum centrifugation 
using a Centrivap Mobile Concentrator System (Labconco Corp, Kansas City, MO). 
Each sample was then resuspended in ddH2O and stored at -20°C until assayed. 
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§ 8 - 2.4 Mitochondrial DNA Subcloning and DHPLC Analysis 
Primers mt-8294F (5’-CCACTGTAAAGCTAACTTAGCATTAACC-3’) and mt-
8436R (5’- CCATACTCCTTACACTATTCCTCATCAC-3’) were used to amplify a 143bp 
mtDNA coding region fragment (Andreasson et al., 2002). The resulting 
amplification products were purified using Wizard® PCR Preps (Promega, 
Madison, WI), ligated into the pGEM®-T vector (Promega) and electroporated 
into DH5α electrocompetent cells. Cells were selected on LB agar plates 
containing 50μg/ml ampicillin and screened by PCR to identify plasmids 
containing target inserts. Plasmids were isolated from overnight cultures of these 
colonies by alkaline lysis and capture on glass-filter binding plates (Millipore, 
Bedford, MA). The aforementioned primers were used to amplify the 143bp 
fragment from isolated plasmids using conditions described above. 
Amplification reactions were assayed by DHPLC under non-denaturing 
conditions (50°C) and differential mixing of buffer A and buffer B, where buffer B 
increased from 49.3% to 58.3% in 4.5 minutes. Samples were detected by UV 
absorbance (260nm) and fluorescence (ex. 490nm, em. 520nm). Fluorescence 
detection was made possible by employing a proprietary DNA intercalating dye 
(Transgenomic Inc.), injected after the eluent had passed the UV detector using 
an inline high sensitivity accessory (HSX) pump (Transgenomic, Inc.). Eluted peaks 
were captured by automated fraction collection and then evaporated by vaccum 
centrifugation. 
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§ 8 - 2.5 Dye-Terminator Sequencing 
Dye-terminator sequencing was performed using the BigDye® Terminator 
v1.1 Cycle Sequencing Kit (Applied Biosystems). Samples were prepared in 10µL 
reaction volumes according to the manufacturer’s protocols using the maximum 
available DNA input quantity up to a maximum of 0.8ng. Dye-terminated 
products were purified on Performa® DTR V3 96-Well Short Plates (Edge 
Biosystems, Gaithersburg, MD) and resolved on a PRISM® 310 Genetic Analyzer 
(Applied Biosystems) according to the manufacturer’s protocols using the POP-
6™ polymer and 47cm x 50µm capillaries (Applied Biosystems). The raw 
electrophoretic traces were analyzed using the KB Basecaller (Applied 
Biosystems) together with the appropriate dye set mobility file for the v1.1 kit 
using Sequencing Analysis Software v.5.1.1 (Applied Biosystems). The resulting 
sequence data were aligned using the Sequencher™ v4.2 DNA analysis software 
(Gene Codes Corp, Ann Arbor, MI). 
Appropriate positive and negative controls were carried through the 
entire sample handling process to enable the detection of any cross 
contamination and ensure proper dye-terminator incorporation efficiency. 
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§ 8 - 3 Results and Discussion 
§ 8 - 3.1 Sample Cross Contamination 
Sample cross contamination as a function of injection-to-injection 
carryover was determined by capture of zero-volume injections (i.e., DNA-free 
samples) following the injection of amplified PCR samples. In these assays, 
samples containing high quantities (approx. 550ng) of amplified 143bp DNA 
fragment (from previously subcloned mtDNA coding region) were injected onto 
the DNASep® column yielding a single peak with maximum absorbance at 3.82 ± 
0.05 min. This was followed by 5 zero-volume injections.  The column eluent 
(flow path buffer) was then collected for the same time frame where DNA from 
the initial injection had eluted (i.e. 3.0 - 4.5 min). Sample detection by UV 
absorbance revealed no evidence of DNA carryover in any of the zero-volume 
injections performed. However, the use of a DNA intercalating dye and detection 
by fluorescence revealed DNA carryover in the initial zero-volume injection, 
ranging from approx. 35pg - 125pg. Four subsequent zero-volume injections 
yielded approx. 17pg, 14pg, 9pg and 8pg, respectively, as determined by 
extrapolating data from a fluorescence quantitiation standard curve determined 
from DNA quantities ranging from 0.625ng - 200ng (R2 = 0.995) (Chapter 3). 
 Eluent captured from the zero volume injections was evaporated by 
vaccum centrifugation and resuspended in 10µL of ddH2O, followed by dye-
terminator labeling of 2µL of the resuspended product. The dye-terminator 
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sequencing reactions from the captured time period yielded no detectable 
sequence (data not shown). It is worth noting, that although injection-to-
injection carryover was seen in the current study, the amount of DNA injected 
onto the DNASep® column (550ng) was significantly higher than the quantity of 
amplified mtDNA from reference samples which typically range from 50ng - 
200ng. When sample quantities are in this more casework-realistic range, no 
injection-to-injection carryover is observed by UV or fluorescence detection.  
In routine DHPLC analysis of over 30000 injections of research and 
forensic validation samples, evidence of cross contamination between injected 
samples was not observed. Only in the case of column saturation, as reported 
above, has there been identifiable column carryover between repeat injections. 
In an effort to completely eliminate any potential for injection cross 
contamination, following injections of large quantities of PCR products, the 
column can be washed with 75% acetonitrile for 10-15min. This removes any 
spurious amplification products that might remain in the system.  
Per the recommendation of the manufacturer (Transgenomic, Inc.) 
columns were regularly inspected for integrity of the column matrix by injecting a 
set of calibration standards. This ensures also that the oven, which the column is 
housed in, is performing according to manufacturers’ specifications. Regularly 
each column was purged of additional amplification materials (i.e., polymerase) 
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which bind to the anterior side of the column. This was done by reversing the 
column within the flow path and purging it with 100% ACN at 70°C. 
§ 8 - 3.2 Amplification reproducibility 
In an effort to demonstrate the reproducibility of DNA analysis by DHPLC, 
ten replicates of all four forensically relevant mtDNA amplicons were amplified 
using previously validated protocols. The resulting PCR products were cross-
hybridized at equal contributor ratios, and sequentially assayed under partially 
denaturing conditions by DHPLC. The resulting data indicate that DHPLC 
resolution is highly reproducible for each of the tested amplicons. Both the 
maximum peak height (Figure 8.1) and retention time for each peak height 
maxima (Figure 8.2) were determined for the four forensically relevant 
amplicons. Assay-to-assay variability was found to be negligible among 
independent amplification reactions as evidenced by the small standard 
deviations for each peak among the replicates. Variability as determined by peak 
retention time for the 10 replicate amplification reactions ranged from ±0.2 to 
±0.8%. Variability as determined by peak height across all replicate amplification 
reactions ranged from ±3.1 to ±14.1%. Differences in maximum peak height may, 
however, be attributed to variables other than DHPLC, such as the efficiency of 
the amplification reaction itself. 
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Figure 8.1: Peak heights (Mean ± SD) determined from chromatographic traces of 
representative 50:50 mixtures across all four forensically relevant amplicons 
under partially denaturing conditions. The results demonstrate the low level of 
assay-to-assay variability among ten independently replicated amplification 
reactions sequentially assayed by DHPLC. 
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Figure 8.2: Retention times (Mean ± SD) determined from chromatographic 
traces of representative 50:50 mixtures across all four forensically relevant 
amplicons under partially denaturing conditions. The results demonstrate the 
low level of assay-to-assay variability among ten independently replicated 
amplification reactions sequentially assayed by DHPLC.   
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§ 8 - 3.3 Injection-to-injection reproducibility 
To demonstrate the reproducibility of DHPLC for independent injections 
of identical DNA samples, four forensically relevant mtDNA amplicons were 
amplified (HV1A, HV1B, HV2A and HV2B). The resulting products were cross-
hybridized at equal contributor ratios, and sequentially injected ten times under 
partially denaturing conditions by DHPLC. The resulting data indicate that 
sequential injections of cross-hybridized products are highly reproducible for 
each of the forensically relevant amplicons. Maximum peak heights (Figure 8.3) 
and peak retention times (Figure 8.4) were determined for each of the four 
amplicons. Assay-to-assay variability was found to be negligible among 
independent amplification reactions as evidenced by the small standard 
deviations for each peak among the replicates. Variability as determined by peak 
retention time for the 10 replicate amplification reactions ranged from ±0.1 to 
±2.4%. Variability as determined by peak height across all replicate amplification 
reactions ranged from ±0.2 to ±1.8%. 
§ 8 - 3.4 Column-to-column reproducibility 
Reproducibility of DHPLC across multiple DHPLC DNASep® columns was 
determined using ten two-component cross-hybridized mixtures. The mixtures 
were sequentially injected onto ten different DNASep® columns and analyzed 
under partially denaturing conditions. The results show that DHPLC assay results 
are highly reproducible even when comparing across multiple DNASep® columns.  
229 
 
Figure 8.3: Peak heights (Mean ± SD) determined from chromatographic traces of 
representative 50:50 mixtures across all four forensically relevant amplicons 
under partially denaturing conditions. The results demonstrate the low level of 
assay-to-assay variability among ten replicate injections of a single amplification 
reaction assayed sequentially by DHPLC. 
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Figure 8.4: Retention times (Mean ± SD) determined from chromatographic 
traces of representative 50:50 mixtures across all four forensically relevant 
amplicons under partially denaturing conditions. The results demonstrate the 
low level of assay-to-assay variability among ten replicate injections of a single 
amplification reaction assayed sequentially by DHPLC.  
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Variability as determined by peak retention time for the replicate injections onto 
10 individual DNASep® columns ranged from ±10.4 to ±23.5%. Although column-
to-column retention times are relatively large compared to amplification and 
injection reproducibility, variability determined by comparison of relative 
retention times of each peak to any other peak detected in the mixture, was 
significantly smaller (Figure 8.5). Variability as determined by relative retention 
times of each peak to any other peak detected in the mixture ranged from ±1.5 
to ±8.4%. Fluctuations in peak height absorbance were minimal although, in one 
case, the observed baseline was slightly above the mean for the other nine 
columns (data not shown). This was most likely an artifact of equilibration time 
as it disappeared with additional injections onto the column. 
The DNASep® column is guaranteed by the manufacturer to last 6000 
injections and can be routinely checked for peak resolution integrity. Qualitative 
assessment of DNASep® column integrity and resolution capabilities is performed 
by routine injection of column integrity standards. A number of compounds are 
known to have detrimental effects on DNASep® column performance. These 
include, but are not limited to bovine serum albumin (BSA), mineral oil, 
formamide, polyethylene glycol (PEG), glycerol, DMSO and a variety of 
detergents. Degradation of the column matrix can also occur as a result of 
improper storage, such as not storing it in 75% acetonitrile or letting the column  
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Figure 8.5: Average peak-to-peak spacing (Mean ± SD) determined from 
chromatographic traces of representative 50:50 mixtures across the two HV2 
forensically relevant amplicons assayed on ten independent DNAsep® columns 
under partially denaturing conditions. The results demonstrate that when 
normalized on the basis of relative peak-to-peak retention times, column-to-
column variability is minimized. 
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run dry. Degradation is observed by decreased resolution of standards peaks, 
given that oven temperatures are accurate. 
§ 8 - 3.5 Negative and Reagent Blank Control Screening 
Due to excessive time and sample handling cost associated with the 
sequencing of negative controls and reagent blanks in mtDNA casework analysis, 
HPLC represents an attractive alternative for the analysis of negative and reagent 
blank controls. UV and fluorescence detection limits using the DNASep® column 
have previously been determined and validated (Chapter 3, automated peak 
detection using the DHPLC Navigator™ Software: UV = 1.85±0.56ng; fluorescence 
= 30.9±1.4pg, manual peak detection: UV = approx. 0.5ng; fluorescence = <10pg). 
HPLC detection of the minimum amount of mtDNA amplicon required by dye-
terminator sequencing was carried out by serial dilutions of purified HV2A 
mtDNA fragments at quantities frequently encountered by forensic practitioners. 
Replicate fragment quantities of 32.5pg, 62.5pg, 0.125ng, 0.25ng, 0.5ng, 1ng and 
2ng were sequentially injected in triplicate onto the DNASep® column and 
analyzed using non-denaturing conditions. Injected amplicon quantities lower 
than 0.5ng showed no detectable deviation from baseline as observed by UV 
absorbance for any of the replicate injections (Figure 8.6). The slight absorbance 
increase observed over time in the UV baseline is a function of increase in 
acetonitrile concentration as the gradient gradually shifts from low to high 
concentrations of acetonitrile. All injected quantities of amplicon onto the  
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Figure 8.6: Representative layered chromatogram showing the lower limits of UV 
detection of a serially diluted DNA sample injected onto a DNASep® column. 
Injected amplicon quantities lower than 0.5ng showed no detectable deviation 
from baseline. 
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DNASep® column were detected by DNA intercalating-dye fluorescence 
detection (data not shown), consistent with results obtained for the cross-
contamination study described above and results obtained in Chapter 3. All 
injected samples were also subjected to dye-terminator sequencing analysis for 
correlation purposes. Samples labeled with 2µL of 0.0125ng/µL (corresponding 
to the 62.5pg HPLC injection of 5µL of the same sample) repeatedly failed to 
yield any detectable sequence data (using 30sec dye-terminator sample injection 
times).  
Based on these data, analysis of negative and reagent blank controls by 
HPLC can, therefore, be performed using fluorescence detection and the HSX 
inline accessory due to the superior detection capabilities. Given that quantities 
of amplificed product in a negative or reagent blank control don’t exceed the 
0.0125ng/µL needed to successfully obtain a detectable sequence there is no 
need to waste valuable time and reagents in confirming the absence of 
sequencing data. 
§ 8 - 4 Summary 
Denaturing High-Performance Liquid Chromatography (DHPLC) was 
validated as a tool for casework analysis of mtDNA amplicons. The WAVE® 
3500HT DNA Fragment Analysis System in combination with the DNASep® 
column was evaluated based on its reliability, sensitivity and consistency of 
236 
 
analysis of cross-hybridized PCR products. Using subcloned mtDNA fragments, 
the WAVE® 3500HT DNA Fragment Analysis System was tested for run-to-run 
sample cross-contamination as detected by UV and fluorescence detection 
methods. Only at DNASep® column saturation was cross-contamination detected 
by high sensitivity fluorescence detection. Capture of run-to-run carryover 
products, however, yielded DNA quantities below that required for dye-
terminator sequencing. Repeated amplification, injection-to-injection and 
column-to-column reproducibility were also determined by serial injections of 
mtDNA amplicons. Variability in peak height and peak retention times was 
negligible as evidenced by the small standard deviations recorded. Column-to-
column variability was slightly higher, although comparison of relative retention 
times of each peak to any other peak detected in the mixture was negligible.  
HPLC screening of negative and reagent blank controls, routinely used in 
casework analysis, was evaluated as a means for reducing dye-terminator 
sequencing load in a forensic context. Negative or reagent blank controls yielding 
less than 0.0125ng/µL were confirmed as not yielding a detectable sequence 
data. 
The results of this study demonstrate that the combination of WAVE® 
3500HT DNA Fragment Analysis System and DNASep® column provides a 
platform for consistent and reliable analysis of cross-hybridized PCR products 
with unparalleled detection sensitivity. Additionally, the use of WAVE® 3500HT 
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DNA Fragment Analysis System and DNASep® column streamlines mtDNA 
analysis by combining sample purification, quantification and length-
characterization into a single step. 
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Chapter 9: Streamlining Mitochondrial DNA Sequencing 
Analysis for Forensic Casework Samples 
§ 9 - 1 Introduction 
In recent years, the number of forensic evidentiary samples that are 
submitted for DNA analysis have increased dramatically. This is in part due to 
significant increase in knowledge of DNA capabilities in the law enforcement 
community and general acceptance of DNA evidence in court. Forensic scientists 
have, therefore, focused significant effort on not only developing new methods 
for retrieving and analyzing DNA evidence (e.g., low copy number (LCN), severely 
degraded remains), but also streamline and enhance methods already in use by 
the forensic community. This has resulted in significant advances in automated 
robotics, sample handling methods and data analysis. 
When traditional short tandem repeat (STR) DNA analyses fail, 
mitochondrial DNA (mtDNA) sequence analysis may provide investigators with 
useful information. This can help to advance criminal investigations (Allen et al., 
1994; Allen et al., 1998) or give emotional closure to families by identifying the 
remains of loved ones (Holland et al., 1993). Mitochondrial sequence analyses, 
however, do have limitations. Due to its strict maternal inheritance, lack of 
recombination and inability to identify single individuals, mtDNA analysis cannot 
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offer the kind of discrimination power that is seen when STR data are obtained. 
Furthermore, mixtures of mtDNA are frequently observed. These mixtures can 
exist within a single individual (i.e., heteroplasmy) or as situational mixtures. This 
negatively impacts the value of mtDNA sequence analysis in two ways. First, it 
lowers the power of discrimination because mixed nucleotide positions must 
either be excluded from the reported results (e.g., length heteroplasmy) or used 
in calculations of the number of possible haplotypes represented by the 
sequence data. Second, the observation of a mixture in the resulting sequence 
data is most typically reported as uninterpretible. A means of accurately and 
readily resolving mixtures in a forensic context would have important 
ramifications for the forensic community by allowing otherwise uninterpretible 
samples to be analyzed. 
§ 9 - 2 The Process of Mitochondrial DNA Analysis 
§ 9 - 2.1 DNA Extraction and Amplification 
The labor intensive manner of DNA extraction by Chelex™ or Phenol 
Chloroform has prompted the development of faster robotic platforms. The 
BioRobot EZ1 DNA extraction robot (Qiagen Inc., Valencia, CA), presents small to 
medium size forensic laboratories with a new, easy to use platform that allows 1-
6 samples to be extracted simultaneously in about 15 minutes. Each sample uses 
a dedicated extraction channel, pipette tip and extraction cartridge as to 
minimize the potential for cross-contamination. This significantly cuts down 
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dedicated analyst time and yields DNA of significantly higher purity than existing 
traditional methods (Montpetit et al., 2005). 
Traditional mtDNA analysis of forensic evidence employs the 
amplification of the mitochondrial control region (D-loop). Due to significant 
degradation of genetic material observed when mtDNA sequencing analysis are 
performed, this is generally achieved in four separate amplification reactions, 
each amplifying a small segment of the control region (i.e., HV1A, HV1B, HV2A 
and HV2B) (Wilson et al., 1995). When amplification of these fragments fail, the 
analyst can further shorten the amplification target by employing a “mini-
primer” set (Gabriel et al., 2001b). These targets divide the traditional amplicons 
into two fragments each, possibly yielding results for severely degraded 
evidentiary material. 
§ 9 - 2.2 Purification and Yield Determination of Amplified PCR 
Products 
Following amplification, a host of methods exist for purifying amplified 
PCR products. In forensic mtDNA laboratories this is typically accomplished by 
use of spin column purification or nuclease/alkaline phosphatase treatment, 
(e.g., ExoSAP-IT®) (Werle et al., 1994; Dugan et al., 2002). While these methods 
are effective at removing small DNA fragments, such as primers, they are less 
efficient at removing larger spurious amplification products. In addition, these 
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methods have the limitation that they cannot distinguish between target PCR 
amplicons and similar size spurious amplification products. 
PCR amplification yield can be quantified by a number of approaches 
including UV spectroscopy, gel electrophoresis, or microchip capillary 
electrophoresis, all of which have a number of shortcomings. UV spectroscopy 
cannot distinguish between an amplified target and residual primers or spurious 
PCR amplification products resulting in the overestimation of the actual amount 
of amplified target DNA. Agarose “yield gels”, are moderately labor intensive and 
require crude comparisons of samples to a quantification ladder. Capillary 
electrophoresis systems offers greater accuracy and precision but requires more 
sample handling steps, investment in expensive dedicated equipment and higher 
consumable costs per sample. 
Purification of DNA fragments by High Performance Liquid 
Chromatography (HPLC) produces suitably purified target amplicons for use in 
labeling reactions for DNA sequencing. Additionally, the height and area of DNA 
fragment peaks on a chromatographic trace is a function of the quantity of DNA 
detected. The use of HPLC, therefore, allows for combination of purification and 
quantification into a single step. This effectively eliminates the need for yield gels 
or other quantification methods, while also yielding information about the 
presence and quantity of spurious co-amplified products (Chapter 3). 
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In addition, HPLC can effectively be used to determine contamination 
levels in negative control and reagent blank samples. Due to the sensitivity of 
fluorescence detection based on the use of a DNA intercalating dye, picogram 
quantities of amplified DNA can be detected. This can eliminate the need for 
downstream sequencing analysis of negative controls and reagent blanks, 
thereby, saving valuable time and money on samples which most of the time 
yield no sequencing results at all. 
§ 9 - 2.3 Mitochondrial DNA Characterization 
To date, no method for mtDNA characterization (i.e., the presence of 
heteroplasmy or multi-contributor mixture), prior to dye-terminator sequencing, 
has been validated for use in the forensic community. A variety of methods have 
been investigated, such as hybridization to linear arrays of sequence-specific 
oligonucleotides (SSO) (Reynolds et al., 2000; Gabriel et al., 2001a); denaturing 
gradient gel electrophoresis (DGGE) (Hanekamp et al., 1996); single-strand 
conformational polymorphism (SSCP) analysis (Alonso et al., 1996; Barros et al., 
1997; Steighner et al., 1999); time-of-flight mass spectrometry (Butler et al., 
2001); and microarray-based analysis (Fukushima, 1999). These approaches, 
suffer from a number of limitations which include: the interrogation of only a 
subset of variant sites; cross-hybridization to non-target sequences; laborious 
manipulations of gels (Meyers et al., 1988; Reynolds et al., 2000); and 
interference by primer impurities (Butler et al., 2001). Most critically, however, 
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these approaches suffer from the fact that they consume often precious forensic 
evidence while not necessarily providing a reliably comprehensive assessment of 
all possible sequence differences across the entire amplicon. 
Denaturing HPLC (DHPLC) circumvents these limitations while offering the 
potential to characterize mtDNA amplicons in an accurate, rapid and cost-
effective manner that can be easily automated. Moreover, DHPLC makes it 
possible to recover the assayed DNA from the column eluent at the end of an 
assay. The accuracy and sensitivity with which sequence variants can be detected 
by DHPLC can be significantly influenced by the length, GC content and other 
thermodynamic characteristics of the amplicon being assayed (Chapter 2). Using 
carefully designed assay conditions the concordance between direct DNA 
sequencing and comparative sequence analysis by DHPLC typically ranges from 
95-100%. In some cases, DHPLC has proven to have greater sensitivity than direct 
DNA sequencing for the detection of minor component sequence variants. 
Mitochondrial DNA characterization allows for determination of sample 
complexity prior to costly dye terminator sequencing and time consuming 
analysis. The analyst can, therefore, gain valuable information on whether a 
sample contains base heteroplasmy, or worse yet, is a mixture of two or more 
contributors. In addition to characterization, and in cases where samples contain 
mtDNA from more than one source, the analyst can divide the mixture into a 
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series of fractions in an attempt to separate individual contributors. The isolated 
fractions can then be subjected to direct dye-terminator sequencing analysis 
without the need to re-amplify the captured PCR product. 
§ 9 - 2.4 Sequencing Analysis 
§ 9 - 2.4.1 Single Contributor mtDNA Analysis 
The profiling of human mtDNA is achieved by comparison of DNA 
sequence data to the revised Cambridge Reference Sequence (rCRS) (Anderson 
et al., 1981; Andrews et al., 1999). Differences are noted and reported by 
indicating the nucleotide position and the identity of the altered base. In cases of 
heteroplasmy, a base is indicated either as the combination of the two mixed 
bases (e.g., a mixture of nucleotides “A” and “G”, is reported as “R”), or as 
undetermined (“N”). 
§ 9 - 2.4.2 Mitochondrial DNA Mixture Analysis 
Samples considered true mixtures by forensic interpretation standards 
are those which display mixed nucleotides at two or more positions. In forensic 
mtDNA analysis, mixed nucleotide positions are generally labeled undetermined 
(“N”), eliminating the nucleotide from the overall analysis. This can prevent an 
analyst from being able to determine the true level of discrimination between 
sequences that are thought to “match” (Fourney, 1998). Although strategies for 
separating mtDNA mixtures have been proposed (Alonso et al., 1996; Hanekamp 
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et al., 1996; Hatsch et al., 2007), all display significant obstacles for 
implementation by forensic laboratories. 
Denaturing HPLC in combination with Linkage Phase Analysis (LPA) allow 
for separation and statistical analysis of mtDNA mixtures in a manner that 
circumvents the limitations of alternative methods. The sensitivity of DHPLC for 
identification and fractionation of non-identical samples and the capability of LPA 
to analyze peak height ratio changes of mixed nucleotides from multiple 
sequencing electropherograms allow for the identification of individual 
contributors to a mixture. Depending on the shift in peak height ratio between 
electropherograms obtained from different fractions, identification of individual 
contributors to the mixture can be achieved with high degree of statistical 
significance (>99%) (Chapter 6). 
§ 9 - 2.4.3 Fractional Linkage Phase Analysis Resource Software 
(FLiPARS) 
Due to the time consuming and tedious nature of sequencing analysis a 
software application has been developed to streamline and speed identification 
of mixed nucleotides and LPA of mixed mtDNA samples. The software application 
initially aligns all imported sequence data to the revised Cambridge Reference 
Sequence (rCRS) using the Needleman-Wunsch global alignment algorithm 
(Needleman et al., 1970). It then scans each analyzed sequencing 
electropherogram, identifying all nucleotide positions which have a secondary 
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peak height above 10% of that of the major component consistent with existing 
interpretation standards for forensic laboratories. The identified nucleotide 
positions are consolidated into a table where the analyst can select which 
nucleotides are used for LPA. The two sequencing electropherograms which yield 
the greatest shift in peak height fluorescence across all mixed nucleotides 
positions are then used to: calculate the shift in peak height fluorescence for 
each mixed positions; determine the confidence of separation based on the shift 
in peak height fluorescence; and identify the two contributors to the mixture. In 
addition to this, the user interface displays the number of data points behind the 
statistical determination performed. Furthermore, confidence of separation is 
indicated for each base next to the confidence and base determination tables. A 
green indicator reveals ≥17% shift in peak height fluorescence and ≥99.9% 
confidence in separation. A yellow indicator reveals ≥6% shift in peak height 
fluorescence and ≥99% confidence in separation, while a red indicator reveals 
<6% shift in peak height fluorescence and <99% confidence in separation. 
The software application has been tested on 43 blind samples using 
results obtained during the manually analyzed validation studies of LPA (Chapter 
6). Figure 9.1 illustrates results obtained using the manual calculation method 
(Figure 9.1A) and FLiPARS (Figure 9.1B) for a HV2A mtDNA mixture with 8 mixed 
nucleotides. For all eight mixed positions, fluorescence ratio shift comparison for 
fractions 7 and 11 are identical, resulting in consistent determination of  
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Figure 9.1: Linkage phase analysis results obtained for a two-component HV2A 
mtDNA mixture containing eight mixed nucleotide positions. (A) LPA performed 
using a manual calculation method. (B) LPA performed using an automated 
software application method (FLiPARS). Comparison of linkage phase results 
yields no differences between the two methods used and complete concordance 
in the contributor haplotypes identified. 
 
  
248 
 
contributor nucleotides and associated confidence of separation. In all mtDNA 
mixtures analyzed by LPA to date, 100% concordance exists between results 
analyzed manually and those analyzed by FLiPARS (Table 9.1). 
This being said, subtle differences do exists in determinations of linkage 
phase between the manual calculation and those analyzed using FLiPARS. These 
exist purely as programming issues, the potential significance of which is not 
entirely known. Briefly though, sequencing of mixed templates yields two 
overlapping peaks at mixed-base positions which typically overlap completely. In 
some cases, however, the minor component peak is shifted slightly up- or 
downstream of the maximum fluorescence peak of the major component. 
FLiPARS compensates for this variability by analyzing ±3 data points (±9.28sec) 
away from the maximum fluorescence of the major component, in attempt to 
determine the maximum peak height for the minor component. However, if the 
minor component peak height maximum falls outside this window, the minor 
components true peak height will be underestimated. As the shift in minor 
component peak increases the larger the underestimation in peak height ratio. 
Any future modifications to the software will have to address this issue, by either 
allowing the user to manually widen the peak crest scanning range or by 
developing an algorithm which detects shifts in secondary component peaks and 
modifies the peak crest scanning range accordingly. 
 
249 
 
Table 9.1: Comparison of LPA for 47 simulated casework samples using the 
manual linkage phase determination and FLiPARS. Deviation in mixture 
separation confidence shows minimal differences between the two analysis 
methods. 
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In addition to the essential modification to the detection of shifted peak 
crests, the ability to view sequencing electropherograms and modify miscalled 
nucleotides would be a welcomed addition to FLiPARS. This would eliminate the 
need for secondary electropherogram viewing/editing applications such as 
Sequencher™ (Gene Codes Corp, Ann Arbor, MI) or Lasergene® (DNASTAR, Inc., 
Madison, WI) and significantly speed analysis of mtDNA mixtures. Finally, the 
ability to compare sequence quality, based on optimal intensity ratio (Chapter 4) 
relative to a pristine reference electropherogram, would allow for a quick quality 
control assessment of questioned electropherograms. 
§ 9 - 2.5 Streamlining of mtDNA Analysis 
Obtaining an mtDNA haplotype from forensic samples is a very labor 
intensive process which requires multiple handling steps (Figure 9.2). Currently, 
mtDNA analyses require that an analyst use separate methods for PCR product 
purification and quantification. Determination of low level amplification in 
negative controls and reagent blanks currently cannot be obtained until results 
from dye-terminator sequencing are analyzed. Determination of whether a 
sample contains multiple starting templates or is site or length heteroplasmic is 
currently not possible until dye-terminator sequencing analyses are performed. 
Furthermore, low level mixtures can go unnoticed or misinterpreted as being 
heteroplasmic due to differential incorporation of dye-terminators. All of these  
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Figure 9.2: Sample process flow for traditional mtDNA dye-terminator 
sequencing based analysis. Two different techniques are used for sample 
purification and quantification. Currently no method is available for detecting the 
presence of mixed templates, screening negative controls and reagent blanks or 
identifying the haplotypes of individual contributors to mtDNA mixtures. 
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factors have prompted the development and implementation of mtDNA analysis 
by DHPLC for forensic samples. 
Analysis of mtDNA amplicons using the demonstrated diversity of DHPLC 
applications streamlines the overall process of PCR product purification, 
quantification and allows for mixture detection prior to dye-terminator 
seuqencing (Figure 9.3). DHPLC yields highly purified amplicons, free of spurious 
amplification products while simultaneously providing information on the 
amplification yield quantity. Determination of mixed templates has traditionally 
required dye-terminator labeling and subsequent sequencing, however, DHPLC 
analysis yields immediate information on sample complexity without the need 
for further sample manipulation. DHPLC also adds mixture fractionation 
capabilities, which in conjunction with LPA allows for mtDNA mixture separation 
and contributor identification. Mitochondrial DNA analyses by DHPLC require 
only minor modifications to standard operating procedures currently employed 
in forensic caseworking laboratories. All DHPLC instrument components and 
applications have been validated in accordance with SWGDAM developmental 
validation guidelines (SWGDAM, 2004). These factors are essential in 
implementing DHPLC analysis in a forensic casework environment and for the 
admissibility of DHPLC and LPA in court. 
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Figure 9.3:  Sample process flow for mtDNA sequence analysis using DHPLC, dye-
terminator sequencing and LPA. DHPLC analyses are used for sample purification 
and quantification in a single step. DHPLC analyses are also used for mixture 
identification/fractionation and to screen negative controls and reagent blanks. 
LPA is used to determine the linkage phase (i.e., the haplotypes) of the individual 
contributors to mtDNA mixtures and to calculate the statistical confidence of 
mixture resolution for each base position.  
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Appendices 
 
Appendix A  
Sequence polymorphisms in HV1 for the 99 samples collected and used in this 
study as compared to the revised Cambridge Reference Sequence (rCRS). 
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Sequence polymorphisms in HV2 for the 99 samples collected and used in this 
study as compared to the revised Cambridge Reference Sequence (rCRS). 
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Appendix B 
 
Reproducibility of electrophoretic peak heights for the mtDNA HV1A amplicon 
sequenced with the A1 primer (Table 2.1) . The data represent the mean peak 
heights ± standard deviations from five independent labeling reactions for each 
of five DNA input quantities. 
 
 
Reproducibility of electrophoretic peak heights for the mtDNA HV1A amplicon 
sequenced with the B2 primer (Table 2.1) . The data represent the mean peak 
heights ± standard deviations from five independent labeling reactions for each 
of five DNA input quantities. 
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 Reproducibility of electrophoretic peak heights for the mtDNA HV1B amplicon 
sequenced with the B1 primer (Table 2.1) . The data represent the mean peak 
heights ± standard deviations from five independent labeling reactions for each 
of five DNA input quantities. 
 
 
Reproducibility of electrophoretic peak heights for the mtDNA HV1B amplicon 
sequenced with the A2 primer (Table 2.1) . The data represent the mean peak 
heights ± standard deviations from five independent labeling reactions for each 
of five DNA input quantities. 
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Reproducibility of electrophoretic peak heights for the mtDNA HV2A amplicon 
sequenced with the C1 primer (Table 2.1) . The data represent the mean peak 
heights ± standard deviations from five independent labeling reactions for each 
of five DNA input quantities. 
 
 
Reproducibility of electrophoretic peak heights for the mtDNA HV2A amplicon 
sequenced with the D2 primer (Table 2.1) . The data represent the mean peak 
heights ± standard deviations from five independent labeling reactions for each 
of five DNA input quantities. 
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Reproducibility of electrophoretic peak heights for the mtDNA HV2B amplicon 
sequenced with the D1 primer (Table 2.1) . The data represent the mean peak 
heights ± standard deviations from five independent labeling reactions for each 
of five DNA input quantities. 
 
 
Reproducibility of electrophoretic peak heights for the mtDNA HV2B amplicon 
sequenced with the C2 primer (Table 2.1) . The data represent the mean peak 
heights ± standard deviations from five independent labeling reactions for each 
of five DNA input quantities. 
